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Thesis Abstract
In the developing nervous system the modelling of axons and their growth cones is 
dependent on the dynamic regulation of the Rho family of GTPases, which play a crucial 
role in the regulation of the actin cytoskeleton. The guidance cues controlling axon path 
finding, either repulsive or attractive, require the Rho GTPases to effect changes in 
morphology. The signalling pathways linking the guidance molecules, and their receptors, 
to the Rho family GTPases remain unclear.
Collapsin Response Mediator Protein-2 (CRMP-2) is a neurospecific protein involved in 
axonal outgrowth and the semaphorinSA collapse pathway. CRMP-2 is also a Rho kinase 
substrate, suggesting an involvement with the Rho GTPases. To investigate this, CRMP-2 
was co-expressed in the neuroblastoma cell line, NIE-115, with active and inactive 
GTPase mutants. Cells expressing dominant active Racl and CRMP-2 became contracted, 
normally a RhoA effect, while co-expression of dominant active RhoA and CRMP-2 
resulted in a phenotype typically associated with Racl signalling.
CRMP-2 could bind directly to RhoA and Racl, and, to a much lesser extent, Cdc42 in an 
overlay assay. In vivo CRMP-2 associated with active RhoA, but immunoprecipitated with 
active and inactive Racl mutants.
CdkS inhibitors, but not Rho-kinase inhibitors blocked semaphorinSA-induced collapse in 
dorsal root ganglion neurones and NlE-115. Mutation of the Cdk5 phosphorylation site in 
CRMP-2 also inhibited semaSA collapse, suggesting a specific role of Cdk5 and CRMP-2 
in the semaphorinSA growth cone collapse pathway.
These results show CRMP-2 can switch RhoA and Racl, and may link the guidance cues 
to the Rho-GTPases, which define growth cone morphology through their regulation of the 
actin cytoskeleton. Downstream of semaSA, CRMP-2 plays a crucial role in growth cone 
collapse, in a pathway involving Cdk5, and possibly phosphorylation at serine 522.
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Chapter 1 Introduction
1.1 The Actin Cytoskeleton
Actins, and actin filaments, form a crucial component of the cytoskeleton, allowing 
cells to maintain or change morphology and to migrate in response to environmental 
factors. They are very abundant proteins in most cells, often consisting of 5% or more 
of total cell protein. The actin in mammalian tissues is divided into 3 different classes; 
a-actin, which is found in various types of muscle tissue, while p and y-actin are non­
muscle actins.
1.1.1 Actin
Actin exists in two forms, G-actin and F-actin. G-actin, or globular actin, consists of 
the monomer actin units, each a single peptide of 375 amino acids. When these 
monomers polymerise they form filamentous actin, or F-actin, in a process requiring 
ATP. Each monomer binds a single ATP molecule that is hydrolysed to ADP when 
the monomers polymerise (Figure 1). The ADP is trapped in the actin monomer once 
it is incorporated into the filament. However when the monomer is removed during 
depolymerisation, the ADP is removed and replaced with ATP, ready for re­
incorporation.
o o o o
y  O  Oo
Figure 1.1 Assembly of actin monomers into filaments, and hydrolysis of ATP.
Actin monomer
^  Inorganic 
phophate
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The two ends of F-actin filaments have different polymerising properties. The barbed 
end polymerises up to 10 times faster than the pointed end. Due to the different 
polymerisation abilities of the different ends, each has a different critical 
concentration for polymerisation (Kd). This is the concentration of monomers 
required to induce spontaneous polymerisation in vitro. Under physiological salt 
conditions the Kd for the barbed end is 0.1 pM, and 0.6pM for the pointed end 
(reviewed in Pollard, 1999). At a monomer concentration between the two Kd, there 
is a net polymerisation at the barbed end, and a net loss at the pointed end. When 
these two reactions proceed at an identical rate, the actin filament undergoes a process 
called treadmilling. Here, although there is a net influx of actin monomers, the 
filament does not change in length.
Figure 1.2. Diagram of actin treadmilling.
The elongation of actin filaments is a balance between the available actin monomers 
and the exposed ends of actin filaments. Regulation of polymerisation can be 
achieved by regulating the availability of either component.
19
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1.1.2 Formation of new actin filaments
Spontaneous formation of actin filaments from actin monomers is an unfavourable 
reaction because of the instability of the dimers and trimers. Although actin 
monomers have been shown to polymerise in vitro under physiological salt 
conditions, this is a slow reaction.
In vivo, the formation of new actin filaments from actin monomers, termed 
nucléation, is regulated by accessory proteins, which either promote or inhibit the 
process. Some of the best studied accessory proteins are those in the Arp2/3 complex. 
The Arp2/3 complex consists of 7 subunits, Actin-related proteins (ARP) 2 and 3, and 
five novel proteins, p40, p35, pl9, p i8 and pl4. Proteins in the Arp2/3 complex are 
very abundant, and highly conserved (Kelleher et al, 1995; Welch et al, 1997). Once 
activated by the WASP/scar proteins (see section 1.1.4), Arp2/3 binds directly to actin 
monomers, allowing barbed ends to become exposed, and hence the nucléation of new 
actin filaments (Rohatgi et al, 1999).
After nucléation, the Arp2/3 is incorporated into the new filament network (Yarar et 
al, 1999), allowing the addition of new filaments onto the side of the first filament. 
Consequently, Arp2/3 enables the anchoring of end-to-side branches, which takes 
place during nucléation (Blanchoin et al, 2000). These side branches are formed at 70° 
angle from the main branch (Mullins et al, 1998), which can also be seen in the actin 
structures at the leading edge of membrane protrusions, where the actin forms 
filaments at 70° from the side filaments. In addition to being able to nucleate the 
formation of new filaments, Arp2/3 can also bind to existing filaments, and serve as 
an additional nucléation site on the side of filaments. This is another way by which
20
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Arp2/3 can allow side branches to form and permit cross-linking between actin 
filaments. The formation of filopodia involves different processes because they 
consist of parallel bundles of actin filaments, which are held together by cross-linking 
proteins, such as fimbrin (Matsudaira et al, 1983). There are no cross-linking or side 
actin filament branches in these structures, although the Arp2/3 complex still appears 
to play a role (Goldberg et al, 2000; Vignjevic et al, 2003).
1.1.3 Regulation of the actin monomer pool
Many cell types can contain cellular concentrations of actin monomers of around 
lOOpM (Pollard, 1999). However, in vitro, these monomers would spontaneously 
polymerise, until a concentration of 0.1 pM, the Kd for the barbed end, was reached. 
Therefore cells have developed methods to maintain these high concentration actin 
monomer pools.
The two main actin monomer binding proteins in vertebrate cells are thymosin-p4 and 
profilin. Thymosin-p4, a small protein of 42 residues, sequesters actin monomers 
(Safer et al, 1994), and has a 50 fold higher affinity for ATP-actin than for ADP-actin 
(Carlier et al, 1993; Pantaloni et al, 1993). Once bound to thymosin-p4, the actin 
monomers cannot polymerise and so thymosin-p4 is thought to play an important role 
in maintaining the high concentration of actin monomers present in many cells types. 
Thymosin-p4 competes for the actin monomers with profilin, the only actin monomer 
binding protein present in lower organisms, such as protozoa and fungi. Profilin binds 
to actin monomers and transports them to the barbed filament ends, to allow 
polymerisation (Pantaloni et al, 1993). Profilin also facilitates the exchange of ADP 
for ATP in released monomers, allowing them to be returned to the actin monomer
21
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pool. ATP-actin is exchanged between thymosin-p4 and profilin to regulate actin 
filament elongation. The concentration of the proteins, and their affinity for the actin 
monomers determines how much actin is available for elongation.
Profilin is important in maintaining an available pool of ATP-actin ready to elongate 
fi*ee barbed ends. However, if all the actin filaments in a cell had fi*ee barbed ends, 
elongation would soon deplete the available pool of ATP-actin monomers. Therefore 
many of the barbed ends are capped by capping protein or gelsolin (Schafer et al,
1996). These proteins bind to the barbed end to prevent addition of new actin 
monomers. As a result, the concentration of fi*ee barbed ends is maintained low. 
Therefore, the combination of thymosin-p4, profilin and capping protein/gelsolin 
enable cells to regulate the actin monomer pool.
1.1.4 Signalling to the Arp2/3 complex
Many external stimuli, such as growth factors and growth cone guidance cues, are 
able to influence actin polymerisation by activating the Arp2/3 complex and drive 
actin filament elongation. There are many signal transduction pathways that can affect 
actin regulation, but many are thought to converge on the WASP proteins. These 
proteins transduce signals carried fi*om the Rho family GTPsaes, Rac and Cdc42 
(Machesky et al, 1999), as well as binding to receptor tyrosine kinases, such as PDGF 
and EGF receptors via the adaptor molecules Nek and Grb2.
WASP, the defective protein in Wiskott-Aldrich syndrome, is expressed in platelets 
and white blood cells (H. D. Ochs, 1998). N-WASP was originally isolated fi*om the
22
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brain and thought to be neurospecific (Miki et al, 1996), but has since shown to be 
ubiquitously expressed. A group of similar proteins, containing three members, has 
been identified and termed WAVE (Miki et al, 1998). The WASP and WAVE 
proteins share sequence similarity in the C-terminal, with all three containing an 
EVHl (Ena/VASP homology) domain, an Acidic (A) domain and a proline rich 
central region, which interacts with profilin or SH3 domains. The A domain consists 
of 30 conserved residues, and interacts with the p i9 subunit of the Arp2/3 complex 
(Machesky et al, 1998). EVH2, also 30 residues in length, binds to and prevents actin 
monomer addition to pointed ends, but not to barbed ends (Higgs et al, 1999). Both 
these domains are required for activation of the Arp2/3 complex. However the WASP 
and WAVE proteins differ in the N-terminal third, where WASP/N-WASP contain an 
EVHl domain, which interacts with proline rich targets such as WASP Interacting 
Protein (WIP), and a Cdc42/Rac interactive Binding domain, (CRIB), which binds to 
Cdc42. WAVE appears to have very few functionally recognised domains in the N- 
terminal. The WASP proteins also interact with, and are activated by P1P2 (Miki et al, 
1996;Rozelleetal, 2000).
WASP
N
N-WASP
WAVE
Figure 1.3. Domain structure of the three members of the WASP family.
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There is some strong evidence to point to these proteins as upstream Arp2/3 
activators. WASP and N-WASP bind Cdc42 and are required for Cdc42 induced actin 
polymerisation (Rohatgi et al, 1999; Yarar et al, 1999) and this Cdc42-induced 
polymerisation is dependent on the Arp2/3 complex (Ma et al, 1998).
1.1.5 The Ena/VASP proteins
The Ena/VASP proteins have also been shown to play an important role in the 
regulation of actin polymerisation. They are related to the WASP family, and contain 
a conserved EVHl domain (Ena/VASP homology) and proline rich domain. The 
EVHl region in the Ena/VASP proteins interacts with ligands such as vinculin and 
zyxin, and the poly-proline region interacts with similar targets to the WASP proteins, 
such as profilin and the SH3 domains of Abl, Lyn and Src (Lambrechts et al, 2000). 
Unlike the WASP proteins, Ena/VASP contain an EVH2 domain, which mediates 
tetramerisation of the protein and F-actin binding.
Ena/VASP co-localise with the Arp2/3 at the leading edge of membrane protrusions, 
as well as other areas of actin assembly such as focal adhesions, and have been shown 
to catalyse the elongation of newly formed actin filaments (Laurent et al, 1999). They 
recruit the actin monomers to the filaments via their interaction with profilin, and are 
then able to promote elongation via their interaction with the monomers and the 
filaments.
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1.1.6 Depolymerisation of actin filament
In order for cells to undergo morphology changes or migration, there must be a rapid 
turnover of the actin. ADF (actin depolymerisation factor) and cofilin promote the 
recycling of the actin from filaments (Carlier et al, 1988). Although these are two 
distinct proteins, their activities exert very similar effects on actin dynamics, and 
usually co-localise in cells.
They have been shown to enhance the actin dynamics in the actin comet tail in the 
endocytic bacteria Listeria monocytogenes (Rosenblatt et al, 1997), which polymerise 
the actin of their host cell to move around the cell, and between cells.
Figure 1.4. Listeria monocytogenes (green) 
forming actin tails (red) in a host cell. Image 
from Portnoy laboratory homepage. 
http://mcb.berkelev.edu/labs/portnov/
In addition ADF and cofilin have been shown to depolymerise pure actin filaments in 
vitro (Bamburg et al, 1980). There are two possible mechanisms for these proteins to 
cause depolymerisation. Firstly they may sever the filaments directly, and secondly, 
they may increase the subunit dissociation at either or both ends. Either method would 
result in the depolymerisation of the filament.
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The ability of ADF/cofilin to depolymerise actin filaments, allows them to co-operate 
with profilin to accelerate actin treadmilling, which is an important process during 
cell motility. Cofilin accelerates the removal of actin monomers firom the barbed end 
of the filament, because of its high affinity for ADP actin, and allows them to be 
recycled by profilin, which facilitates exchange of ADP for ATP, returning them to 
the pointed end for re-polymerisation (reviewed Pollard, 2003).
The ADF/cofilins can be regulated downstream of the Rho family GTPases, just like 
the Arp2/3. The downstream effector of Rac or Cdc42, p21 activated kinase (PAK), 
and the RhoA effector Rho kinase, both phosphorylate and activate LIM-kinase 
(Edwards et al, 1999; Ohashi et al, 2000; Sumiet al, 2001), which then phosphorylates 
cofilin (Yang et al, 1998; Maekawa et al, 1999). The result of this phosphorylation is 
a reduction in the affinity of cofilin for actin, and therefore stabilises the filaments.
The capping protein, gelsolin has been shown to sever actin filaments in response to 
Ca^  ^ ions. Once severed, the new barbed end is then capped by gelsolin to prevent 
elongation. Breaking up an actin network is an important process in a number of 
cellular processes. One example is the fusion of a phagosome with a lysosome 
following phagocytosis, which requires the breakdown of the dense actin network 
surrounding the phagosome.
1.1.7 Actin and the plasma membrane
In order to effect changes in cell morphology, or induce cell migration, the actin 
filaments must be able to impose a force on the plasma membrane, and push it 
forwards. The way actin does this is still yet to be confirmed, but there are two main
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theories at present. First, the polymerisation of actin will itself exert a force on the 
membrane, allowing the filaments to push outwards (Tilney et al, 1981). There is 
some evidence for this idea. Firstly, giant liposomes containing pure actin will 
undergo some membrane deformation. If actin cross-linking proteins are added, this 
deformation is quite severe (Miyata et al, 1999). Also, in Listeria monocytogenes 
assembly of the actin filaments is sufficient to move the bacteria through the cell. The 
only proteins required for this process other than actin are Arp2/3, ADF/cofilin and 
capping protein (Loisel et al, 1999). None of these are force-producing proteins, and 
so the polymerisation of the actin is sufficient to produce the force.
An alternative theory, suggests that the filaments act like springs, and move side to 
side due to thermal motion, before exerting a force and springing back to their 
original position (Mogilner and Oster, 1996). When moving to the side they are away 
from the membrane, and it is here when the actin monomers are added to the barbed 
end. When the filament returns to its original position, the extra actin units push the 
membrane outwards (Mogilner and Oster, 1996). One important observation that 
supports this idea is that actin filaments are 45° from the direction of protrusion, and 
this is the optimum angle to transmit force by this method (Svitkina et al, 1997). In 
addition the cross links produced by the Arp2/3 complex are quite stiff, also enabling 
the force to be transmitted through the side chains (Blanchoin et al, 2000).
1.1.8 Myosin
Myosin is an actin associated motor protein allowing actin filaments or other cellular 
structures to be moved. All myosins contain a conserved “head” domain, which is the 
motor unit that hydrolyses ATP in order to induce the force (Reviewed in Tyska and
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Warshaw, 2002). In addition to the motor domain, myosins contain additional 
domains, which vary depending on the myosin type and function. Some bind to 
plasma membrane to allow vesicle movement, while others bind to actin filaments to 
allow filaments to move with respect to each other. In addition, myosins bind to 
microtubules, and enable movement of vesicles or organelles, which plays an 
important role in axonal transport in neurones (Reviewed in Bridgeman, 2004). When 
moving along actin filaments, all myosins move along the filaments fi*om the pointed 
end towards the barbed end, with one exception, myosin 6 (Wells et al, 1999), which 
plays a role in endocytosis.
1.1.9 The actin cytoskeleton and integrins
One prominent component of the actin cytoskeleton, especially in fibroblasts, are 
actin stress fibres. These dense actin bundles are anchored at one end at specialised 
sites called focal adhesions, while the other end is anchored to other focal adhesions 
or to intermediate filaments around the nucleus, allowing the cell to exert tension on 
the matrix. The focal adhesions are areas where the membrane is in very close 
proximity to the extracellular matrix, and consequently is firmly attached. The 
transmembrane linkers for these sites of adhesion are the integrins (Choquet et al,
1997). These proteins contain an extracellular domain, which binds to the matrix, a 
single transmembrane domain, and an intracellular domain, which interacts with 
components of actin regulation. Integrins play an important role in actin regulation, 
linking the extracellular matrix to the actin cytoskeleton and generating traction 
during migration but also allowing biochemical signals to be transmitted across the 
membrane directly to the actin cytoskeleton.
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Figure 1.5. The integrins, iinking the extraceilular matrix to the actin 
cytoskeieton (Adapted from Burridge and Chrzanowska-Wodnicka, 1999)
There are two main families of integrins, a  and p integrins, which form heterodimers 
(Reviewed in Burridge et al, 1996). The cytoplasmic tail from the p integrins is 
sufficient to link the integrins to the actin filaments, but there is evidence to suggest 
that the tails from the two integrin heterodimers interact, and that this interaction is 
under the regulation of ligand binding (Haas et al, 1996; Leisner et al, 1999). At the 
site of focal adhesions, the integrins cluster to allow the anchoring of the stress fibres, 
although this interaction is indirect (Burridge et al, 1996).
There are a number of proteins required to link the cytoplasmic tails of the integrins to 
the actin bundles. Talin is an important component of focal adhesions and has been 
shown to co-localise with the integrins. During the formation of focal adhesions, Talin 
has been shown to accumulate early in the process (Moulder et al, 1996), which 
requires the presence of the integrins, but not other interacting proteins such as 
vinculin. Talin contains two 270kDa subunits, which form an anti-parallel 
homodimer, and has binding sites for actin, vinculin, focal adhesion kinase, 
phospholipids and the transmembrane protein laylin (Jockusch et al, 1995; Borowsky
29
Chapter 1 Introduction
et al, 1998). Talin binds to p i, P2, and P3 integrins at regions at either end of the 
protein, suggesting that Talin can bind to two or more integrins at once (Pfaff et al,
1998).
Filamin is another P-integrin binding protein that is present in focal adhesions. These 
proteins comprise of two parallel 250kDa subunits and an N-terminal actin-binding 
domain. They cross-link actin filaments, and reinforce loose actin filament networks 
or tight actin bundles like stress fibres (Loo et al, 1998). It is not exclusive to focal 
adhesions, and is also found associated with actin filaments throughout the cell, and 
along the stress fibres (Jockusch et al, 1995).
Two further proteins associated with the focal adhesions are a-actinin and vinculin. 
a-actinin forms rod-like lOOkDa monomers which localise to focal adhesions, by 
interacting with the tail of P-integrin tails (Cattelino et al, 1999). Vinculin, a 120kDa 
protein, is one of the most abundant in focal adhesions. It can interact with F-actin, 
Talin, a-actinin, paxilin and VAS? (Bubeck et al, 1997), but can not interact directly 
with the integrins, and is not absolutely required for the integrin-actin linkage (Priddle 
etal, 1998).
As well as allowing anchorage of the cell membrane to the matrix, the focal adhesions 
allow the transduction of signals between the matrix and the actin cytoskeleton. This 
signal transduction moves in both directions, with intracellular signals also able to 
regulate the adhesions of the integrins to the matrix, in a process referred to as inside 
out signalling, as well as signalling fi*om the matrix to the actin filaments (Hughes and 
Pfaff, 1998). The proteins most likely to play a role in transducing signals fi*om the
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integrins to the actin cytoskeleton are members of the Ena/VASP family. Their EVHl 
domain allows binding to vinculin a major component of the focal adhesions, and they 
localise to areas of actin assembly, including focal adhesions. Once Ena/VASP have 
been recruited, the other key proteins involved in actin assembly are recruited such as 
the WASP proteins and the Arp2/3 complex. With all these proteins present, actin 
polymerisation can take place.
1.1.10 The actin cytoskeleton and the nervous system
The precise regulation of the actin cytoskeleton plays a crucial role in the developing 
nervous system. Neurones migrate to their correct destination, and then differentiate 
to produce neurites and growth cones that must respond to many guidance cues in 
order to innervate their correct targets.
The growth cone is a very sensitive cellular structure that can respond to many 
guidance cues, such as semaphorins, and shows similar features to an independent 
migrating cell. There are however some differences in the actin regulation between 
neuronal growth cones and fibroblasts. The actin in a growth cone is different from 
that seen in fibroblasts, with bundles of actin filaments that radiate from the leading 
edge towards a central area of the lamellipodia (Lewis and Bridgeman, 1992). N- 
WASP and Arp2/3 are crucial components in the actin regulation in all cells types, 
and they are involved in the mechanisms behind neurite growth. The p34 and p21 
subunits of the Arp2/3 complex are concentrated in actin filaments of NGF-stimulated 
growth cones of rat sympathetic neurones and PC 12 cells (Goldberg et al, 2000). Also 
mutations in the Arp3 and p40 subunits of the Arp2/3 have been shown to cause 
abnormal neuronal development (Zallen et al, 2002)
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N-WASP was first isolated from brain (Miki et al 1996), but has since shown to be 
ubiquitously expressed. N-WASP is found throughout the brain, but is concentrated at 
nerve terminals (Fukuoka et al, 1997). Mutation of the EVH2 region of N-WASP 
blocks NGF stimulated neurite growth in PCI2 cells and hippocampal neurones. In 
addition, mutation of the CRIB to prevent Cdc42 binding blocks neurite growth 
altogether, (Banzai et al, 2000). Interestingly, mutations in Drosophila WASP have 
no effect on neuronal development, but instead affect cell fate determination, 
suggesting the two WASP proteins play different roles in the regulation of the actin 
cytoskeleton (Ben-Yaacov et al, 2001).
The EnaWASP proteins have been shown to be concentrated to F-actin rich regions of 
NGF-stimulated sympathetic growth cones (Goldberg et al, 2000), and are also highly 
expressed in the developing cortical plate (Goh et al, 2002). When Ena/VASP 
function is inhibited before cortical neuron migration, early neurones migrate too far, 
reaching the superficial layers of the cortex, which is normally inhabited by older 
neurones. Neurone morphology remains normal, suggesting Ena/VASP proteins 
function in vivo to correctly position migrating cortical neurones (Goh et al, 2002).
The mammalian homologue of Ena, Mena, has been shown to play an important role 
in neuronal development. Mena knockout mice show severe brain defects, suggesting 
Mena is essential for correct development (Lanier et al, 1999). Mena knockout mice, 
also heterozygous for profiling knockout show even more severe phenotypes and die 
in utero. Further examination showed defects in the formation of the neural crest, and 
neural tube, suggesting together Mena and profilin are crucial during neuronal growth
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and correct path finding (Lanier et al, 1999). Taken together these observations show 
that correct actin regulation is crucial for normal neuronal development.
Another class of actin associated proteins, ADF/cofilin also play a role in the nervous 
system. Both proteins were originally identified fi*om brain, with ADF isolated firom 
chick brain (Bamburg et al, 1980) and cofilin isolated fi*om porcine brain (Nishida et 
al, 1984). ADF is expressed in cerebella neurones and in the dendrites of Purkinje 
cells (Lena et al 1991), and has been shown to travel with actin monomers in axonal 
transport, and so may function in some transport capacity (Bray et al, 1992).
ADF has been suggested to play some role in neurodegeneration. In some cases of 
Alzheimer’s disease, there is a large loss of synapses, potentially up to 50%, without a 
corresponding loss of the neurones themselves. Further examination has shown that, 
in some cases, there is a disruption in the axonal transport of these neurones resulting 
in a loss of processes (Masliah et al, 1989). This disruption to axonal transport may 
also play some role in degeneration caused by the superoxide dismutase mutation, 
responsible for 15% of cases of familial amyotrophic lateral sclerosis (Williamson et 
al, 1999). The disruption to axonal transport appears to be due to rod like structures 
containing actin, ADF and cofilin in the axon. These rods can be induced in cultured 
hippocampal neurones, by overexpressing ADF/cofilin. When these rods become 
large enough, they span the width of the axon, and disrupt the microtubules, affecting 
axonal transport (Minamide et al, 2000).
LIM kinase, which regulates cofilin by phosphorylation, is highly expressed in the 
brain (Mizuno et al, 1994) and plays an important role in the regulation of the actin
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cytoskeleton. Inactive LIM kinase can block Racl or insulin induced lamellipodia 
(Yang et al, 1998) as well as blocking RboA induced stress fibres and Cdc42 induced 
filopodia (Sumai et al, 1999). LIM kinase is pbospborylated at the same site by the 
Rac/Cdc42 effector PAK (Edwards et al, 1999) and the RboA effector ROK 
(Maekawa et al, 1999). Once pbospborylated, LIM kinase becomes active and 
phosphorylates cofilin inactivating it, and so stabilising actin filaments.
The phosphorylation of cofilin by LIM kinases has been shown to be important in the 
semapborinSA (semaSA) guidance pathway. Following treatment with sema3A, there 
is an increase in the phosphorylation of cofilin, followed by a decrease in the 
phosphorylation. This phosphorylation is probably due to LIM kinase, as inhibition of 
LIM kinase inhibits the sema3A collapse (Aizawa et al, 2000). Finally, the LIM 
kinase gene is one of those lost in William’s syndrome, caused by the deletion of a 
segment on chromosome 11 spanning several genes (Donnai and Kamiloff-Smith, 
2000). As a result of this deletion, there are some developmental abnormalities and 
cognitive impairment, although it is difficult to access the role the loss of LIM kinase 
plays in this disorder.
1.1.11 Microtubules
Another component of the cytoskeleton is microtubules. These structural proteins 
show some similarities with actin. They consist of large chains composed of 
polymerised subunits, and the rates of polymerisation and depolymerisation regulate 
the growth or shrinkage of the microtubules. The monomer units are tubulin dimers 
consisting of a  and p subunits. Tubulin polymerises more quickly at the plus end, 
which is terminated by the p subunit, while the minus end, which is terminated by the
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a  unit, polymerises more slowly. Another form of tubulin, y-tubulin, forms the 
centrosome, a ring of tubulin that acts as a nucléation site for microtubules, during 
cell division (Reviewed in Howard and Hyman, 2003). Once assembled, microtubules 
act as tracks for the transport of cell organelles and chromosomes, through the motor 
protein, kinesin. However, microtubules can themselves, provide forces, and 
polymerisation of tubulin can exert forces on the cell membrane (Reviewed in 
Howard and Hyman, 2003).
The microtubule dynamics are driven by GXP hydrolysis. Tubulin is a GTPase 
(David-Pfeuty et al, 1977), and this enzymatic activity is promoted by polymerisation 
of the tubulin (Carlier and Pantaloni, 1982). However, the p-tubulin contains the GTP 
binding domain, but the a-tubulin contains the hydrolysing activity, and hydrolysis of 
GTP only occurs once two tubulin dimers polymerise (Nogales et al, 1999).
Recently, there has been found to be an interplay between the regulation of 
microtubules and the actin cytoskeleton through RhoGTPases. A member of the Rho 
family of GTPases, Racl, binds directly to tubulin (Best et al, 1996), and a 
downstream kinase of Racl and Cdc42, PAK, phosphorylates stathmin, preventing it 
from destabilising microtubules (Daub et al, 2001). The downstream RhoA effector, 
mDia stabilises microtubules in fibroblasts, in a Rho-kinase independent fashion 
(Palazzo et al, 2001).
In neuronal growth cones, a large bundle of microtubules are located in the centre of 
growth cones, with a few dynamic microtubule processes extending towards to 
periphery of the growth cone, where actin forms filopodia and lamellipodia 
(Reviewed Rodriguez et al, 2003). Inhibition of actin polymerisation in the growth
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cone causes the microtubules to advance into the growth cone periphery, suggesting 
that microtubule dynamics and actin dynamics are closely linked (Forscher et al, 
1988). The dynamics of actin and microtubules are functionally linked in developing 
growth cones, where the inhibition polymerisation of one, prevents the polymerisation 
of the other (Dent and Kalil, 2001). Also, the inhibition of either actin or microtubule 
dynamics prevents axonal branching, but not axonal elongation. As the axonal 
elongation is undirected, this points to a role for actin and microtubule dynamics in 
axonal pathfinding (Dent and Kalil, 2001). In fact, local and specific disruption of 
actin bundles in the growth cone causes microtubule growth into the areas where actin 
bundles remain, resulting in growth cone turning (Zhou et al, 2002).
1.2 The Rho family of GTPases
Some of the most important, and best characterised regulators of the actin 
cytoskeleton are Rho GTPases. This family of small enzymes belong to the larger Ras 
superfamily of GTPases, and hydrolyse GTP to GDP, and so cycle between GTP and 
GDP bound forms. When bound to GDP they are inactive, but when they bind GTP a 
conformational change takes place, allowing the GTPases to bind to and activate 
downstream effectors.
The Rho family can be divided into six groups. Rho (comprising RhoA, RhoB, and 
RhoC,) Rac (comprising Racl, Rac2, Rac3 and RhoG), Cdc42 (comprising Cdc42, 
G25K and TCIO), Rnd (comprising RhoE/Rnd3, Rndl/Rho6 and Rnd2/Rho7), RhoD 
and TTF. Of these Rho GTPases, the best studied are Racl, RhoA and Cdc42.
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1.2.1 The morphological effects of the Rho GTPases
In Swiss 3T3 fibroblasts, it has been shown that RhoA is activated in response to 
external factors, such as Lysophosphatidic acid (LPA), resulting in the formation of 
actin stress fibres and focal adhesions (Ridley and Hall, 1992). Racl was shown to 
respond to platelet-derived growth factor (PDGF), resulting in the formation of 
membrane ruffles and lamellipodia (Ridley et al, 1992). There is also some cross talk 
between RhoA and Racl. Treating fibroblasts with PDGF causes membrane ruffling, 
but after 10-15 minutes, some stress fibres and focal adhesions are formed.
Filopodia
Lamellipodia
Ruffles
S tress  fibres Focai 
adhes ions
Figure 1.6. The morphological effects and the hierarchal relationship of the Rho 
GTPases. (Cell images taken from Hall, 1998; diagram adapted from Lim et al, 1996)
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These stress fibres and focal adhesions have been shown to be RhoA dependant 
(Ridley and Hall, 1992), suggesting that RhoA can be activated downstream of Racl. 
In addition to the ability of Racl to regulate actin polymerisation, an involvement in 
microtubules regulation was suggested with the ability of GTP Racl to bind to tubulin 
(Best et al, 1996), and Racl has also been implicated in the production of reactive 
oxygen species (ROS) (Ozaki et al, 2000). Swiss 3T3 fibroblasts were used to show 
Cdc42 could be activated in response to bradykinin to induce the formation of actin 
microspikes and filopodia (Kozma et al, 1995). Further evidence of the cross talk 
between the GTPases was demonstrated by the formation of Racl-dependant 
membrane ruffles and lamellipodia following Cdc42 activation suggesting Racl can 
be activated downstream of Cdc42 (Kozma et al, 1995).
1.2.2 Effectors of the Rho GTPases
In order for the Rho GTPases to activate their signalling pathways, they bind to and 
activate a large number of downstream effectors. These effectors only bind to Rho 
proteins when GTP bound, and can be either kinases or non-kinases. A large number 
of effectors have been identified, although only some have been suggested to play a 
role in neuronal development, are discussed here.
1.2.2.1 PAK
p21-activated kinase, PAK, was isolated as a Racl and Cdc42 effector. Both GTP 
Racl and GTP Cdc42 bind PAK causing auto-phosphorylation and increase in kinase 
activity (Manser et al, 1994). A region crucial to the binding of GTP bound Racl or 
Cdc42 was identified as a 16 amino acid sequence (Manser et al, 1993; Manser et al,
1994). It was subsequently found in other proteins and termed Cdc42/Rac interactive
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binding (CRIB) (Burbelo et al, 1995). Racl and Cdc42 have been shown to recruit 
PAK to focal complexes, where it exerts its kinase activity. In addition, activated 
PAK results in loss of stress fibres and focal adhesions (Manser et al, 1997). These 
effects are similar to those observed by activating Racl and Cdc42 (Manser et al,
1997)
A number of other proteins have now been identified by their interactions with PAK. 
A novel Racl exchange factor was identified by its direct interaction with PAK, and 
termed PAK-interacting exchange factor (PIX). This protein can induce Racl- 
dependant membrane ruffling, and because PAK is an effector for both Racl and 
Cdc42, suggests a role for PIX in the cross talk signalling between Cdc42 and Racl 
(Manser et al, 1998; Obermeier et al, 1998).
PAK has also been shown to phosphorylate and activate LIM kinase (Edwards et al,
1999), in a pathway that can link Racl and Cdc42 to regulation of the actin 
cytoskeleton. LIM kinase was first identified as a novel kinase highly expressed in 
developing nervous tissue (Mizuno et al, 1994), although an additional LIM kinase 
has since been identified, LIM kinase 2, which is more widely expressed (Okano et al,
1995). Phosphorylation of LIM kinases by PAK results in increased kinase activity 
towards cofilin, an important component of actin recycling. Activation of Racl and 
Cdc42 causes an increased interaction between PAK and LIM kinase. Kinase inactive 
LIM kinase can interfere with Racl, Cdc42 or PAK induced cytoskeletal changes 
(Edwards et al, 1999). This phosphorylation pathway suggests one way in which Racl 
and Cdc42 can induce their changes in cell morphology.
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LIM kinase also provides a convergence point between Racl/Cdc42 and RhoA 
signalling pathways. As well as being a substrate for PAK, LIM kinase is also a 
substrate for the RhoA effector Rho kinase. Rho kinase phosphorylates LIM kinase on 
the same site as PAK, threonine 508, also increasing the kinase activity towards 
cofilin (Maekawa et al, 1999; Ohashi et al, 2000). Therefore LIM kinase offers one 
pathway by which the Rho GTPases can effect changes to the actin cytoskeleton.
1.2.2.2 WASP (See section 1.1.4)
The protein responsible for Wiskott Aldrich syndrome, WASP is an effector for 
Cdc42, but does not bind to either RhoA or Racl (Aspenstrom et al, 1996; Symons et 
al, 1996). WASP, and the related protein N-WASP both bind directly to the Arp2/3 
complex and facilitate the formation of actin filaments, and so form a bridge between 
Cdc42 and reorganisation of the actin cytoskeleton. A WASP related protein, WAVE, 
has been shown to play a role in Racl induced ruffles and lamellipodia (Miki et al, 
1998) although this protein is not a Racl effector, and does not bind the GTPase.
1.2.2.3 Rho-kinase
Another key effector is Rho-kinase-a (ROKa). ROK-a was first identified as a kinase 
that binds to GTP RhoA and is translocated to the membrane, (Leung at al, 1995; 
Mitsui et al, 1996). In addition to binding to RhoA, ROK-a was shown to bind RhoB 
and RhoC, but not to Racl or Cdc42, and induces stress fibres and focal adhesions in 
a kinase dependant manner (Leung et al, 1996; Amano et al, 1997). The RhoA 
binding domain was narrowed to a 30 amino acid sequence, and shown to be essential 
for GTPase binding. A second member of the Rho kinase family, termed ROK-p was
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identified, with 90% homology in the kinase domain. Of the 30 amino acids 
comprising the Rho-binding domain, 20 are identical between the two sequences 
(Leung et al, 1996), emphasising the importance of sequence for RhoA binding.
Further studies have shown that ROK-a also binds to RhoE (Rnd3), although this 
interaction is quite different from that with RhoA. Although RhoA and RhoE cannot 
interact with ROK-a simultaneously, the RhoE binding site was localised to the 
kinase domain. In addition, RhoE can inhibit the Rho kinase-a induced stress fibres 
and focal adhesions, suggesting RhoE has an inhibitory role in the regulation of ROK- 
a  (Riento et al, 2003).
ROK is activated by lysophosphatidic acid, which signals thorugh the G protein G13 
(Gohla et al, 1998). Activation of this G protein results in activation of the Guanosine 
Exchange Factor, pi 15 RhoGEF (Hart et al, 1998), which upregulates RhoA GTP 
(Kranenburg et al, 1999). The down stream targets of the ROK-a are components of 
the myosin contraction machinery. ROK-a phosphorylates the myosin-binding 
subunit of myosin phosphatase, resulting in inactivation. As a result of inactivation of 
myosin phosphatase, there is an increase in the phosphorylation levels of myosin light 
chain, causing contraction in muscle, and interaction between actin and myosin in 
non-muscle cells (Kimura et al, 1996; Kureishi et al, 1997).
Some evidence for the interplay between different effectors has been shown between 
ROK-a and another RhoA effector mDia. mDia is the mammalian homologue of the 
Drosophila gene. Diaphanous, which was shown to be required for cytokinesis during 
development (Castrillon and Wasserman, 1994). mDia is a RhoA effector, which
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binds to profilin (Watanabe et al, 1997), and stabilises microtubules in fibroblasts 
(Palazzo et al, 2001). mDia co-operates with ROK-a in the formation the RboA 
associated actin structures, stress fibres and focal adhesions (Watanabe et al, 1999), 
but is antagonised by ROK-a in the Rbo-dependant activation of Racl, and the Racl- 
induced lamellipodia (Tsuji et al, 2002).
1.2.2.4 Citron
Further searches for novel RboA effectors discovered citron, and the related effectors, 
CRIK and CRIK-SK. It would appear these three proteins are splice variants fi-om the 
same gene. Citron was discovered in a yeast two hybrid system, and was found to 
interact with both RhoA and Racl, but not Cdc42 (Maduale et al, 1995). This 183 
kDa protein has no kinase domain, and as yet no function has been assigned to it. 
However two related proteins were identified. CRIK, citron Rho-interacting kinase, 
consists of a kinase domain fused onto the whole of the citron sequence, while CRIK- 
SK consists only of the kinase domain (Di Cun et al, 1998). No substrate has been 
found for these effectors, and they have limited effect on the actin cytoskeleton. 
Expression of these effectors is limited mainly to brain and testis, suggesting a more 
specific and selective function than ROK-a.
1.2.3 The regulation of the Rho GTPases
There are three different classes of regulating proteins for the Rho family of GTPases, 
Guanosine Exchange Factors (GEF’s), GTPases Activating Proteins (GAP’s) and 
Guanosine Disassociation Inhibitors (GDI’s). Regulation of these controls the activity 
of the GTPases, and hence their downstream effects. There is a high degree of
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complexity within all these groups of regulating molecules, with a high degree of 
redundancy and promiscuity. There are over 60 different proteins identified which 
regulate RhoA, Racl and Cdc42, and many of these can act on more than one 
GTPases. Consequently, through their ability to regulate GAP’s, GEF’s and GDI’s, 
cells can exert highly specific control over the Rho GTPases, and their effects within 
the cell.
One of the first characterised GAP’s, was found to be one of the genes translocated in 
Philadelphia leukaemia. In this cancer there is a fusion between the Breakpoint cluster 
region (BCR) and Abl genes resulting in the production of a functional fusion protein. 
The full length BCR gene product has been shown to have GAP activity towards 
Racl, Rac2 and Cdc42, as well as GEF activity towards Cdc42, RhoA, Racl and 
Rac2 (Chuang et al, 1995). In addition, neutrophils from BCR null mice show an 
increase in reactive oxygen species production, and an increase in the membrane 
translocation of Rac2 (Voncken et al, 1995), suggesting BCR is responsible for 
regulation of Rac-mediated superoxide production via the NADPH-oxidase pathway.
GAP’s for the Rho family of GTPases share related GAP domains, and other protein 
domains can regulate their function. An in vivo and in vitro comparison of the GAP 
domains from three different GAP’s, BCR, RhoGAP and p i90 RhoGAP 
demonstrated different specificity, with BCR acting on Rac2, RhoGAP acting on 
Cdc42, and pl90RhoGAP acting on RhoA (Ridley et al, 1993).
Even between the GAP’s there is evidence of some cross talk. The N-terminal of 
RasGAP contains two SH2 domains and one SH3 domain. These domains are
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responsible for the interaction with P-PDGF receptors, but also with pl90RhoGAP. A 
complex of the RasGAP N-terminal and pl90RhoGAP is active, suggesting RasGAP 
can activate pl90RhoGAP, and so regulate RhoA function (McGlade et al, 1993).
GDI’s were first identified from bovine brain, and shown to inhibit the release of 
GDP from the Rho GTPases (Fukumoto et al, 1990; Ueda et al, 1990). In addition 
they have also been shown to exert a concentration dependant inhibition of GTP 
hydrolysis, and GAP function (Chuang et al, 1993), as well as solubilising membrane 
associated Rho proteins (Isomura et al, 1991). RhoGDl was also shown to relocate 
RhoA, Cdc42, Racl and Rac2 but not other Rho proteins such as RhoB or TCIO 
(Michaelson et al, 2001). Consequently, GDI’s have been shown to down regulate 
Rho GTPases in a number of ways.
Rho GEF’s were first identified through the discovery of a novel oncogene, called Dbl 
(Eva and Aaronson, 1985). Dbl is a truncated protein that contains a region with high 
homology to a region in the yeast protein Cdc24 (Ron et al, 1991), and this led to the 
discovery that Dbl was able to facilitate the exchange of GDP for GTP in Cdc42 (Hart 
et al, 1991). Dbl is an 115kDa cytoskeletal-associated protein, and expression is 
limited to selective tissues such brain, adrenal glands, testis and ovaries. The region 
responsible for the GEF activity was termed Dbl homologue domain (DH) (Hart et al, 
1994), and was found to be essential for the transforming ability of Dbl (Ron et al 
1991). In addition to the DH domain, Dbl also contains a Pleckstrin homology domain 
(PH), which although poorly conserved, appears to adopt a common 3D structure 
(Ferguson et al, 1994; Harlan et al, 1994), and is thought to be involved in the cellular 
localisation of Dbl. All Dbl-like GEF’s contain both these domains in close proximity.
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Tiam-1, for T lymphoma invasion and metastasis, is a well-studied Dbl-like GEF. It 
too was discovered due to its involvement in cancer and shown to have two domains 
with homology to DH domain and two PH domains (Habets et al, 1994). Since then it 
has been shown to be a Racl GEF (Michiels et al, 1995), and has been implicated in 
neuronal migration and neurite outgrowth in the developing nervous system (Ehler et 
al, 1997).
1.2.4 The Rho GTPases in cellular migration and the extracellular 
matrix
The involvement of Rho GTPase activating proteins, such as Dbl, Tiam-1 and BCR in 
cancers, suggested that GTPases play an important role in cell migration, a pivotal 
process in cancer metastasis. In fact all three key members of the Rho GTPases play 
important roles in cell migration. Racl is essential for lamellipodia protrusion and 
forward movement, Cdc42 is important for cell polarisation, and the correct 
localisation of the lamellipodia to the leading edge (Nobes and Hall, 1999). RhoA and 
ROK activation are required for monocyte migration (Honing et al, 2003; Worthylake 
and Burridge, 2003), while RhoA induced phosphorylation of FAK is required for 
tumour cell invasion (Mukai et al, 2003). Further studies have shown PAK is required 
in the migration of endothelial cells (Kiosses et al, 1999) and Racl is important in the 
actin reorganisation in response to chemoattractants in chemotaxis (Chung et al,
2000).
An important factor in cell migration is the signalling pathways from the extracellular 
matrix, through adhesion sites, to the Rho GTPases to regulate the actin cytoskeleton.
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The ability of Racl and Tiam-1 to induce migration can be inhibited by plating cells 
on fibronectin, although other collagens have no affect on migration (Sander et al,
1998). There has been shown to be an initial RhoA inhibition followed by a phase of 
RhoA activation in response to fibronectin adhesion (Ren et al, 1999). The initial 
inhibition of RhoA appears to be due, at least in part, to the activation of 
pl90RhoGAP. Following integrin activation, there is a c-Src dependant 
phosphorylation, and hence, activation of pl90RhoGAP (Arthur et al, 2000).
The effect of fibronectin on Rho GTPase activity is dependant on substrate 
concentration. In neutrophils and CHO cells, intermediate fibronectin concentrations, 
which are optimal for migration, induce activation of both Racl and Cdc42. However, 
higher concentrations result in activation of RhoA, and an inhibition of migration 
(Cox et al, 2001).
In addition to cell-to-substrate interactions, cell-to-cell interactions have also been 
shown to regulate the RhoGTPases in MDCK cells. Racl is localised to the sites of 
cell-cell adhesions (Nakagawa et al, 2001), and there is an activation of Racl and an 
inhibition of RhoA, following the formation of cell-cell contacts.
1.2.5 The Rho GTPases in the Nervous System
Due to their ability to drive morphological changes and migration, the Rho family of 
GTPases play important roles in the development of the nervous system. The growth 
cones of neurones can be considered similar to migrating cells, but responding to a 
huge variety of repulsive and attractive signalling cues, utilising the Rho GTPases to 
effect these morphological changes. Consequently, the role played by the GTPases,
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and their regulatory proteins, in the ability of growth cones to correctly guide to their 
targets, is of great interest.
The complex relationship that exists between the three key members of the Rho 
GTPases has been demonstrated in the neuroblastoma cell lines, where Cdc42 and 
Racl produce filopodia and lamellipodia respectively, and RhoA causes neurite 
retraction (Kozma et al, 1997). Both Racl and Cdc42 can be activated by 
acetylcholine via the muscarinic acetylcholine receptor, which acts in competition 
with LPA activation of RhoA (Kozma et al, 1997). In the same neuroblastoma cell 
line, Cdc42 and Racl have been shown to regulate neurite formation downstream of 
Ras (Samer et al, 2000). Racl also plays an important role in the differentiation of rat 
pheochromocytoma PC 12. These cells are often used as a model of neuronal 
differentiation, as they respond to nerve growth factor (NGF) to produce long 
neurites, and in response to NGF, Racl is activated and recruited to protrusion sites 
(Yasui et al, 2001).
Rho GTPases are important in neuronal and morphological development; RhoA is 
highly expressed during Caenorhabditis elegans larval development (Chen et al, 
1994), and Racl is important in dorsal closure in embryonic development of 
Drosophila (Harden et al, 1995). Further studies in Drosophila have shown that 
although Cdc42 can regulate the formation of filopodia, this does not affect the 
pathfinding ability of growth cones (Kim et al, 2002). However, Cdc42, Rac and Rho 
are all required in the repulsive axon guidance at the midline of Drosophila CNS. 
Midline repulsion requires down-regulation of Cdc42 and Rac and activation of Rho 
(Fritz et al, 2002). All three key members of the Rho GTPase family play an
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important role mXenopus laevis optic nerve development, and dendritic arbor growth 
(Li et al, 2002), while crosstalk between RhoA and Cdc42 is important for guidance 
of spinal neurones (Yuan et al, 2002).
Recent work has now placed the Rho GTPases downstream of specific guidance cues 
in growth cone morphology. In neuroblastoma cells lines, Racl and Cdc42 are 
required for Netrin-1 induced neurite outgrowth, while this is independent of RhoA 
and ROKa (Li et al, 2002). In C. elegans a constitutively active construct of the 
Netrin-1 receptor, Unc40 (DCC homologue), causes axon guidance defects, which are 
dependant on the Rac homologue, ced-10 (Gitai et al, 2003).
The ephrins are repulsive guidance cues, causing growth cone collapse. EphrinA-5 
has been shown to activate RhoA and down regulate Racl to induce growth cone 
collapse, and inhibition of RhoA blocks ephrinA-5 induced collapse (Wahl et al,
2000). In addition to the role of RhoA in collapse, Racl also plays an important role 
in negative guidance. Although ephrin-A’s induce a down regulation of Racl, there is 
also a subsequent Racl activation stage that is required for growth cone collapse. This 
activation is required to enable endocytosis of the growth cone membrane, although 
the role this plays in the collapse pathways is not clear (Jumey et al, 2002).
Another family of repulsive guidance cues, the semaphorins, have also been shown to 
regulate the Rho GTPases. Collapsin-1, the chick homologue of semaphorinBA, 
induced collapse in dorsal root ganglia neurones, which is dependant on Racl. 
Dominant negative Racl, Rac INI 7, can block the collapse (Jin et al, 1997) and the 
role of Racl in the collapse is dependant on the effector interacting domain, amino
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acids 17-32, since deleting this region also blocks the growth cone collapse, (Vastrik 
etal, 1999)
The semaphorin guidance cues signal through a plexin/neuropilin receptor complex. 
However, while neuropilins have a short cytoplasmic domain, plexins have large 
cytoplasmic signalling domains, suggesting that they transduce the signal through the 
Rho GTPases. The cytoplasmic domain of the plexins, show some sequence similarity 
to GAPs, and plexin-Bl binds to Racl in a GTP dependant manor, while plexin-Al 
binds to Rndl independent of GTP/GDP state (Rohm et al, 2000). Binding of Rnd 1 to 
plexin-Al is sufficient to cause growth cone collapse, while RhoD can compete for 
binding, blocking plexin-Al activation and semaSA repulsion (Zanata et al, 2002). 
Plexin-Bl competes with PAK in vitro to bind activated Racl, suggesting a 
mechanism by which the plexins can downregulate Racl signalling, and induce RhoA 
activation, (Vikis et al, 2000; Driessens et al, 2001; Hu et al, 2001). Furthermore, a 
different region of plexin-B binds to RhoA in a GTP independent manor (Hu et al, 
2001).
In addition to their role in the developing nervous system, the Rho GTPases also play 
a role in neuronal regeneration following injury. The potent growth inhibitor, myelin- 
associated glycoprotein (MAG), which is released following nerve damage, activates 
the p75 receptor resulting in RhoA activation (Yamashita et al, 2002.) This activation 
could be blocked by neurotrophin binding, resulting in neurite elongation (Yamashita 
et al, 1999). Another growth inhibitor associated with nerve injury, Nogo-66 has also 
been shown to activate RhoA (Fournier et al, 2003). Spinal cord injury in rats and 
mice induces RhoA activation, which is p75 dependant. There is also an upregulation
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of p75, which is RhoA-dependant, suggesting some feed back system (Dubreuil et al, 
2003).
1.2,6 Rho GTPases regulators and effectors in the nervous system
The Rho GTPases play important roles in the development, and regeneration of the 
nervous system, and so their regulators and effectors play important roles in 
transducing the signals to the cytoskeleton, or regulating their activity.
1.2.6.1 GAPs in the nervous system
A large number of RhoGAP’s have been identified to date including the Ras GAP’s 
pl20GAP, and NF-1, which both play a role in neurofibromatosis (Reviewed in 
Scheffzek et al, 1998; Dasgupta and Gutmann). However, of these GAP’s, only a few 
have been suggested to play an important role in the control of neuronal 
differentiation and development of the nervous system.
Chimaerin is a RacGAP that is highly expressed in the nervous system and exists as 
two splice variants, a l  and a2-chimearin. Both contain a GAP domain and a phorbol 
ester receptor, but a2-chimearin also contains an N-terminal Src homology (SH2) 
domain. Both are expressed in the cerebral cortex, hippocampus and thalamus, but 
a2-chimearin is also expressed in the testis (Hall et al, 1993). a2-Chimearin is 
expressed much earlier in development than al-chimearin, and is highly expressed in 
embryonic stages, including in dorsal root ganglia (Hall et al, 2001). Expression of 
al-chimearin in the neuroblastoma cell line NlE-115 induces the formation of 
lamellipodia and filopodia, which are Racl and Cdc42 dependant, respectively. While 
the GAP activity was not required, activation of the GAP using phorbol ester
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abolished these effects, suggesting that some GAPs may have functions in addition to 
the down regulation of GTPases (Kozma et al, 1996). In the same cell lines, a2- 
chhnaerin forms neurites, but the point mutation, N94H of the SH2 domain activates 
the GAP resulting in retraction and loss of peripheral structures (Hall et al, 2001). 
Although a precise physiological function of this Rac GAP has yet to be found in cell 
signalling, its expression pattern suggests it plays an important role in development.
P190RhoGAP is a potent regulator of Rho A, and is highly expressed throughout the 
nervous system. Knock out of pl90RhoGAP in mice causes wide spread defects in the 
development of the brain (Brouns et al, 2000), while pl90RhoGAP inactivation 
causes local axon retraction, suggesting a role for pl90RhoGAP in the control of 
structural plasticity of neurones (Billuart et al, 2001). Also, following fear 
conditioning, pl90RhoGAP associates with the adaptor protein GRB2. Inhibition of 
the pl90RhoGAP pathway impaired long-term memory, but had no effect on short­
term memory (Lamprecht et al, 2001).
In addition to the well established GAPs, new neurospecific GAPs are being 
identified and characterised. Grit is a novel GAP that acts on all three key members of 
the Rho family, and interacts with the NGF receptor, TrkA, suggesting a role in 
NGF-induced differentiation (Nakamura et al, 2002). SynGAP acts on Ras and 
interacts with the PDZ domain of PSD-95. It is highly enriched in excitatory 
synapses, where is forms large complexes with PSD-95 and the NMDA receptor, and 
may play an important role in modulating synaptic plasticity (Hae Kim et al, 1998).
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1.2.6.2 GEFs in the nervous system
The other main group of GTPases regulating proteins, GEF’s, have also been 
implicated in the development of the nervous system. Trio contains two GEF 
domains, which activate Racl and Rho A respectively, and appears to play a role in 
regulating axonal outgrowth in the developing nervous system (Liebl et al, 2000). 
From phenotypic studies, it appears that Trio acts in cooperation with the tyrosine 
kinase Abl (Liebl et al, 2000). In Drosophila, Trio knockouts demonstrate defects in 
both the central and peripheral nervous systems, similar to those observed from 
GTPase dysfunction. Trio also interacts with the receptor phosphatase EAR, and a 
reduction in Trio activity potentiates the phenotypes seen from EAR mutants, 
suggesting these proteins act in synergy during axon development (Bateman et al,
2000). Trio is also important in the NGF-induced differentiation pathway in PCI2 
cells, and mutants can affect neurite outgrowth (Estrach et al, 2002).
In addition to their role in axonal development, GEF’s are also being placed in 
specific signalling pathways from axonal guidance cues. Activation of the EphB 
receptor is important in the formation of dendritic spines in the hippocampus, and the 
Racl GEF, kalirin is crucial in this process. Inhibition of the Eph receptor, kalirin, 
Racl or PAK inhibits ephrin induced dendritic spine formation (Penzes et al, 2003). A 
novel GEF, ephexin acts on RhoA and interacts with the EphA receptor Shamah et al,
2001). Following activation of the receptor, ephexin upregulates RhoA, resulting in 
down regulation of Racl and Cdc42, and growth cone collapse. Mutant ephexin can 
block the Ephrin-A induced growth cone collapse in cultured primary neurones 
(Shamah et al, 2001).
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The plexin-B family of receptors interact with the RhoAGEFs, PDZ-RhoGEF and 
LARG. Following activation of the receptor by semaphorin4D this GEF activates 
RhoA, resulting in growth cone collapse (Perrot et al, 2002; Swiercz et al, 2002). The 
association of PDZ-RhoGEF with the plexin-B receptor is promoted by the binding of 
Rndl to the plexin, dramatically increasing RhoA activation (Oinuma et al, 2003).
1.2.6.3 Effectors in the nervous system
In order for the GTPases to regulate the actin cytoskeleton, they must activate their 
effectors. Like the GTPases and their regulators, the role of various Rho family 
effectors in the nervous system has been studied.
The major effector of RhoA, ROK, is responsible for many RhoA-dependant effects 
on cell morphology, and activation of ROK can cause neurite retraction in PCI2 cells, 
independently of RhoA (Katoh et al, 1998). In neuroblastoma cell lines, activation of 
ROK causes neurite retraction, while inhibition causes Racl and Cdc42 dependant 
outgrowth. Therefore ROK is an important component of neurite retraction pathways, 
but also inhibits the activities of Racl and Cdc42 (Hirose et al, 1998).
In cultured neurones inhibition of ROK causes an increase in the size and motility of 
growth cones produced, while activation of ROK prevents initiation of axon growth 
(Bito et al, 2000), suggesting that the role of ROK in the developing nervous system 
mirrors that seen in model cell lines. ROK also plays a role in the morphological 
changes during Drosophila development, acting with the frizzled/dishevelled 
signalling pathway to control cell polarity (Winter et al, 2001).
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Two other RhoA effectors, mDia and citron have been implicated in neuronal 
development. MDia enters the nucleus and binds to the transcription factor Pax6, 
resulting in mislocalisation of Pax6 and an increase in neurite branching and length 
(Tominaga et al, 2003). Therefore it appears that mDia can have an opposite effect to 
ROK on neuritogenesis and can regulate gene transcription during neuronal 
development.
Citron associates with PSD-95 at the postsynaptic side hippocampal synapses of 
GABAergic neurones. This localisation is specific to the hippocampus, although 
citron is expressed throughout the nervous system, for example in most thalamic 
neurons. This suggests that citron acts in the inhibitory neurones of the hippocampus, 
in a signalling complex that is unique to these neurones (Zhang et al, 1999).
The Racl effector PAK is expressed in olfactory neurones, and plays an important 
role in their precise wiring (Ang et ai, 2003). While PAK does not affect neuronal 
differentiation, it does appear to regulate the correct guidance of the axons along the 
correct trajectories (Ang et al, 2003). Another Racl effector, C.elegans une-115, 
which is similar to human abLIM, a F-actin binding protein contain LIM domains 
(Roof et al, 1997), is also involved in pathfinding. It can bind directly to actin, and 
double mutants of unc-115 with Racl cause axon pathfinding defects (Struckhoff et 
al, 2003).
1.3 Axonal guidance in the developing nervous system
During the development of the nervous system, axon growth cones must respond to a 
huge variety of guidance cues in order to reach their correct targets. These guidance
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cues can be either attractive or repulsive, and utilise the ability of the Rho GTPases to 
regulate the actin cytoskeleton, to control the pathfinding of the growth cones. There 
are many guidance factors that regulate axonal pathfinding, but the four main families 
are the netrins, slits, ephrins and semaphorins (See figure 1.7). Each family is broken 
down into subclasses, some with their own receptors and signalling pathways, while 
with others there is some redundancy between the receptors and signalling pathways. 
It is clear from the number of different signalling cues and pathways controlling the 
growth of axons and dendrites, that the correct development of the nervous system is 
a very complicated and carefully controlled process. Many of the studies on these 
guidance cues have been done on simple organisms such as Drosophila and 
C.elegans. It has become clear that many of the systems that influence growth 
guidance are highly conserved across species at the molecular level.
1.3.1 The Netrins
The netrins are a family of highly conserved secreted growth cone guidance cues. To 
date, one member has been found in C.elegans, two in Drosophila, and three in 
vertebrates (Van Raay et al, 1997). Netrins are expressed at the midline of the nervous 
system and are involved in the attraction of axons to the midline. So far, netrins have 
been expressed at the midline of every species examined, and netrin knockouts show 
defects in their guidance to the midline (Serafini et al, 1996). In addition to their role 
in attracting axons to the midline, netrins also play a role in attracting axons to 
peripheral targets such as muscle (Mitchell et al, 1996), and retinal axons into the 
optic nerve (Deiner et al, 1997). Netrins are bifunctional, and have been shown to 
demonstrate repulsive action on axons (Winberg et al, 1998). The ability of netrins to 
both repel and attract axons has been attributed to different receptors.
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Attraction from netrins is mediated by the DCC (Deleted in Colorectal Cancer) 
receptor, while the repulsion is due to an UNC-5 homologue (Fazeli et al, 1997; 
Leonardo et al, 1997). These two receptors are structurally different, with the DCC 
receptor consisting of four Ig domains and six fibronectin repeats, and UNC-5 
consisting of two Ig domains and two thromobospondin repeats, although it does not 
appear that there is one receptor for attraction and one for repulsion. DCC is required 
for both attraction and repulsion, during repulsion the DCC receptor binds to the 
UNC-5 receptor allowing their intracellular domains to interact and result in the 
activation of a repulsion pathway (Hong et al, 1999).
Activation of the DCC receptor by netrin-1 leads to activation of Racl and Cdc42. 
Expression of DCC in HEK 293T cells enables netrin-1 to induce filopodia and 
peripheral actin structures, which can be blocked with dominant negative Racl and 
Cdc42 (Shekarabi et al, 2001). The mechanism by which the netrins can influence the 
Rho GTPases has not been identified, but the adaptor protein Nek may be involved, as 
it associates with DCC in neurones, and Nek lacking an SH2 domain can block all 
DCC induced cytoskeletal changes (Li et al, 2002). Nek also could regulate the actin 
cytoskeleton by recruiting PAK to the plasma membrane (Bokoch et al, 1996), or by 
interacting and regulating the dual GEF, Trio (Newsome et al, 2000). How UNC-5 
mediates growth cone repulsion is not known.
1.3.2 The slits
The slit family of guidance cues play a role in a number of processes during neuronal 
development, including neuronal migration, axonal path finding and dendritic 
branching. Three slits have been identified in vertebrates with overlapping patterns of
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expression (Holmes et al, 1998; Itoh et al, 1998), although there appears to be a 
degree of redundancy amongst them (Plump et al, 2002). Work in Drosophila has 
demonstrated that the slits are important in preventing some axons from crossing the 
midline, and prevent others from re-crossing (Kidd et al, 1999; Simpson et al, 2000). 
Although the slits have been shown in vitro to act as axonal repellents, an N-terminal 
cleavage product can promote branching in dorsal root ganglia neurones (Wang et al,
1999). Both these processes require the slit receptor, robo (Nguyen Ba-Charvet et al,
2001).
The robo receptors contain large extracellular domains and an intracellular domain, 
consisting of domain repeats called CC repeats, which have no apparent enzymatic 
activity but are required for slit mediated axonal repulsion (Figure 1.7; Bashaw and 
Goodman, 1999). The intracellular domain has also been shown to inhibit netrin- 
mediated attraction by binding to the DCC receptor (Stein and Tessier-Lavigne,
2001). The CC repeats of the intracellular domain are important for robo function, and 
different CC domains mediate different aspects of robo function. For example, the 
CCI domain of robol is crucial for silencing of the DCC receptor, but is dispensable 
for repulsion of spinal axons (Stein and Tessier-Lavigne, 2001).
Studies in Drosophila suggest a role for Abl tyrosine kinase and one of its substrates, 
Ena in the downstream signalling pathways mediated by the robo receptor. 
Association of Ena with the CCI and CC2 domains positively regulates the robo 
pathway, while phosphorylation of CC3 by Abl inhibits robo function (Bashaw et al,
2000). The robo receptors also regulate the Rho GTPases. Slit-2 downregulates 
Cdc42, and dominant positive Cdc42 can block slit-2 mediated repulsion on neuronal
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migration (Wong et al, 2001). In addition, a novel family of GAPs, termed srGAPs 
(slit-robo GAPs), associate with the robo CC3 motiff via their SH2 domains. These 
GAP’s are important for both the downregulation of Cdc42, and the slit-mediated 
repulsion on neuronal migration (Wong et al, 2001).
1.33 The ephrins
The ephrins are another large family of guidance cues, which are involved in the 
development of the nervous system. There are two classes of ephrins; Ephrin-A, 
consisting of A1-A5 and ephrin-B, consisting of B1-B3. Class A Ephrins are GPl- 
linked while class B ephrin’s are transmembrane proteins, and so both require cell-to- 
cell contact in order to mediate their effects. The receptors for the ephrins are the Eph 
receptors, a large family of receptor tyrosine kinases, which are further divided into 
two classes, A (EphAl-A8) and B (EphBl-EphB3). As well as their involvement in 
the axonal guidance, ephrins and Eph receptors are also involved in cell migration, 
vascular development, tissue-border formation and synaptic plasticity (Knoll and 
Drescher, 2002).
As a result of the requirement of cell-to-cell contact, the ephrins and Eph receptors are 
able to mediate both forward and reverse signalling. Forward signalling is the usual 
direction of signalling pathways, with the ephrin ligand binding to and activating the 
Eph receptor, which then autophosphorylates. The Eph receptors can influence the 
Rho GTPases through the RhoA GEF, Eph-interacting exchange factor, ephexin 
(Shamah et al, 2001). In addition to ephexin, Eph activation has been shown to 
inactivate the Ras pathway, resulting in neurite retraction, although the mechanism 
underlying this pathway is yet to be identified (Elowe et al, 2001).
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The reverse signalling allows the cell contact to signal from the Eph receptor to the 
ephrin-bearing cell. Conserved tyrosine residues in the ephrinB cytoplasmic domain 
are phosphorylated following the formation of the ephrinB/EphB complex (Bruckner 
et al, 1997), possibly by Src tyrosine kinases, fibroblast growth factor or platelet- 
derived growth factor receptor tyrosine kinases (Chong et al, 2000; Palmer et al,
2002). A result of the tyrosine phosphorylation of ephrinB is the recruitment of the 
SH2/SH3 adapter protein Grb4. Grb4 binds via its SH2 and can regulate the activity 
of focal adhesion kinase (FAK), the distribution of paxillin and the disassembly of 
actin stress fibres (Cowan and Henkemeyer, 2001). In addition to the tyrosine 
phosphorylation of ephrinB, reverse signalling can also be mediated through a C- 
terminal PDZ-binding motif, contained in all ephrinBs. This motif enables the binding 
of PDZ-domain containing proteins such as PTP-BL tyrosine phosphatase (Palmer et 
al, 2002), glutamate-receptor-interacting protein GRIPI and 2 (Bruckner et al, 1999) 
and PDZ-RGS3 (Lu et al, 2001). The latter contains a regulator-of-heterotrimeric G 
protein-signalling (RGS) domain, enabling it to regulate the downstream signalling 
from heterotrimeric G proteins.
Reverse signalling can probably also occur with the ephrinA family, although there 
are some differences. The recruitment of ephrinBs to lipid rafts is regulated by Eph 
binding (Bruckner et al, 1999), however ephrinAs are constitutively clustered around 
these membrane compartments. The binding of EphA to ephrinAS results in signalling 
pathways requiring the activation of the lipid raft-associated tyrosine kinase, Fyn 
(Davy et al, 1999), while activation of EphA2 results in the dephosphorylation of 
focal adhesion kinase and reduced adhesion (Miao et al, 2000). However the
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activation of ephrinAs promote adhesion in the ephrin-bearing cell by an integrin 
dependant mechanism (Davy and Robbins, 2000).
1.3.4 The semaphorins
The semaphorins are a large family of secreted and membrane anchored guidance 
cues that can mediate repulsive responses on growth cones, although some attractive 
responses can occur. Although they have been widely studied in the nervous system, 
they have also been shown to play a role in the development of the cardiovascular 
system (Serini et al, 2003), morphogenesis of the lung (Ito et al, 2000) and in invasive 
growth of epithelial cells (Giordano et al, 2002). Over 30 members of the semaphorin 
family have been identified so far, all of which contain a N-terminal sema domain.
The functional receptor for class 3 semaphorins is a complex of plexins and 
neuropilins. The neuropilins are required for ligand binding while plexins, with a 
large cytoplasmic domain, forms the signalling component (Takahashi et al, 1999).
Neuropilin-1 expression varies during development depending on neurone type and 
stage of development. NT-3 dependent sensory axons from embryonic chick drg are 
sensitive to sema3A, although from E7 to ElO there is a progressive decrease in 
neuropilin-1 expression and a corresponding decrease in the sema3A response (Pond 
et al, 2002). NGF-dependant drg neurone axons express progressively higher levels of 
neuropillin-1 and progressively higher response to sema3A during the same stages of 
development (Pond et al, 2002). Expression of neuropilin-1 is maintained into the 
adult in dorsal root ganglia neurones, although only nociceptive sensory axons are 
sensitive to sema3A (Reza et al, 1999). Although neuropilins have only a small
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cytoplasmic domain, they may serve some signalling purpose. Neuropilin Interacting 
Protein (NIP) is a PDZ domain containing protein, which interacts with neuropilin 
cytoplasmic domain (Cai et al, 1999). It has been shown to interact with RGS-GAIP 
(a protein located to the membrane of clatherin-coated vesicles), and so may play 
some role in vesicle transport of the neuropilin receptor (De Vries et al, 1998).
Plexins also contain an N-terminal sema domain, which binds to neuropilin to inhibit 
signalling. Upon binding of semaSA, this interaction is disrupted and the inhibition is 
removed (Takahashi and Strittmatter, 2001). Other semaphorins have been shown to 
bind directly to plexins, such as sema4D, which binds to plexinBl, and sema?A, 
which binds to plexinCl (Tamagnone et al, 1999). All plexins and neuropilins found 
so far are membrane associated. Of the seven classes of semaphorins, only two are 
soluble, sema2 and sema3. All others are membrane associated and so require cell 
contact to mediate their effects (Reviewed Dickinson, 2002)
Another component of the semaphorin receptor complex is LI, a cell adhesion 
molecule of the Ig super family (Reviewed Schachner, 1991). LI is an important part 
of the plexinA/neuropilin-1 complex, and is required for the repulsive reaction of 
cortical and dorsal root ganglia axons to semaSA, but is not required for semaSB, 3C 
or 3E mediated responses (Castellani et al, 2000).
As Avith many growth cone guidance cues, the semaphorin receptor complexes signal 
through to the Rho GTPases, although many of the signalling components are 
unknown. Sema3A induced growth cone collapse is a Racl dependant process, and 
dominant negative Racl inhibits collapse (Jin and Strittmatter, 1997). The
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cytoplasmic tail of plexinBl binds to Racl in a GTP-dependant manor, possibly 
inhibiting Racl activation of PAK (Vikis et al, 2000), as well as modulating the 
binding of sema4D to plexinBl (Vikis et al, 2002). A different region of plexinB also 
binds directly to RhoA, although this interaction is independent of the GTP/GDP- 
bound state of RhoA (Hu et al, 2001). The identification of a novel RhoGEFs 
presented another way by which the plexins can regulate the RhoGTPases. PDZ- 
RhoGEF/LARG is crucial for sema4D/plexinBl induced growth cone collapse in 
hippocampal neurones (Swiercz et al, 2002), therefore providing mechanisms for 
plexinBl to both down regulate Racl and up regulate RhoA (Driessens et al, 2002).
PlexinAl does not bind Racl, although it does binds to RhoD and Rndl. RhoD and 
Rndl compete for the same binding site. Recruitment of Rndl activates plexinAl 
signalling, while RhoD binding inhibits both plexinAl signalling and Rndl 
activation, consequently blocking semaSA induce growth cone collapse (Zanata et al, 
2002). Sema3A induces the phosphorylation of cofilin by LIM kinase (Aizawa et al,
2001), resulting in inactivation of cofilin. Cofilin is required for depolymerisation and 
turn over of actin, which is an important process in maintaining actin structures 
(Carlier et al, 1988).
The plexins themselves do not have any kinase activity, although some kinases have 
been shown to associate with them, providing additional mechanisms for plexin 
signalling. The tyrosine kinase Fes, interacts with, and phosphorylates plexinAl, 
although co-expression of neuropilin 1 attenuated this process. Fes appears to be able 
to activate plexin signalling, and expression of kinase inactive Fes suppresses 
semaSA-induced growth cone collapse (Mitsui et al, 2002). A member of the Src
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family of kinases, Fyn is associated with plexinAl, and phosphorylates the 
cytoplasmic tail of plexinAl. In addition Fyn phosphorylates Cdk5, which can also 
associate with the plexin/neuropillin complex, although this appears to be indirect 
(Sasaki et al, 1001). Tyrosine phosphorylation of Cdk5 by Fyn plays a role in semaSA 
collapse, and mutation of this site, tyrosine 15, in Cdk5 partially inhibits collapse. 
Treatment of drg neurones with Cdk5 inhibitors can also block collapse, while drg 
neurones prepared from either Cdk5 or Fyn knockout mice showed that both kinases 
are crucial for semaSA signalling (Sasaki et al, 1001).
Another kinase, glycogen synthase kinase (GSK-3), is localised as an inactive pool in 
the growth cone. Following semaSA treatment, GSK-S becomes activated (Eickholt et 
al, 1001), although it is unclear what the consequence of activation is. With the 
demonstration that 11/15-Lipoxygenase is required, further components of the 
semaSA signalling pathway are implicated. Inhibiting this enzyme blocks semaSA- 
mediated collapse, while application of the enzyme/substrate product mimics 
collapse, causing loss of adhesion at the growth cone (Mikule et al, 1001). Again, the 
role played by these signalling molecules has yet to be identified.
Another protein, MICAL (molecule interacting with CasL) also plays a role in 
semaphorin signalling. MICAL, a member of the family of putative flavoprotein 
monooxygenases, interacts with plexinA and is required for semalA/plexinA 
mediated axon repulsion in Drosophila neurones (Terman et al, 1001). Mutations in 
the flavoprotein monooxygenase domain blocks semalA collapse in Drosophila 
motor neurones, while flavoprotein monooxygenase inhibitors block semaSA induced 
collapse in vertebrate neurones (Mikule et al, 1001), suggesting redox reactions play
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some role in semaphorin signalling, although it remains unclear what this role is. 
Further searches for novel components of semaphorin signalling identified Off-Track, 
(OTK), a transmembrane protein that associates with plexinA (Winberg et al, 2001). 
OTK mutants demonstrate similar phenotypes to plexinA or Drosophila semalA 
mutants suggesting they act in the same pathway, although no function has yet been 
assigned to OTK.
Although semaSA has been widely characterised as a repulsive guidance cue, there is 
some evidence to suggest that, under some circumstances, it can also act as an 
attractive cue. While semaSA repels cortical axons, it can attract cortical dendrites. 
This response is dependant on the presence of guanylate cyclase in the growth cone 
(Polleux et al, 2000), and thereis an involvement of cyclic nucleotide molecules in the 
modulation of guidance cues (Song et al, 1998).
1.3.5 The role of guidance cues in nervous system development
The role of guidance cues in the development of the nervous system has become an 
area of intensive research. This has been examined using well-defined processes in 
the development of both vertebrate and invertebrate nervous systems. One such 
developmental process is the development and guidance of the commissure neurones. 
These neurones are bom on one side of the nervous system midline, and develop 
axons that are guided through the midline onto the other side of the nervous system, 
allowing the two halves to communicate. In the vertebrates these axons cross the 
spinal cord midline, while in invertebrates they cross the ventral nerve cord.
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Figure 1.8. Guidance of commissure axons to the spinal cord 
midline.
The guidance of axons to their targets can be broken down into stages, with the end of 
each containing a “choice point”. These choice points are determined by accessory 
cells, which provide the guiding axon with information needed to guide to the next 
choice point (reviewed in Tessier-Lavigne and Goodman, 1996). The midline of the 
nervous system provides a very important choice point, which some axons cross while 
others do not. On reaching the midline, axons will turn at right angles to the midline, 
growing on either the ipsilateral side (same side), or the contralateral side (opposite 
side) of the midline. Further to the decision whether or not to cross is the decision to
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grow either in a rostral (anterior) or caudal (posterior) direction, and the guidance 
cues required to enable axons to make these decisions are provided by the floor plate 
cells. The floor plate is a group of cells spanning the width of spinal cord at the 
ventral midline, and is required for correct guidance of axons along and across the 
midline.
In the early development of the nervous system, commissure neurones are formed at 
dorsolateral positions on both sides of the spinal cord. The first axons, pioneer axons, 
follow the ventral edge of the spinal cord, round until they reach the midline. 
Subsequent axons, termed follower axons, follow the original path of the pioneer 
axons, but leave the edge of the spinal cord after a while to take a more direct route to 
the midline. On reaching the midline, the axons cross the ventral third of the 
floorplate, and on reaching the contralateral edge of the floor plate turn at right angles 
and grow in either the rostral or caudal direction. Once they have crossed the midline, 
these axons do not re-cross.
Another group of neurones, called association intemeurones, form axons that 
originally follow the same path as the commissure neurones, and project to the 
midline. However these axons do not cross the midline, and instead turn right angles 
and grow along parallel to the midline, but on the ipsilateral side (reviewed by 
Colamarino and Tessier-Lavigne, 1995). The floor plate appears to be crucial to 
enable commissure axons to cross the midline, although is unclear whether the 
intemeurones require the floorplate to run along parallel to the midline.
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Figure 1.9. The role of the midline in the guidance of commissure axons, 
(Adapted from Tessier-Lavigne and Goodman, 1996).
The floor plate cells secrete the axonal attractant netrin-1 (Kennedy et al, 1994), 
which helps guide both the commissure and intemeurone axons towards the midline 
(Serafini et al, 1996). As the netrins can also exhibit repulsive effects in growth cones, 
it is possible they are also responsible for preventing axons from entering the midline 
when entering the floor plate is inappropriate.
A further three different axonal repellents also appear to play a role in preventing 
axons either crossing the midline, or in the case of commissure axons, re-crossing the 
midline. The slit-robo signalling pathways are a crucial component of the growth 
inhibition activity of the midline. Knockout studies of robo in Drosophila showed that
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there is excessive axonal crossing of the midline with ipsilateral axons crossing, and 
contralateral axons recrossing (Seeger et al, 1993). Expression of robo is very low in 
axons crossing the midline, while it is high in ipsilateral axons and commissure axons 
that have reached the contralateral edge of the midline, strongly suggesting a role of 
the slit/robo pathway in defining the midline guidance. Consequently, axons crossing 
the midline appear to be insensitive to the slits in order to allow them to cross. 
However, once they have crossed the midline, they become sensitive to slit, and so do 
not re-enter the midline (Zou et al, 2000). In the case of slit mutants, the axons enter 
the midline but do not leave, and instead grow through the spinal cord (Sonnenfield 
and Jacobs, 1994)
Class B-ephrins also appear to play a role in the guidance of axons through the 
midline. There are 3 different B-ephrins expressed in the floor plate, and the receptor 
EphBl is expressed on many different axons projecting to the midline (Imondi et al, 
2000). In addition, B ephrins can collapse commissure growth cones, suggesting the 
ephrins are involved in preventing axons from inappropriate crossing of the midline. 
Finally, the semaphorins have also been implicated to play a role in the repulsive 
guidance from the midline. Several semaphorin proteins are expressed at the midline, 
as well as other surrounding tissues, and are required to enable correct pathfinding of 
commissure axons (Zou et al, 2000).
The semaphorins are also important in the development of the peripheral nervous 
system, and of particular interest is their role in the development of dorsal root 
ganglia (drg) neurones. In mice drg axons enter the spinal cord by E ll , and form 
branches, which reach the grey matter by E l5, and reach their specific targets by E l7.
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During this time sema3 mRNA is highly expressed in the entire ventral half of the 
spinal cord, except for the floor plate. By El 1, the peripheral sensory axons enter the 
sclerotome, a region of developing cells that will form the vertebrae and ribs, and 
semaS mRNA is expressed throughout these areas, especially regions the axons pass 
en route to their targets, but do not penetrate (Wright et al, 1995).
Between E12 and E l5, the peripheral axons project and branch into smaller fascicles, 
which then extend into their targets. Many of the tissues surrounding the peripheral 
nerves express sema3 at this time, before being downregulated, and disappearing by 
birth (Wright et al, 1995). However, adult sensory drgs retain their ability to respond 
to semaS (Tanelian et al, 1997).
The importance of semaphorins in correct neuronal development has been 
demonstrated in knockout studies in mice, which show abnormal peripheral 
projections. Homozygous knockouts of semaSD show defects in many nerves such as 
the trigeminal nerve, which normally projects to the eye (Taniguchi et al, 1997). The 
nerves still reach the eye in semaSD knockout mutants, although the nerves 
defasciculate and spread out, resulting in some axons projecting to the wrong targets. 
In addition, without semaSD, axons project into the lens of the eye, which does not 
normally occur (Taniguchi et al, 1997).
A semaSD deficiency also causes defects in the structures of the drgs themselves, 
which are normally exposed to semaSD expression from the surrounding tissues. In 
the normal environment, the peripheral projections of the sensory neurones leave the 
drg’s at a ventral site before meeting the ventral roots from the spinal cord. However,
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in sema3 knockouts, these axons leave the ganglia from a lateral site and innervate the 
dorsal muscles directly (Taniguchi et al, 1997).
1.3.6 Modulation of guidance cues
Although the predominant effects of many guidance cues have been identified, many 
can exhibit both attractive and repulsive effects. For example, sema3A attracts 
cortical dendrites, (Polleux et al, 2000). Conversely, netrin-1 can become repulsive 
when Unc-5 associates with the DCC receptor (Hong et al, 1999). There are, however 
intracellular mediators, which can switch the response of neurones to the guidance 
cues. In Xenopus spinal cord neurones, an increase in Ca^  ^ in the growth cone is 
required for growth cone turning in response to netrin-1 or acetyl choline, and 
preventing this increase can block growth cone turning (Zheng et al 1994; Hong et al 
2000). In addition to Ca^ ,^ cAMP and cGMP can modulate growth cone responses. 
The response of growth cones to all guidance cues tested can be modulated by either 
cAMP or cGMP, and so they have been placed into two groups. Group 1, including 
netrin-1, BDNF, Ach and MAG can all be altered by increased PKA activity; Netrin- 
1, BDNF and Ach are all converted to repulsive signals, while MAG is converted to 
an attractive signal. Group 2, including semaSA and NT-3 are converted by PKG 
activity, with semaSA converting to attraction and NT-S converting to repulsion 
(Song et al, 1998). The intracellular targets of PKG or PKA involved in modulating 
growth cone responses are yet to be identified, but the Ena/VASP proteins may be 
involved as they are phosphorylated by both PKA and PKG, and play a role in 
regulation of the actin cytoskeleton (Waldmann et al, 1987; Lambrechts et al, 2000; 
Reviewed in Krause et al, 200S). Many other proteins may be involved downstream 
of PKA and PKG during axonal guidance, such as RhoA which is phosphorylated by
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PKA (Lang et al, 1996), affecting its interaction with ROK and RhoGDl (Dong et al, 
1996).
1.3.7 Collapsin Response Mediator Protein
The Collapsin Response Mediator Proteins (CRMP) are a family of highly conserved 
neurospecific phosphoproteins, which appear to play a role in axonal guidance. The 
first member of the CRMP family to be identified was CRMP-62, a 62kDa protein 
expressed exclusively in the developing chick nervous system (Goshima et al, 1995). 
It is homologous to unc-33, a nematode protein involved in axonal pathfinding 
(Mintum et al, 1995), and is important in the sema3A-induced collapse pathway 
(Goshima et al, 1995), as antibodies against CRMP-2 can block sema3A-induced 
growth cone collapse. The same protein was independently isolated from rat, and 
termed Turned On After Division-64, (TOAD-64), due to its high expression during 
initial neuronal differentiation (Mintum et al, 1995). It was shown to localise to 
lamellipodia and filopodia of growth cones, and is tightly associated with membranes 
(Mintum et al, 1995). Three additional members of the family were subsequently 
identified in rat with distinct expression pattems (Wang et al, 1996). CRMP-2 (same 
as TOAD-64) is the most widely expressed throughout the nervous system, with the 
highest expression at postnatal day 1, although can still be detected by postnatal day 
30. CRMP-4 and CRMP-1 both show similar expression pattem to CRMP-2, but 
levels of CRMP-4 expression drop more quickly following birth, and cannot be 
detected at postnatal day 30. CRMP-1 expression is intermediate between CRMP-2 
and CRMP-4. CRMP-3 is quite distinct, with maximum expression in the cerebellum, 
and persisting with high levels into adulthood (Wang et al, 1996).
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A fifth member of the CRMP family, CRMP-5 (also called CRAM), was discovered 
and shown to be highly expressed in postmitotic neural precursors of the developing 
nervous system, suggesting an involvement in neuronal migration and differentiation. 
It is also expressed in some adult neurones, such as oligodendrocytes, and has also 
been shown to play a role in the sema3A collapse pathway (Fukada et al, 2000; Ricard 
et al, 2001).
Using CRMP-2 as bait in a yeast two-hybrid screen, CRMP-1 and CRMP-4 were 
isolated, and shown to form heterotetramers, similar in structure to liver 
dihydropyrimidinase heterotetramers, although they do not appear to share related 
enzyamtic functions (Wang and Strittmatter, 1997). The amino acids 8-134 and 281- 
435 are essential in the ability to form these hetramers (Wang and Strittmatter, 1997). 
Another study has shown that CRMP-2 forms a membrane-associated complex with 
glyceraldehydes-3-phosphate dehydrogenase isoform, enolase y and aldolase C 
(Bulliard et al, 1997), although there is no indication to the function of this complex.
It has been recently demonstrated that CRMP-1, 2 and 4 all exist as two splice 
variants, a 64kDa protein, and an N-terminal extended protein of 80kDa (Leung et al, 
2002; Quinn et al, 2003). The splice variant of CRMP-4, termed CRMP-4b, appears 
to play a role in vesicle trafficking in the growth cone (Quinn et al, 2003), while the 
extended variant of CRMP-1 interacts with ROK inhibiting the kinase activity 
towards other substrates, although it is not itself a substrate (Leung et al, 2002).
With the exception of other members of the family, very few proteins were found to 
interact with the CRMP proteins until recently, and there are no identified functional
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domains in the sequence. CRMP Associated Molecule (CRAM, also called CRMP-5) 
is a CRMP-3 interacting protein sharing about 50% homology with other members of 
the CRMP family. It is brain specific and is highly expressed in the embryonic rat 
brain, with much lower expression in the adult brain. Although there is no indication 
of c r a m ’s function, it does immunoprecipitate from brain with the tyrosine kinase, 
Fes, and is up regulated during differentiation of PI 9 and PC 12 cells, suggesting some 
role in neuronal differentiation (Inatome et al, 2000; Mitsui et al, 2002). Fes also 
associates with, and phosphorylates plexinAl, and expression of kinase inactive Fes 
suppresses semaSA-mediated collapse in drg neurones (Mitsui et al, 2002), suggesting 
a role for Fes, CRAM and CRMP-3 in sema3A-mediated growth cone collapse.
CRMP-2 interacts with phopholipase D2 (PLD2) via a region between 243 and 300 
amino acids, and inhibits PLD2 activity in vitro and in vivo in PC 12 cells (Lee et al,
2002). In addition, treatment of PC 12 cells with sema3A could also inhibit PLD2 
activity. PLD2 is localised with CRMP-2, in the distal tips of PC 12 neurites, and 
suggests a role for CRMP-2 and PLD2 in neuronal pathfinding.
CRMP-2 interacts with Numb (Nishimura et al, 2003), a protein involved in 
regulation of the Notch signalling pathway and associates with a-adapatin, during 
endocytosis (Reviewed in Jafar-Nejad et al, 2002; Cayouette and Raff, 2002). CRMP- 
2 associates with Numb during endocytosis of the LI receptor, and suppression of 
CRMP-2 expression blocks receptor endocytosis and neurite outgrowth (Nishimura et 
al, 2003), suggesting a role of CRMP-2 in endocytosis, as well as in the sema3A 
collapse pathway.
74
Chapter 1 Introduction
CRMP-4 interacts with chondroitin sulfate, an important component of the 
extracellular matrix in the nervous system, suggesting CRMP’s may also play a role 
as ligands of the extra cellular matrix, in an unknown function (Franken et al, 2003).
CRMP-2 has been implicated to have some involvement in Alzheimers disease, due to 
the presence of CRMP-2 in neurofibrillary tangles (Yoshida et al, 1998). Although the 
role CRMP-2 plays in these tangles is unclear, it is hyperphosphorylated at 3 sites, 
thr-509, ser-518 and ser-522, suggesting it may be due to the deregulation of a kinase 
(Gu et al, 2000).
Although the CRMP family of proteins are known to play a role in neuronal 
development, their function is yet to be ascertained. However there is some evidence 
to suggest CRMP-2 is involved in microtubule dynamics. CRMP-2 associates with 
microtubule bundles in the spindles at metaphase, and the midbodies at late telophase 
in mitotic cells (Gu et al, 2000). In addition, CRMP-2 binds to tubulin monomers via 
a region stretching from 323-381, and promotes microtubule assembly while deletion 
of the microtubule-binding domain inhibits axonal growth and branching (Fukata et 
al, 2002). The ability of CRMP-2 to affect microtubule dynamics is dependent on the 
splice variant, as the 62kDa CRMP-2 causes organised microtubules, while the 80 
kDa splice variant CRMP-2b results in disorganised microtubules (Yuasa-Kawada et 
al, 2003). These results suggest that the role of CRMP-2, in sema3 A-mediated growth 
cone collapse, could be due to the ability of CRMP-2 to regulate microtubule 
dynamics.
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In addition to its role with microtubules, CRMPs also provide some link to the Rho 
GTPases. CRMP-2 is a substrate of the RhoA effector, ROK, at site thr-555 (Arimura 
et al, 2000). This site is phosphorylated in LPA-induced collapse, and its mutation can 
block LPA collapse. This site is, however, not phosphorylated during sema3A- 
induced collapse, suggesting the two distinct signalling pathways can converge on 
CRMP-2 (Arimura et al, 2000). As well as binding to ROK, the N-terminal extended 
CRMP-1 can also bind to CRMP-2 to block ROK and RhoA induced neurite 
retraction, suggesting a complex can form which can regulate RhoA signalling in the 
growth cone (Leung et al, 2002).
S5 Upper lobe
Lower lobe
Figure 1.10. 3D structure of CRMP-1. (Taken from Deo et al, 2004.)
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A more recent study has resolved the structure of CRMP-1, (Deo et al, 2004; Figure 
1.10), and demonstrated that CRMP-2 associates with plexinAl. This interaction is 
increased in response to sema3A, in Cos? cells expressing both plexinAl and 
neuropilin-1, suggesting a direct interaction between CRMP and the plexins may play 
a role in sema3A signalling (Deo et al, 2004). In addition, deletion of surface amino 
acids, enabled the production of CRMP-1 proteins that could delay semaSA collapse 
(amino acids 487-489, or 367-368), or cause collapse in the absence of sema3A 
treatment (amino acids, 49-56 or 38-43) (Deo et al, 2004). How these deletions affect 
the activity of the CRMPs is unclear, but suggests intermolecular interactions are 
important, although these residues were not involved in the formation of the tetramers 
(Deo et al, 2004).
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2.1 Materials
2.1.1 General laboratory reagents
General laboratory chemicals were obtained from Sigma or BDH. Water was obtained 
from an Elga purification system, provided sterile and de-ionised water, which was then 
autoclaved to sterilise. Ethanol, isopropanol, and acetic acid were obtained from BDH, 
and glycerol from Gibco Invitrogen. Phosphate Buffered Saline (PBS) tablets were from 
Oxoid, ampicillin, kanamycin and sodium dodecyl sulphate (SDS) from Sigma. Bovine 
Albumin was from Jackson Laboratories.
2.1.2 Materials for bacterial work
E.coli, XL 1-Blue and BL21 strains were from Stratagene. Bacterial LB medium 
contained: 1% Tryptone (DIFCO), 1% NaCl (BDH), 0.5% Yeast Extract (DIFCO) in 
ddHzO (purified from Elga purification system) previously autoclaved to sterilise. LB 
agar was made using a 15% Agarose solution (DIFCO) in LB medium. Antibiotics were 
added to the medium when selection was required. Ampicillin was used at lOOpg/ml, 
and Kanamycin at 30ug/ml.
2.13 Reagents for DNA work
Agarose was from Sigma, DNA restriction enzymes, and ligases were obtained from 
Gibco-Invitrogen, Stratagene, Promega or New Englang Biolabs. DNA markers, Haelll- 
digested q>xl74 and HindlU-digested bacteriophage obtained from Gibco-Invitrogen. 
Site-directed mutagenesis kit from Stratagene. DNA extraction columns from Amicon. 
Wizard miniprep DNA kit from Promega. Midi prep DNA kit from Qiagen. Vectors 
used, pGEX bacterial expression vector, pXJ40, pXJ41 mammalian Flag, HA and GFP
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tagged vectors, pEGFP (Clonetech) and pERFP (from Edward Manser) mammalian 
expression vectors.
2.1.4 Reagents for protein work
Protein markers were from NEB, TEMED, protein quantification assay solution from 
Bio-Rad, Bis-acrylamide (30%/0.8%) from Scotlab, PVDF membranes from Perkin- 
Elmer, p-mercaptoethanol, Triton X-100 from BDH, DTT, Sodium Vanadate and 
Sodium Floride from Sigma, protease inhibitor cocktail tablets from Roche, ECL 
hyperfilm, and ECL solution from Amersham, ^^ P GTP from NEN, Glutathione 
sepharose beads from Pharmacia Biotech, Centriprep Concentrators from Amicon. 
HRP-tagged secondary antibodies from DAKO.
2.1.5 Reagents for tissue culture
DMEM, Lipofectamine, Lipofectamine 2000, DMSO, Hams:F12 media, 30% BSA, 
Hanks Buffered Saline Solution and Poly-L-lysine were all from Sigma and Foetal 
Bovine Serum from Gibco Invitrogen. Collagenase from Worthington Biochemical. 
Disposable supplies were from Greiner. Laminin from ICN or Gibco Invitrogen. For all 
cell staining coverslips and slides (BDH), TRJTC-labelled phalloidin (Sigma), TRITC, 
FITC or Cy5 tagged secondary antibodies from DAKO or Jackson laboratories were 
used. Slide mountant was from ICN. Electroporator and solution from Amaxa.
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2.2 Bacterial Work
2.2.1 Transformation of competent bacteria
XL-1 Blue E.coli from Stratagene were thawed on ice. 1.7pl of p-Mercaptoethanol was 
added to lOOpl of bacteria, and incubated on ice for 10 minutes. Ipg of plasmid DNA 
was added to 25pl of bacteria, and incubated on ice for 30 minutes. The bacteria were 
subsequently heat shocked, by heating them to 40°C for 30 seconds, and then returned to 
incubate on ice for 2 minutes. 1ml of LB media was added to the bacteria, and incubated 
at 37°C for 1 hour. 25|il was pipetted onto the agar plates, supplemented with suitable 
antibiotic, and streaked using a sterile glass pipette, and incubated at 37°C overnight.
2.2.2 Growing bacterial cultures for DNA preparation
A single bacterial colony was selected and placed into 5ml of LB, supplemented with 
suitable antibiotic, using a sterile toothpick and incubated at 37°C, with agitation, for 
approximately 7 hours. The 5ml culture was subsequently added to 500ml of LB with 
appropriate antibiotic, and incubated at 37°C with agitation overnight. The 500ml 
culture was centrifuged at 3,500 rpm for 15 minutes, and the medium decanted. The 
bacterial pellets were re-suspended in 10ml PBS, and re-centrifuged in 50ml Falcon 
tubes. PBS was removed, and the bacterial pellets placed at -20°C until ready for DNA 
extraction.
2.23 Bacterial stocks
If bacterial stocks were to be made, 900pl of the 500ml over night culture was placed 
into an eppendorf tube with lOOpl of glycerol. The solution was vortexed to mix, and 
stored at -70°C indefinitely.
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2.2.4 Isolation of plasmid DNA
The plasmid DNA was extracted from the bacterial pellets using a Midi-kit from 
Qiagen, as directed by the manufactures instructions. Briefly, bacterial pellets were 
lysed, and the lysate passed through a filter to remove genomic DNA and cellular 
debris. The plasmid DNA was then retained in a second filter washed and eluted. DNA 
of a concentration of approximately 0.3mg/ml was typically obtained using this kit.
2.2.5 Quantification of DNA concentration and quality
5 pi of the DNA obtained from the Qiagen kit was added to 1ml of TE buffer. The 
absorption of this solution was then measured at two different wavelengths, 260nm and 
280nm, using a spectrophotometer. The reading at 260nm gave the concentration of 
DNA, while 280nm gave the quantity of protein in the sample. A ratio of 260/280 
provided an indication of the purity of the sample, with a reading of between 1.8 and 2.0 
considered good. A blank sample of TE was used to obtain a base reading.
2.3 DNA Work
2.3.1 Polymerase Chain Reaction (FCR)
PGR was carried out to multiply up plasmid DNA inserts that were to be cloned into 
different vectors, as well as for mutagenesis. The PGR reaction was set up as follows:
0.5pl Taq Polymerase (5u/pl) (stratagene), lOpl Taq Buffer, 2pl lOmM NTP, 30ng 
template DNA, 250ng Primer 1,250ng Primer 2, and adjusted to lOOpl with ddHiO.
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The thermal profile parameters were:
De-naturation (xl) -94°C -  5 minutes 
 ^-94°C -  30 seconds 
Cycles (x30) x -50°C -  60 seconds 
-72°C -  90 seconds 
Final (xl) -72°C -  5 minutes and then TC  indefinitely.
lOpl of the PCR sample was run on a DNA electrophoresis gel to check for the product.
If the product was of the correct size, the whole PCR sample was run on a gel, and the 
band corresponding to the product extracted from the gel.
2.3.2 DNA Electrophoresis
Gels for electrophoresis were made using 1.5% agarose, in 100ml of Ix TBE buffer, 
(lOx TBE buffer stock: 900mM Tris-Base, 900mM Boric Acid, 0.02 M EDTA pH 8.0). 
The agarose solution was heated and melted in a microwave, allowed to cool and then 
poured into the prepared electrophoresis tray with comb, and left to set. Once set, the 
tray and gel were placed into the electrophoresis tank, with 0.5x TBE buffer. DNA 
samples were prepared by adding 6x loading buffer (30% glycerol, 0.25% bromophenol 
blue in Ix TBE), and then loaded into the lanes. The gel was run at 140 volts, for 
approximately 1 hour. Following electrophoresis, the gel was soaked in ethidium 
bromide for approximately 45 minutes, to allow visualisation of the DNA.
2.33 Purification of DNA fragments from the gel
Once the band of interest was located, it was excised from the gel, and placed into a 
Millipore spin column, and centrifuged at 14,500 rpm for 20 minutes. This forces the gel
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through a funnel, reducing it to a liquid. The product was then cleaned using Promega 
resin and filter columns, to remove salts or impurities, which could interfere with 
ligation. Once cleaned the DNA was ready to use.
2.3.4 Promega DNA clean up
Promega clean up resin and filter columns were used to clean the DNA following gel 
extraction. 1ml of resin was added to the DNA, and left to incubate at room temperature 
for approximately 10 minutes. A syringe was used to force the resin through a filter 
column, and the flow through discarded. The filter column was cleaned by forcing 
through 2ml 80% Isopropanol. The filters were centrifuged at 14,500 rpm for 20 
minutes to ensure no isopropanol carry over. 50pl of TE buffer heated to 80°C was 
added to the filters, left for 10 minutes, and then centrifiiged at 14,500 rpm, to elute the 
DNA solution. This could then be used directly in any ligation reactions.
2.3.5 Digestion of DNA using Restriction Enzymes
In order to ligate an insert into a vector, both the insert and vector were digested with 
two restriction enzymes to produce complimentary overhangs, and allow directional 
cloning. Typically, when digesting the vector, a 20pl reaction was set up using lOpl 
vector, 2pl corresponding reaction buffer, 1 pi first enzyme, 1 pi second enzyme, and 6pl 
of water. For digestion of insert DNA, a 50pl reaction was set up using 25pl of insert 
DNA, 5pl of corresponding reaction buffer, Ipl first enzyme, Ipl second enzyme, and 
ISpl ddHiO. Both reactions were left from 2 hours to overnight. Following digestion, 
the DNA was cleaned using the Promega clean-up resin.
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2.3.6 S’-Dephosphorylation using Alkaline Phosphatase
When ligations were to be carried out using a blunt ended site, the vector was treated 
with Alkaline Phosphatase (Shrimp enzyme, Promega), to prevent re-annealing. 4pl of 
the vector were added to 2pi Phosphatase enzyme, 3pi buffer and 2Ipl ddHiO, and 
incubated at 37°C for 15 minutes. Following this incubation, the enzyme was heat 
inactivated at 65°C for 15 minutes. The DNA was then used directly in the ligation 
reaction.
2.3.7 Ligation of insert and vector DNA
Following digestion and cleaning, the insert DNA was ligated into the vector. The 
reaction was set up by adding, Ipl vector, 5pi insert, 4pl manufacturers ligation buffer, 
9pl ddHzO and Ipl T4 DNA ligase (Promega), and incubated overnight at room 
temperature. The whole 20pl reaction mix was then used to transform 50pl of competent 
E.coli.
2.3.8 Selection of clones
All ligations carried out were directional, and the presence of bacterial colonies on the 
agarose plates indicated either ligation, or empty vector re-annealing had occurred. To 
check for the presence of the insert, five bacterial colonies were selected from the plates 
using sterile toothpicks, and incubated overnight at 37°C, with agitation, in 5ml of 
selective LB media. The following day, the toothpicks were removed, and the cultures 
centrifiiged 3,500rpm for 15minutes, to form a pellet, and then frozen. The plasmid 
DNA was extracted from the pellets using a Promega Wizard Miniprep kit, following 
the manufactures instructions. Briefly, the bacterial pellet was re-suspended and then
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lysed. The lysate was cleared by centrifugation at 14,500 rpm to remove cellular debris 
and genomic DNA. The cleared lysate was passed through a filter to capture the plasmid 
DNA. The filter was washed, and the DNA eluted, in lOOpl of nuclease free water. The 
isolated DNA prep was then digested with the same restriction enzymes used to set up 
the corresponding ligation reaction, and run on an electrophoresis gel, to confirm the 
presence of the insert.
2.3.9 Site-Directed mutagenesis
To mutate single phosphorylation sites in the CRMP-2 sequence, the QuikChange XL 
Site-Directed Mutagenesis Kit from Stratagene was used. Two complimentary mutation 
primers were made for each site in the FLAG-CRMP-2 vector.
Wild Type: 5’CAGCTAAGACATCCCCTGCCAAGCAG 3’
S522A -1 5’CAGCTAAGACAGCCCCTGCCAAGCAG 3’
S522A -2  3’ GTCGATTCTGTCGGGGACGGTTCGTC 5’
Wild Type: 5’GCCTCATCAGCTAAGACATCCCCTGCCAAGCAGCAGGCG 3’
S522E -1 5’GCCTCATCAGCTAAGACAGAGCCTGCCAAGCAGCAGGCG 3’
S522E -2  3’ CGGAGTAGTCGATTCTGTCTCGGACGGTTCGTCGTCCGC 5’
Wild Type: 5’ CCGCCGCACCACCCAGCGCATTGTGG 3’
T555A -1 5’ CCGCCGCACCGCCCAGCGCATTGTGG 3’
T555A -2  3’ GGCGGCGTGGÇGGGTCGCGTAACACC 5’
Wild Type: 5’ CCGCCGCACCACCCAGCGCATTGTGG 3’
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T555E -1 5’ CCGCCGCACCGAGCAGCGCATTGTGG 3’
T555E -2  3’ GGCGGCGTGGCTCGTCGCGTAACACC 5’
In the first reaction, the serine at position 522 was mutated to an alanine to knock out 
the phosphorylation site (See Chapter 5, Results 3), and also to a glutamine to mimic 
phosphorylation. These same mutations were made to the threonine at position 555. The 
site-directed mutagenesis kit is based on PCR, using the mutant primers to incorporate 
the mutations. Also included were reagents for a control reaction. In this case, the 
template plasmid has a mutated B-galactosidase gene, and so bacteria expressing this 
plasmid would be white when grown on agarose plates containing Isopropyl 
Thiogalactopyranoside (IPTG) and X-gal. However the control primers in this kit 
restore expression of this gene, and so following a successful reaction the bacteria 
would be blue.
The control reaction was set as directed by the manufacturer, and the sample reactions 
were set up as follows, 5pi lOx reaction buffer, lOng of template DNA, 125ng primer 1, 
125ng primer 2, Ipl of lOmM dNTP mix, 3pi of QuikSolution and ddHiO to make 
reaction up to 501p. Finally Ipl of Pfu Turbo DNA polymerase was added. These 
samples were then processed through a PCR cycle using the following parameters:
De-naturation (xl) 95°C for 1 minute 
 ^95°C for 50 seconds 
Cycles (xl 8) < 60°C for 50 seconds
 ^68°C for 8 minutes 
Final (xl) 68°C for 7 minutes and then 7°C indefinitely.
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Once the PCR cycle was complete, l i p  Dpnl restriction enzyme was added to each 
sample, and incubated at 37°C for 1 hour. This restriction enzyme digests the methylated 
parental DNA template, leaving only the mutated plasmid in the sample. Following 
digestion, 2pl of the DNA was used to transform XL 10-Gold ultracompetent bacteria. 
Five bacterial colonies were selected, and the DNA isolated following miniprep DNA 
extraction. The plasmid DNA obtained from these minipreps, were sent for commercial 
DNA sequencing (Cytomix -  Cambridge, UK) to confirm incorporation of the point 
mutation.
2.3.10 Cloning of CRMP-2 and CRMP-2S522A into GST vector
Following the mutation of S522 to an alanine, both CRMP-2 wild type and the S522A 
mutant were cloned into the pXJ40 Glutathione-S-transferase (GST) vector.
The GST vector has the same cloning site and sequences at the pXJ40 FLAG vector, 
therefore the whole insert could be cut out and ligated in. Firstly the FLAG CRMP-2 
and FLAG CRMP-2S522A were digested with Hindlll and Kpn-1. These sites were 
used in the original cloning of the CRMP-2 sequence, and produce opposing over hang 
ends, which would minimise re-annealing.
Following digestion, the samples were run on a DNA gel and the excised insert cut from 
the gel. The DNA fragment was cleaned and ligated into linearised GST vector also 
digested with Hindlll and Kpn-1. Following ligation, XL-1 Blue bacteria were 
transformed, and positive clones identified as described.
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2.3.11 Cloning of CRMP-2 fragments into GST vector
In order to clone fragments of CRMP-2 into a GST vector, the intact FLAG-CRMP-2 
construct was digested. Firstly, the construct was digested with Hindlll and Smal, 
resulting in two fragments, of 336bp and 5700bp. The smaller 336bp fragment was 
isolated from a gel, and used to clone into an HA vector digested with the same 
enzymes. Smal produces a blunt end, which could increase the chances of the vector re­
annealing during ligation, and so the linearised vector was treated with alkaline 
phosphatase. Once the ligation had been completed, and positive clones identified and 
grown up, the insert was excised from the HA vector using Hindlll and Kpn-1. The 
336bp insert was then ligated into pXJ40-GST vector that had been digested with 
Hindlll and Kpn-1. This construct allowed the expression of the first 112 amino acids of 
CRMP-2, fused to a GST tag, which was used for immunoprécipitation studies.
The second fragment was made by digesting the CRMP-2 construct with Hindlll and 
Bgl2. This produced three fragments of 539bp, llSObp and 4318bp. The 539bp 
fragment was isolated and ligated into an HA vector, also digested with Hindlll and 
Bgl2. Once complete, the insert was excised from the HA vector, by digesting with 
Hindlll and Bgl2, and then cloned into the pXJ40-GST vector. This construct allowed 
the expression of the first 180
amino acid residues of CRMP-2 fused to GST. The cloning of this fragment into the 
vector destroyed a large section of the cloning site.
The third fragment was made by digesting the CRMP-2 construct with Hindlll and Oli- 
1, resulting in four fragments, 760bp, 517bp, 442bp and 4318bp. The 760bp fragment 
was used to clone into the GST vector. The Oli-1 restriction enzyme is a blunt cutter.
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and so the insert was ligated into a GST vector digested with Hindlll and Sma-1. The 
linearised vector was treated with alkaline phosphatase to prevent re-annealing. This 
construct allowed expression of the first 252 amino acids of CRMP-2.
In addition to the fi’agments obtained by digesting the construct, further fragments were 
made by PCR. Two C-terminal deletions were made to remove 22 and 70 amino acids 
fi*om the C-terminal. The forward primer (provided by C.Monfries) was the standard 
primer used to PCR the full N-terminal.
Reverse Primer 1 22 amino acid deletion:
5’ GACGTCGGTACCTTAATCATACAGGCCACGAGGGAC 3’
Reverse Primer 2 70 amino acid deletion:
5’ GACGTCGGTACCTTAGGGAATGTTGTCGTCAATCTGAGCAC 3’
In addition, the N-terminal and C-terminal halves were made by PCR. The N-terminal 
Augment was made using the standard forward primer, along with a reverse primer 
designed to anneal halfivay along the sequence.
Reverse primer for N-terminal:
5’ GACGTCGGTACCTTAGGCAGCGGCCTTGGCCCAGTTC 3’
The C-terminal was made using the standard reverse primer (provided by C.Monfiies) 
along with a forward primer designed to anneal halfway along the sequence.
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Forward primer for C-terminal:
5’ GACGTCAAGCTTAGCAAGAACTGGGCCAAGGCCGCTGCC 3’
PCR was run as described, and the fragments ligated into FLAG and GST vectors.
2.4 Protein Work
2.4.1 Expression of recombinant protein in E.coli
In order to express, and isolate recombinant protein, XL-1 Blue E.coli bacteria were 
transformed with the pGEX vector containing the required sequence. This vector 
produces a protein fused to Glutathione-S-Transferase (GST), an enzyme with a very 
high affinity for its substrate, glutathione. Therefore, using sepharose beads attached to 
glutathione the fusion protein can be easily purified from the bacterial lysate.
The bacteria were plated out on agarose, and the selected colonies grown up to obtain 
50ml cultures. These 50ml cultures were then added to flask containing 500ml of LB 
medium, and incubated, with agitation, at 37°C, until the culture had reached an optical 
density of 0.8 - 1.0. This was ascertained by pipetting 1ml of the culture into a visible 
light wavelength cuvette, and taking a reading at a wavelength of 595nm, using LB 
medium to take a base reading.
Once the optical density was at the required level, the bacteria were induced into 
expressing the protein using Isopropyl Thiogalactopyranoside (IPTG), at a working 
concentration of 200pM. The induction step was usually carried out at 37°C with 
agitation, however when expressing the GST-PAK CRIB (70-104), the induction was
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carried out at 30°C, due to an adverse effect of the protein on the bacteria. The cultures 
were then left to express the protein for 1-2 hours, before being centrifuged and frozen.
2.4.2 Purification of GST fusion proteins.
The bacterial pellets were thawed on ice, and re-suspended in 20ml of lysis buffer, 
containing 1% Triton, ImM PhenylMethylSulfonylFluoride (PMSF), ImM 
Dithiothrentol (DTT) and supplemented with protease inhibitor cocktail tablets (Roche). 
Following re-suspension, the mixture was sonicated for 5 minutes, and centrifuged at 
15,000 rpm for 30 minutes. The supernatant was removed and glutathione sepharose 
beads prepared. The beads are stored in an ethanol-based buffer, and so were washed 
three times in ddH20 prior to use. 1ml of beads was added to each 500ml bacterial 
culture lysate, and incubated at 4°C, with rotation, for 2 hours. Following the incubation, 
the beads were spun down, the supernatant removed, and the beads re-suspended in 
20ml of fresh lysis buffer. They were then incubated again at 4°C for 45 minutes. This 
wash was repeated, before the protein was eluted off the glutathione beads. The GST 
fusion protein was eluted off with 10ml of lOmM glutathione/50mM Tris HCl pH7.5, 
incubated at room temperature for 10 minutes. Sepharose beads were removed by 
passing the mixture through filter columns. Any excess glutathione was removed by 
concentrating the protein in Amincon concentrating filters, and adding PBS back up to 
10ml. This step was repeated three times, although no PBS was added at the final step 
so the protein was in a smaller volume, and so more concentrated.
When the Rho GTPases were being made a p21 buffer (50mM TrisHCl pH 7.5, 2.5mM 
MgCli) was used as PBS has an adverse effect on GTPase ftmction.
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2.4.3 Measuring concentration of GST fusion proteins
Following recombinant protein preparation, concentrations was determined using a Bio- 
Rad protein assay. 2pl of the protein sample was added to 800pl of water and 200|il of 
Biorad protein assay reagent, A blank sample was also used, which contained no 
protein. These were left at room temperature for five minutes, and the absorbance at 
595nm measured, using the blank sample as a base reading. The absorbance readings 
were calibrated using a Bovine Serum Albumin (BSA) standard curve in order to 
determine the protein concentrations for each of the samples. The BSA standard curve 
was obtained using 1, 2, 5 and lOmg of protein in the protein assay, and a graph of 
absorbance against protein concentration was plotted.
2.4.4 Purification of MBP fusion proteins
An alternative to GST fusion proteins is the Maltose Binding Protein (MBP) fusion 
protein. MBP binds to maltose with high affinity and maltose conjugated to sepharose 
beads are used to purify the protein from the bacterial lysate. Once the protein had been 
extracted bound to the column and washed in lysis buffer, it was eluted off with lOmM 
maltose, and then concentrated as before. All proteins to be stored long term were kept 
at -70°C otherwise they were kept at -20°C.
2.4.5 Protein Dot Blot Assay
Dot blot assays were carried out to test the ability of the Rho family of GTPases to bind 
directly to CRMP-2. 5pg of the target protein was blotted onto a Icm^ square of 
nitrocellulose. The target proteins used were, GST, GST-CRMP-2, cleaved CRMP-2, 
PAK CRIB and ROK Rho-binding domain. The nitrocellulose was allowed to dry, and 
soaked in re-naturation buffer (3% BSA, 0.1% Triton, 0.5mM MgCb, 5mM DTT) for 1
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hour at 4°C. The GTPase probes were then prepared by adding 25pi of NEB buffer 
(50mM NaCl, 25mM Mes pH6.5, 25mM Tris HCl pH 7.5, 1.25mM EDTA, 1.25mg/ml 
BSA, 1.25mM DTT), Sjig of RhoAV14, RaclV12 or Cdc42V12, lul of GTP a “ P to 
19pl of ddH20. This was then incubated for ten minutes at room temperature. After the 
ten minute period, 25pl of cold GTP was added to 4ml of binding buffer (50mM NaCl, 
25mM Mes pH6.5, 25mM TrisHCl pH7.5, 1.25mM MgCl] 1.25mg/ml BSA, 1.25mM 
DTT). The GTPase probes were then added to the binding buffer, and poured over the 
blots. After five minutes, the nitrocellulose filters were removed from the probes and 
washed five times in wash buffer (50mM NaCl, 25mM Mes pH6.0, 5mM MgCli, 0.25% 
Triton). The filters were allowed to dry, wrapped in cling film, placed into a cassette 
with a sheet of radiofilm and left at -70°C overnight. The film was exposed the 
following day.
2.4.6 Analysis of proteins by SDS Polyacrylamide Gel Electrophoresis 
(PAGE)
Protein samples were separated by SDS PAGE in order to verify their molecular weight. 
The percentage of the polyacrylamide varied depending on the size of proteins needed to 
be resolved, but typically a gel of 12% polyacrylamide suited most cases. The gel mix 
was made (12% polyacrylamide, 0.4M TrisHCl pH 8.8, 0.1% SDS, 10% Glycerol, 
0.02% TEMED, 0.05% Ammonium Persulphate), poured into the prepared cassettes and 
allowed to set, typically 45 minutes to 1 hour. Once set, the stacker was prepared and 
poured on top of the gel, and the comb added to make the lanes. The stacker was made 
by adding to water, 25% stacking buffer (0.5M TrisHCl pH 6.8, 0.4% SDS), 4% 
polyacrlyamide, 0.05% Ammonium Persulphate and 0.2% TEMED. This was also 
allowed to set, the combs removed, and the cassette fixed into the electrophoresis
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equipment. The electrophoresis tank was filled with Ix running buffer (made fi’om lOx 
stock, 250mM TrisBase, 1.92M Glycine, 1% SDS), and then to each sample, a 5x 
solution of Lammeli sample buffer (62mM TrisHCl pH 7.8, 10% Glycerol, 2% SDS, 
0.5% P-mercaptoethanol, 0.05% bromophenol blue) was added. Samples were heated to 
80°C for ten minutes to ensure complete de-naturation of the proteins before being 
loaded into the lanes. Protein markers (New England Biolabs) were also run to allow the 
sizes of the sample proteins to be identified. The samples were electrophoresed at 170 
volts for 1 hour or until the dye fi*ont has reached the edge of the gel.
2.4.7 Coomassie stain of proteins
Following PAGE, the proteins in the gel were visualised by staining with coomassie 
blue dye. The gel was soaked in a 0.1% coomasie dye dissolved in destain solution, for 
at 1 hour, and then soaked in destain (40% methanol, 10% glacial acetic acid, 50% 
water) overnight to remove fi’ee dye. If the gel was to be kept, it was dried in a vacuum 
drier.
2.4.8 Transferring protein to membranes
In order to perform a Western blot on samples, proteins were transferred fi*om the gel 
and immobilised on a membrane. Polyscreen PVDF membrane (PerkinElmer), which 
was cut into the correct size pieces, and soaked in methanol for 45 minutes prior to 
transfer. The gels were removed fi*om the electrophoresis equipment, and soaked in Ix 
Transfer Buffer (lOx stock 25mM TrisBase, 192mM Glycine, made up to Ix with water 
and 20% methanol). Extra thick filter paper was also soaked in the transfer buffer, and 
applied to the Bio-Rad semidry transfer blotter, followed by standard filter paper, also 
soaked in the transfer buffer. The PVDF membrane was laid on top, and the gel on top
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of the PVDF. The edges of the gel were marked on the PVDF to indicate the size of the 
gel. Another layer of standard filter paper was applied on top of the gel, and then finally 
a second layer of the extra thick filter paper. Care was taken to ensure no air remained 
between any of the layers. Transfer was carried out at 4°C, for either 1 hour at 15 volts, 
or overnight at 9 volts.
2.4.9 Immuno detection of proteins immobilised on PVDF membrane
Once transfer had been completed, the PVDF was removed from the blotter, and stained 
in 0.15% coomasie stain for 2 minutes. The membrane was then soaked in destain for 
20-30 minutes, changing destain in between. This would allow visualisation of the 
proteins on the membrane, and also reduces background detection with the antibodies. 
The PVDF was washed in water, and then blocked in 5% marvel/0.1% Tween PBS, for 
1 hour at room temperature, after which the membranes were added to 50ml flacon 
tubes and placed on to a spiralmix and rotated. Primary antibodies were diluted in to 
5ml 1% marvel/0.1% Tween-20 PBS, at the optimal dilution, typically 1:1000 -  1:2000, 
then added to the PVDF, and incubated for 1 hour at room temperature. Following 
incubation with the primary antibody, the PVDF was washed five times in 0.1% Tween 
PBS. The secondary antibody was conjugated to Horse Radish Peroxidase to allow 
proteins to be visualised by chemiluminescence. This was also diluted in 5ml 1% 
marvel/0.1% Tween PBS before being incubated with the PVDF, and incubated at room 
temperature for 1 hour. After the final incubation the PVDF was removed from the 
falcon tubes and placed into a dish, and washed with excess 0.1% Tween PBS. This 
would ensure a harsher washing step, and so reduce the background. Following the 
wash, the PVDF was dried, soaked in ECL solution (Amersham), and placed into a 
cassette. Under safe lighting, a single sheet of ECL film was added to the cassette and
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exposed for 2 minutes, after which the film was removed, and developed in Ix 
developer solution (Kodak). Once developed, the film was fixed (Ix fixer solution - 
Kodak) and washed in water, before being left to dry. Typically two further exposures 
were taken, at 5 minutes and 20 minutes, depending on the strength of signal. Once dry, 
the film was placed in the cassette and lined up with the PVDF to allow the protein 
markers to be indicated.
2.5 Cell Work
2.5.1 Tissue Culture
Four different types of cell line were used in this study. All cell lines were maintained in 
incubators at 37°C with 5% CO2.
The cell line NlE-115, a mouse neuroblastoma cell line, was used for morphological 
studies on the Rho family of GTPases. Cells were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) (Gibco), with 10% Foetal Calf Serum (FCS) and 1% 
antibiotic/antimitotic (Ab/Am) (Gibco), and plated out on Nunc coated petri dishes 
(Gibco). To passage the cells, one plate was taken, and the media removed. 10ml of 
fi-esh, pre-warmed media was added to the dish, and the cells removed by pipetting. The 
cell suspension was then transfered into a 50ml falcon tube, and centrifuged at 750 rpm 
for 8 minutes, after which the media was removed. The cells were re-suspended in fi-esh 
media and plated out at the required density.
The second cell line used was the a2-chimaerin permanent expression cell line a2.13. 
These cells are a permanent NlE-115 cell line previously transfected with a ct2- 
chimaerin vector encoding a neomycin selection gene. These cells were cultured in the
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antibiotic G418 (Calbiochem) to ensure the transfected vector was maintained in all the 
cells. G418 was made up into a lOOmg/ml stock, and used at 800pg/ml. To passage 
these cells it was necessary to trypsinise them, due to their increased adhesion to the 
dishes. The media was removed, and the cells washed once in PBS to remove any 
residual FCS, a potent inhibitor of trypsin. Subsequently, 1ml of lOx trypsin (Gibco) 
was added to the dish, and incubated at 37°C for 2 minutes. The dishes were placed 
under a microscope to check for loss of adhesion, and then passaged as for the standard 
NlE-115 cell line.
Cos-7 cells derived from monkey kidney cells, were used for interaction studies, and to 
verify protein expression, due to their ability to express very high levels of a transfected 
cDNA construct. Culturing was the same as described for the NlE-115 cells line, except 
like the a2.13 cells, they required trypsin in order to detach from the dish.
Swiss 3T3 cells, a fibroblast cell line, were cultured following the same protocol for the 
Cos-7 cells.
Cell stocks were made for all cell lines used. One confluent plate was taken and the cells 
centrifuged to pellet them. They were then re-suspended in a filter sterilised solution of 
90% FCS/10% Dimethyl Sulphoxide (DMSO). This suspension was then pipetted into 
cryotubes (Gibco), which were labelled and placed in -70°C overnight. The following 
day the tubes were placed in liquid nitrogen.
To resuscitate cell stocks from liquid nitrogen, they were thawed quickly at 37°C in the 
water bath, and the cell suspension was added to 10ml of fresh media. This was then
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centrifuged to pellet the cells, and so remove DMSO. The cell pellet was re-suspended 
in media, and plated out.
2.5.2 Preparation of coverslips
Glass coverslips were placed into a 10cm dish, and 10ml of 60% ethanol/40% HCl was 
added. The coverslips were left for 10 minutes, and then rinsed three times in ddH20. 
They were dried on filter paper, wrapped in polyfoil and baked in an oven to sterilise. 
Before use, the coverslips were coated with laminin (Gibco/ICN) (lOpg/ml) or Poly-L- 
lysine (Invitrogen) (5pg/ml). The substrate was added to the coverslip and left 1 hour 
for laminin or 10 minutes for Poly-L-lysine, after which they were washed 3 times in 
PBS and left to dry. Once coated, the coverslips could be kept at 4°C for up to a week 
before use. Chamber slides were coated using the same protocol.
2.53 Transfection of the cell lines
In order to express the required constructs, NlE-115, a2.13 and Cos-7 cells were 
transfected with the required vectors, typically pXJ40. For morphology studies, NlE- 
115 or o2.13 were plated on acid washed, substrate coated coverslips, or chamber slides, 
and left to plate down over night. The following day, the media was removed from the 
dishes and replaced with plain DMEM, with no FCS or Am/Ab. The DNA was prepared 
by adding Ipg of DNA, along with 5pl of Lipofectamine, or Lipofectamine 2000 
(Invitrogen) to 200pl of DMEM. This mixture was pipetted up and down to form 
liposomes with the DNA, and then left for 45 minutes at room temperature before being 
added to the cells. The cells were left in serum-free media for 5 hours. It was then
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replaced with fresh DMEM with FCS and Am/Ah, and the cells left to express 
overnight.
2.5.4 Cell Immunostaining
Cultures and cells to be assessed by immunostaining were washed with PBS and fixed 
with 3% paraformaldehyde (PF) for 20 minutes at room temperature. The PF was 
removed, and cells washed with PBS for 10 minutes, and then lOOmM Glycine/PBS was 
added for 10 minutes to quench any residual PF. Cells were permeabilised in 0.2% 
triton/PBS for 10 minutes, rinsed in PBS, and blocked in 3% BSA/PBS for 10 minutes. 
The primary antibody was diluted in 1% BSA/PBS and added to the coverslip at a 
typical dilution of 1:100. If chamber slides were used, the volume of primary 
antibody/1 % BSA solution added was 500pl, while if coverslips were used, only lOOpl 
was added, parafilm was laid on top to spread the solution over the coverslip. The 
coverslips were incubated with the primary antibody for 1 hour at 37°C, making sure the 
cells did not dry out. Following the primary antibody, the coverslips were washed three 
times in PBS, and then the secondary antibody conjugated to a fluorescent label (FITC- 
Fluorescein Isothiocyanate, TRITC-Tetramethyl Rhodamine Isothiocyanate or Cy5) 
diluted in 1% BSA/PBS, was added. The FITC label has an excitation wavelength of 
488nm, while TRJTC is excited at 545nm, and Cy5 at 633nm. The secondary antibody 
was also typically at a dilution of 1:100. In addition to the secondary antibody, TRITC 
conjugated phalloidin was often added at a concentration 1:100. This compound has a 
very high affinity for actin, and so was used to stain for actin, without having to use an 
antibody. When more than one antibody was used, care was taken to ensure there was 
no risk of any cross reactivity. The coverslips were incubated with the secondary 
antibodies, and phalloidin for 1 hour at 37°C, and washed three times in PBS and
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allowed to dry. Coverslips were then mounted onto slides using immunofluor mountant 
(ICN). When using chamber slides, the chamber was removed from the slides, and the 
gasket cut off using a razor. Once the slide was smooth, a coverslip was mounted onto 
the slide using immunofluor mountant. The mountant was allowed to dry over night, and 
the slides were examined the following day.
If cells were to be stained with phalliodin, but no antibodies, they were fixed as 
described, and queched with lOOmM glycine. They were washed with PBS, and the 
phalliodin added without permeabilising.
2.5.5 Transfection of Cos-7 cells
Cos-7 cells were usually used for interaction studies and to check expression of 
constructs. As such 10cm dishes of Cos-7 cells were transfected. The cells were serum- 
starved in 5ml of DMEM, and 5pg DNA prepared in 1ml of DMEM with 20pl of 
Lipofectamine. As for the neuroblastoma cells, the DNA was left for 45 minutes and 
then added to the dishes. After 5 hours the media was replaced with FCS media and the 
cells left overnight.
2.5.6 Immunoprécipitation
One of the main experiments undertaken in Cos-7 cells was immunoprécipitations (IP). 
Two proteins were expressed in the Cos-7 cells using the transfection protocol 
described, both were tagged, one was usually FLAG and GST due to the availability of 
both anti-FLAG antibodies and glutathione conjugated to sepharose beads. The 
following day the cells were washed with PBS, and lysed in 600pl of lysis buffer 
(25mM Hepes (pH 7.5), 0.3M NaCl, ImM MgCb ImM EGTA, 20mM P-
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glycerophosphate, 5% Glycerol, 0.5% Triton X-100) and supplemented with freshly 
added, ImM Sodium Vanadate, lOmM Sodium Floride, 5mM DTT, ImM PMSF and Ix 
complete protease inhibitor cocktail (Roche). The cells were scraped off, and pipetted 
into tubes, before being sonicated in a reservoir sonicator for 5 minutes. The lysates 
were centrifuged at 14,500 rpm for 10 minutes in a cooled centrifuge, and the 
supernatant pipetted off. 50pl were kept for expression analysis, and the remainder was 
incubated with 20pl of anti-FLAG beads (or prepared glutathione beads), on a rotor for 
3 hours at 4°C. Following incubation, the beads were pelleted in a cooled centrifuge, and 
washed three times in lysis buffer. After the final wash, the beads were left in 
approximately 30pl of buffer, and lOpl of 5x sample buffer was added. lOpl of cell 
lysate was also taken, and 2pi of 5x sample buffer was added. Both the bead samples, 
and the lysate samples were boiled for 10 minutes and resolved by PAGE, before being 
transferred onto PVDF. The PVDF’s were tested for the presence of the secondary 
protein by immuno analysis, and hence demonstrate an interaction. Probing for the 
immunoprecipitated protein, i.e. FLAG or GST tagged, was also performed to confirm 
successftil immunoprécipitation.
2.5.7 Expression in Swiss 3T3 fibroblasts
Swiss 3T3 fibroblasts are not suitable for transfection, and consequently all work 
involving Swiss 3T3 fibroblasts was performed using microinjection. The cells were 
plated onto poly-L-lysine coated coverslips, and left overnight to plate down. They were 
then placed onto a Zeiss Axiovert 135 microscope with a heated stage and CO2 box, to 
maintain temperature and CO2 levels. Using a microinjector, DNA, at a concentration of 
50pg/ml was microinjected directly into the nucleus. Approximately 100 cells were
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injected in a marked area, and left for 5 hours to express the construct. Cells were then 
fixed and stained as described.
2.5.8 Time Lapse Microscopy
In order to observe the changes in cell morphology over time, time-lapse microscopy 
was used. NlE-115 or a2.13 cells were plated out on coverslips, and left to plate down 
over night. For some experiments, the cells were transfected, otherwise they were used 
the following day. They were placed on the microscope, in the CO2 chamber, and in 
some instances were injected with DNA as described. Movies were then made using a 
monitor and a video recorder, with 30 second movies being made approximately every 
10 minutes or so, depending on requirement. Once completed, the movies were 
converted to digital images using frame capture software on a confocal microscope. 
Later, movies were made using a digital camera connected to a computer, and using 
Metamorph software, which also enabled fluorescent movies to be made.
2.5.9 Microscopy
Once the slides had been fixed and stained, they were observed on a Zeiss 135 Axiovert 
microscope using fluorescent filters to observe staining. This microscope was used for 
general examination, and all cell counting. For more detailed pictures with higher 
resolution, a Zeiss LSM 410 confocal microscope was used.
2.5.10 Preparation of rat dorsal root ganglia (drg)
Drg cultures were isolated and maintained according to G. Michaels (Queen Mary 
Westfield College, London). Growth media was prepared by supplementing Hams:F12 
media with 1% lOOx N2 supplement (lOOx N2 supplement: 10ml Hams:F12
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supplemented with 5mg insulin, lOOmg transferring, 6.3 pg progesterone, 16mg 
putrecine, and 5.2ug selenium (all from Sigma)), 0.3% fatty acid free BSA (Sigma), 
lOnM AraC (Sigma) and SOOpl antibiotic solution (Gibco). The solution was filter 
sterilised and stored at -20°C. This media was then filter sterilised, and stored at 4°C for 
no longer than 1 month.
Prior to drg extraction, all coverslips and dishes to be used, were coated with lOpg/ml 
laminin (Gibco). Drg’s were isolated from day 1 postnatal Wistar rats. The rats were 
culled in accordance with the Scientific Procedures Act, and the spines removed. Under 
a microscope, the vertebrae were cut open, exposing the spinal cord. The drg’s were 
removed from the vertebrae using tweezers, and placed into Hams:F12. As many drg’s 
were removed as possible, before being incubated, at 37°C/5% C02, in 0.125% 
collagenase in 5%FCS/F12, for 30 minutes. Following three washes in calcium chloride/ 
magnesium sulphate-free Hank’s buffered saline solution (HESS) (Sigma), the drg’s 
were incubated in Ix trypsin/HBSS (Sigma) for ten minutes. Enzymatic treatment was 
needed to break down the ganglia capsule and tissue, as well as break the cells apart. 
Trypsin treatment was carefully limited to ten minutes to ensure minimal damage to the 
cells. Following trypsin treatment, the ganglia were washed three times in 5% FCS/F12, 
and a further three times in F12. After these washes, the ganglia were triturated in 1ml 
Hams:F12, using a pipette and PI000 tip with the end 0.5cm cut off. Once a suspension 
had been formed, trituration was repeated using a standard P I000 tip. The cell 
suspension was centrifuged through a 15% BSA/F12 gradient, at lOOOrpm for 10 
minutes, to remove debris. The cell pellet was re-suspended in F12, and centrifuged 
again, before being plated out in growth media supplemented with lOOng/ml NGF.
104
Chapter 2 Materials
and Methods
2.5.11 Electroporation of drg’s
If the cells were to be electroporated, the cell pellet was re-suspended in room 
temperature nucelofector reagent (Amaxa), using lOOpl for each DNA construct to be 
used. lOOpl of the cell suspension was pipetted into the provided cuvettes, along with 1- 
3ug DNA. The cuvettes were placed into the electroporator (Amaxa), and the cells 
processed, using programme 0-03. Following electroporation, SOOpl of growth media 
was added to each cuvette, and the cells either plated out immediately, or incubated at 
37°C/5%C02 until ready to be used. Drg’s were plated out in growth media 
supplemented with lOOng/ml NGF. If Sema3A collapse assay were to be performed on 
the cells, the media was replaced the following day, with growth media supplemented 
with 20ng/ml NGF.
2.6 Statistical Analysis
Where stated error bars indicated represent Standard Error of the Mean (SEM), or 
Standard Deviation (SD). Following transfection or treatment, cell morphology was 
quantified accordingly with percentages calculated, and three different fields of view 
were averaged. Each experiment was repeating three times, to allow SEM’s over three 
averages to be used. For drg neurone growth cone collapse assays, certain experiments 
were carried out in triplicate, allowing SEM’s to be calculated over three experiments, 
while others were carried out individually over three experiments, and consequently 
SD’s were used.
Significant values were obtained using a two-tailed students t-test, using all the original 
values before averages were taken. Stars used to indicate significance, relate to standard 
format, * = 0.05, ** = 0.01, *** = 0.001.
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3.1 The effect of CRMP-2 of Rho GTPase morphologies in 
NlE-115 neuroblastoma cells.
The role of the Rho family of GTPases in cell morphology has been widely studied in 
a variety of cell lines (Ridley and Hall, 1992; Ridley et al, 1992; Kozma et al, 1995). 
Of the three key members, RhoA causes cell retraction and formation of stress fibres, 
while both Racl and Cdc42 form peripheral actin structures, such as lamellipodia and 
filopodia, respectively. Although there can be an antagonistic relationship between 
RhoA and Racl (Kozma et al, 1997; Sander et al, 1998), as well as between RhoA 
and Cdc42, in Swiss 3T3 fibroblasts (Kozma et al, 1995), there can also be a 
hierarchal relationship, with Cdc42 activating Racl (Nobes et al, 1995), and with 
Racl activating RhoA (Ridley and Hall, 1992).
The neuroblastoma cell line, NlE-115, is one of the best characterised neuronal cell 
lines. In these cells, the GTPases display similar effects on cell morphology as in 
other cells described previously, with both Racl and Cdc42 inducing the formation of 
peripheral actin structures, and RhoA causing neurite retraction (Kozma et al, 1997). 
However, because the NlE-115 cell line is of neuronal origin, it can be used to 
investigate the possible role of the GTPases in neurite formation, and this provides 
information on morphological differentiation and development in the nervous system 
(Leeuwen et al, 1997; Samer et al, 2000). Therefore these cells were selected as a 
model system to examine possible interplay between the Rho GTPases and CRMP-2 
in neurite outgrowth.
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Collapsin Response Mediator Protein-2 (CRMP-2), is a neurospecific phosphoprotein, 
which is homologous to the C.elegans protein, Unc33 (Goshima et al, 1995; Mintum 
et al, 1995). It is a component of the semaphorin3A signalling pathway (Goshima et 
al, 1995) and is involved in axonal outgrowth (Inagaki et al, 2001; Fukata et al, 2002), 
although its involvement in these fimctions is not well established. The effect of 
CRMP-2 and its possible relationship with the Rho GTPases was investigated in NlE- 
115 cells. An involvement of CRMP-2 with the Rho GTPases had been suggested by 
the finding that it might interact with the RacGAP, a2-chimaerin (PhD Thesis, M. 
Teo) and by studies showing that CRMP-2 is a substrate of ROK, a major RhoA 
effector (Arimura et al, 2000).
3.1.1 The role of the Rho family of GTPases on cell morphology
In order to investigate the role played by Rho GTPases in neuronal morphology, and 
the effect of CRMP-2 on GTPase function, cDNA constructs coding for mutated Rho 
GTPases were used. These were dominant positive mutants, which result in a loss of 
GTPase enzymatic function and causes the GTPase to be constitutively active, and 
dominant negative mutants, which sequester guanosine exchange factors (GEF’s), and 
so reduce the proportion of active GTPase in the cells (Reviewed in Feig, 1999). 
These two mutants of RhoA, Racl and Cdc42 are commonly used to respectively 
mimic or block the effects of the GTPases (Ridley et al, 1992; Kozma et al, 1997; 
Samer et al, 2000).
108
Chapter 3 Results 1
NlE-115 cells demonstrate heterogeneous morphologies, but when cultured in media 
containing 10% FCS are generally round, with few small filopodia (Figure 3.1g). This 
is due to the presence of LPA (lysophosphatidic acid) in the media, which activates 
RhoA and ROK (Ridley and Hall, 1992; Kranenburg et al, 1999), hence resulting in 
contraction of peripheral actin structures (Ridley and Hall, 1992).
M utant E x am p le s D esc rip tio n
Dom inant Positive RhoAV14
Rac1V12
Cdc42V12
M utants have a  defective 
G T P ase  enzym atic 
activity, and so  a re  
unable to  hydrolyse 
GTP. Consequently, they 
rem ain GTP bound, and 
strongly activate 
dow nstream  effectors.
D om inant Negative RhoAN19
Rac1N 17
Cdc24N 17
M utants seq u e s te r  
en d o g en o u s G EF’s, and 
so  a re  ab le to interfere 
with normal signalling 
pathw ays of endogenous 
G T P ases.
T ab le  3.1. D esc rip tio n  o f  th e  d o m in a n t p o s itiv e  a n d  d o m in a n t n eg a tiv e  
R ho  G T P ase  m u ta n ts  u s e d  in th is  s tu d y .
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The neuroblastoma cells were transfected with different GTPase constructs and plated 
on poly-L-lysine in 10% FCS media. Poly-L-lysine provides an adhesion substrate for 
the cells, thought to be due to the anionic cell surface, and the cationic polylysine 
(Mazia et al, 1975) but unlike laminin does not signal through integrins (Rodriguez et 
al, 1989; Guan et al, 1991; Burridge et al, 1992), which activate GTPases (Reviewed 
in Arthur et al, 2002). Therefore, poly-L-lysine was chosen as a substrate to assess the 
effect of the Rho GTPases on the morphology of NlE-115 cells.
After transfection and fixation, the cells were stained for actin using TRITC- 
conjugated phalloidin, and with antibodies to detect protein expression from 
transfected cDNA. Examples of some of the morphologies generated by the GTPases 
obtained using confocal microscopy are shown (Figure 3.1). The dominant positive 
Racl mutant, RaclV12 produced cells that were large, flat and had large lamellipodia 
around the whole periphery (Figure 3.1a), as has been described previously (Leeuwen 
et al, 1997; Samer et al, 2000). This morphology is characteristic of Rac activation in 
NlE-115 neuroblastomas cells (Leeuwen et al, 1997; Samer et al, 2000). Cdc42V12 
also resulted in a proportion of cells exhibiting this Rac phenotype, presumably 
because of the hierarchal relationship between Cdc42 and Racl, with Cdc42 
signalling through to Racl (Nobes and Hall, 1995).
The dominant negative Racl, RaclN17, expressing cells, demonstrated a very 
different phenotype to that seen with the Racl VI2. Cells did not form the Rac
110
Chapter 3 Results 1
GFP Rac1V12 GFP Rac1N17
GFPCdc42V12 GFP Cdc42N17
GFP RhoAV14 GFP RhoAN19
Figure 3.1. Examples of morphologies observed from NlE-115 cultured In 10% 
FCS media.
Cells were transfected with GFP tagged dominant positive (active) and dominant 
negative (inactive) mutants of the Rho GTPases (see Table 3.1). Images show TRITC 
labelled phalloidin (green), and GFP expression (blue). Scale bar equals 25pm.
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phenotypes, and had very few lamellae. Many cells produced short filopodia, (Figure 
3.1b) which are thought to be of sensory rather than structural fimction (Davenport et 
al, 1993), and exhibited features normally associated with Cdc42 activity. Cdc42V12, 
in addition to the Rac phenotypes formed, also produced cells with many filopodia 
(Fig;ure 3.1c), as previously described (Samer et al, 2000). This phenotype was very 
similar to that seen with Rac IN 17 (Figure 3.1b). It is possible that Racl and Cdc42 
can be activated simultaneously, as well as in a hierarchal relationship, and so 
blocking Racl signalling could result in Cdc42 activation, and filopodia formation.
The dominant negative Cdc42 construct, Cdc42N17, formed cells exhibiting the Rac 
phenotype (Figure 3.Id). The morphologies generated by dominant positive Cdc42 
and dominant negative Racl suggest some interplay between Racl and Cdc42, with 
Cdc42 being activated when Racl is inhibited. In addition some cells expressing the 
dominant negative Cdc42 construct exhibited typical Rac phenotypes.
In contrast to RaclVI2 and Cdc42V12, the RhoA dominant positive mutant, 
RhoAV14 expressing cells produced very little outgrowth (Figure 3.le), as previously 
shown (Tigyi et al, 1996; Kozma et al, 1997). Most cells expressing RhoAV14 were 
round with few or no filopodia or lamellipodia. The dominant negative RhoA mutant, 
RhoAN19, demonstrated a very different effect from RhoAV14. Cells had many more 
filopodia (Figure 3.If). This could possibly be attributed to activation of Cdc42 and 
Racl following RhoA inhibition, since RhoA and Cdc42/Racl have an antagonistic 
relationship in neurite outgrowth (Kozma et al, 1997). It is unclear why expression of 
dominant negative RhoA (Figure 3.If) does not induce the formation of round Rac
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phenotypes similar to those observed (Figure 3.1a), especially considering both 
Cdc42V12 and RaclV12 can produce these phenotypes.
The various morphologies of these cells were quantified using the following four 
categories, (i) Rac phenotype, (ii) spiky Rac phenotype, which are similar to Rac 
phenotype with large spread cells, but having filopodia or microspikes around the 
edge instead of ruffles, (iii) cells with processes equal to 1 cell diameter and (iv) cells 
with processes greater than one cell diameter (Figure 3.2).
Morphologies of cells expressing GFP alone were similar to non-transfected cells, 
cultured in 10% serum; they had very few peripheral structures, lamellae or processes, 
although most did produce some small filopodia.
The proportion of cells expressing RaclVI2 adopted the characteristic full Rac 
phenotype (Figure 3.1a), was 7% (Figure 3.2a), whilst cells expressing GFP or 
Rac INI 7 did not produce any of this phenotype. Rac INI 7 expressing cells instead 
formed a variety of phenotypes, such as the formation of filopodia and processes, but 
in conditions of 10% serum, showed no significant morphological changes from the 
GFP control in the categories counted. Although some cells expressing Racl V I2 also 
formed morphologies of the other categories, these were not significantly different 
from the GFP control values.
113
Chapter 3 Results 1
a)
O)
b)
o>c
I .
Ji­
l l-
c)
O)
.£ .
II
C  ^ I SII
■ O  - c  ,0
tl
Rjc phenotypes 
I  Spiky Rac phenolypci 
I  I  ProccMC* « 1 cell dianu 
Procctiea > I cell dianu
(0 (/)
o o
1
i
m tIi:
GFP GFP CRMP-2 Rac1V12 Rac1V 12+ Rac1N17 Rac1N17^
CRMP-2 CRMP-2
DNA Transfected
Rac phoiolypcs 
I  Spiky Rac phenotypes 
I  I  Proceascs -  I cell dianu 
H  Processes > 1 cell dianu I
GFP GFPCRM P-2 Cdc42V12 Cdc42V12 + Cdc42N17 Cdc42N17<
CRMP-2 CRMP-2
DNA Transfected
H  Kac phenotypes 
I  Spiky Rac phenotypes 
I I  Processes I cell dianu 
Processes > I cell dianu
JË & .
GFPCRM P-2 RhoAV14 RhoAV14 ♦ RhoAN19 RhoAN19 + 
CRMP-2 CRMP-2
DNA Transfected
Figure 3.2. Graphical representation of morphologies observed In N1E-115 
cultured In 10% serum.
Cells were plated on Poly-L-lysine and transfected with GFP Rad constructs (a), 
GFP Cdc42 constructs (b) and GFP RhoA constructs (c), with HA CRMP-2. Data 
taken from single experiment performed in triplicate. GFP and GFP CRMP-2 data 
shown in each graph for comparison. Error bars indicate SEM.
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In the NIE-115 cells plated on poly-L-lysine, Cdc42V12 produced a larger number of 
round Rac phenotypes (16%), than Racl V12 (Figure 3.2a). This could be due to the 
hierarchal relationship of the Rho family GTPases, with Cdc42 rapidly signalling to 
Racl (Kozma et al, 1995). It is possible that activation of endogenous Racl under 
these conditions is more effective in the production of the round Rac phenotypes than 
the constitutively active Racl mutant. This may be due to the time of expression. 
Cdc42V12 may induce up regulation of Racl GTP after 16 hours. RaclV12 may 
generate a larger number of these phenotypes at an earlier time point. This may also 
be due to the ability of wild type Racl to cycle between GTP and GDP binding, 
which may be important in the signalling from the GTPases. Cdc42 is usually 
associated with the production of filopodia, and sensory structures, however this was 
not observed after 16 hours in NlE-115 cells plated on poly-L-lysine in 10% serum, 
possibly because of the signalling to Racl. Although expression of Cdc42V12 also 
produced cells with filopodia and short processes, the counts for these categories 
proved to be variable. Cdc42N17 produced a few Rac phenotypes but which was less 
than Cdc42V12, (only 1%), although the presence of these Rac phenotypes suggests 
that Racl can be activated independently of Cdc42.
Finally, quantification of these peripheral structures in RhoAV14 transfected cells, 
showed RhoAVM generated round cells with very little peripheral structures and 
values were low for all categories counted (Figure 3.2c). RhoAN19, however, elicated 
more processes equal to, (9%), and longer than, (12%), 1 cell diameter in length, 
although results showed variability. However there was a significant increase (P < 
0.03), in processes equal to 1 cell diameter, when compared to the GFP control.
115
Chapter 3 Results 1
o
GFP CRMP-2
GFP Rac1V12
GFP CRMP-2
d
GFP Rac1V12 
+ HA CRMP-2
GFP RhoAV14 
+ HA CRMP-2GFP RhoAV14
Figure 3.3. Representative morphoiogies of N1E-115 co-expressing HA CRMP-2 with 
either Rac1V12 or RhoAV14.
HA CRMP-2 was co-expressed with dominant positive mutants, GFP Rac1V12 and GFP 
RhoAV14 in N1E-115. These mutants, are constuituvely active, and so result in strong 
signalling from the relavent GTPase. TRITC labelled phalloidin is shown (green), along 
with GFP expression (blue). HA-staining confirmed expression of CRMP-2 (not shown in 
Fig.3.3d). Scale bar equals 25pm.
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3.1.2 The effect of CRMP-2 on GTPase function
CRMP-2 has been implicated in axon elongation (Inagaki et al, 2002) and its effects 
on neurite outgrowth and associated Rho GTPase morphology were therefore 
investigated. CRMP-2 was expressed alone, and in combination with the dominant 
positive and dominant negative GTPases, to assess whether it exerted any effect on 
cell morphology and GTPase function. When expressed alone in NlE-115 cells, in 
10% serum, GFP CRMP-2 had very little affect on morphology, and all morphology 
categories were very similar to the GFP control (Figure 3.2,a,b,c). GFP CRMP-2 had 
a punctate localisation (Figure 3.3a,b) suggesting that CRMP-2 may localise to 
vesicles or internal membranes. However, it is also possible that this localisation may 
not be physiological, and may be an artefact of overexpression. This was investigated 
further in section 5.6.1.
CRMP-2 had a significant effect when co-expressed with the dominant positive 
mutants, RaclV12 and RhoAVM. When co-expressed with RaclVI2, CRMP-2 
significantly reduced (P < 0.00026) the number of round Rac phenotypes from 7% to 
2% (Figure 3.2a), although there was no increase in the number of processes 
produced. Some of the cells co-expressing CRMP-2 with Racl VI2 appear to show a 
broken outline of the typical Rac phenotype, but instead have filopodia or retraction 
fibres (Figure 3.3d). It appeared that the Rac phenotypes might have been formed, but 
subsequently collapsed, and this was further investigated using time-lapse analysis in 
section 3.5. Not every cell demonstrated this phenotype, and this could well depend 
on the relative expression levels or some cell variability on the time scale at which the 
two constructs are expressed.
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When co-expressed with RhoAVM, CRMP-2 resulted in a significant increase (P < 
0.001) in the number of cells with processes > 1 cell diameter from 5% to 13% 
(Figure 3.2c). Typical phenotypes formed from co-expression of CRMP-2 with 
dominant positive RhoA are shown (Figure 3.3). Cells expressing both RhoAVM and 
CRMP-2 demonstrated more processes and more lamellipodia (Figure 3.3f), both of 
which are not usually associated with RhoA activation.
CRMP-2 did not significantly affect the percentage of Rac phenotypes generated by 
Cdc42V12, although there was a trend towards its reduction (Figure 3.2b). Unlike co­
expression with RaclVI2, CRMP-2 did not significantly alter the number of cells 
exhibiting the Rac phenotype. This could be because CRMP-2 inhibits the response to 
endogenous Racl, but does not affect Cdc42V12, which could continue to signal 
through to Racl. However, overexpressed CRMP-2 may be expected to inhibit 
signalling through to endogenous Racl eventually. CRMP-2 also had little effect 
when co-expressed with any of the three dominant negative RhoGTPases, (Figure 
3.2,a,b,c), resulting in no significant differences in morphologies, when compared 
with expression of the dominant negative constructs alone.
3.1.3 Laminin enhances Racl morphology
To investigate whether the substrate affected the morphologies produced, 
transfections were repeated with cells plated on laminin. The preceding experiments 
were carried out on poly-L-lysine, which provides little substrate signalling. 
Therefore, in order to investigate whether the substrate exerts any effect on the 
morphology, the experiment was repeated using mouse laminin, which activates ap 
integrins and enhances adhesion (Buck and Horwitz, 1987).
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Figure 3.4. Examples of morphologies observed in N1E-115, expressing dominant 
positive RhoA or Rad, with and without CRMP-2, plated on laminin.
HA CRMP-2 was co-expressed with GFP RhoAV14 or GFP Rac1V12 in N1E-115 plated 
on laminin, and cultured in 10% serum. Cells were stained for actin using TRITC labelled 
phalliodin (green), anti HA (red), while GFP expression (blue) acted as a marker of 
GTPases expression. HA stain was used to confirm CRMP-2 expression (not shown in 
Fig3.4d). Scale bar equals 25pm.
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Morphologies of NlE-115 cells cultured on laminin were similar to those on poly-L- 
lysine (Figure 3.4). Cells expressing GFP CRMP-2 were very similar in appearance to 
those expressing GFP alone (Figure 3.4a,b). On laminin, GFP and GFP CRMP-2 
produced 1-2% cells with processes longer than 1 cell diameter. GFP CRMP-2 
produced a small but significant increase (P < 0.02) in the number of cells with 
processes equal to 1 cell diameter, 5% for GFP and 8% for GFP CRMP-2 (Figure 3.5, 
c). There were fewer cells with processes longer than 1 cell diameter when expressing 
GFP or GFP CRMP-2, and cultured on laminin (Figure 3.5a-d) when compared with 
those cultured on poly-L-lysine (Figure 3.2).
On laminin, cells expressing GFP RaclVI2 were typically large, flat with 
lamellipodia (Figure 3.4c), similar to those seen with cells cultured on poly-L-lysine 
but a higher proportion of these phenotypes were formed (10%). On laminin, 
Rac IV12 expression also resulted in more round flat Rac phenotypes (10%) than 
Cdc42V12 expression (5%) unlike results with cells cultured on poly-L-lysine (Figure 
3.5a). Thus, the laminin substrate enabled expression of Racl VI2 to produce more 
cell exhibiting spread phenotypes and lamellipodia. Laminin enhances adhesion to the 
substrate, and adhesion may be an important component of the Rac phenotype.
Co-expression of HA CRMP-2 with GFP Racl VI2 gave rise to cells that did not form 
the usual Rac phenotype, but which did form some filopodia and lamellipodia (Figure 
3.4d). There was a larger effect of CRMP-2 co-expression with Racl VI2 on NlE-115 
cells plated on laminin, compared to poly-L-lysine. Expressed alone, RaclVI2 
produced 10% round flat Rac phenotypes (Figure 3.5a). However co-expression with
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CRMP-2 resulted in only 2% flat round Rac phenotypes (Figure 3.5a), and this 
difference was significant (P < 0.001).
Although there was a trend towards an increase in spiky Rac phenotypes when 
CRMP-2 was co-expressed with RaclVI2, this was variable and not significant 
(Figure 3.5b). There was however, a significant increase (P < 0.0003) in the numbers 
of cells with processes equal to one cell diameter (Figure 3.5c). This increase was not 
maintained in the processes longer than 1 cell diameter (Figure 3.5d). This may be 
due to the time scale of the experiment, which was 16 hours. However, these short 
processes, equal to 1 cell diameter, maybe a result of the collapse of the round fiat 
Rac phenotypes, leaving short retraction fibres.
Cdc42V12 expressing cells cultured on laminin demonstrated a reduction in the 
number of Rac phenotypes when compared to poly-L-lysine, with 5% as opposed to 
10% on poly-L-lysine (Figure 3.5a). Values for the other categories remained similar 
to the NlE-115 cells cultured in poly-L-lysine. This would suggest that Cdc42V12 is 
able to active endogenous Racl more effectively in cells plated on poly-L-lysine, 
compared with cells plated on laminin.
Co-expression of CRMP-2 with Cdc42V12 did not produce any large morphological 
differences, compared with expression of Cdc42V12 alone. There was a small but 
significant decrease (P < 0.02) in the number of fiat round Rac phenotypes when 
Cdc42V12 was co-expressed with CRMP-2 (Figure 3.5a), which had not been 
observed when cells were cultured on poly-L-lysine. When co-expressed with 
Cdc42V12, CRMP-2 also produced a significant increase (P < 0.008)
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Figure 3.5. Quantification of morphologies in N1E-115, plated on laminin and 
expressing dominant positive Rho GTPases, with or without HA CRMP-2.
HA CRMP-2 alone or co-expressed with either GFP Rac1V12, GFP Cdc42V12 or GFP 
RhoAVM. Counts for Rac phenotypes (a), spikey Rac phenotypes (b), processes 1 cell 
diameter in length (c) or processes longer than 1 cell diameter in length (d) were quantified 
from the same study and plotted on different graphs. Data is from three separate experiments. 
Error bars represent SEM.
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in the percentage of cells bearing processes longer than 1 cell diameter, when 
compared with Cdc42V12 alone. These results are similar to those observed with 
RaclV12 and CRMP-2, although there was an increase in cells bearing processes 
equal to 1 cell diameter with RaclVI2 and CRMP-2, and an increase in cells bearing 
processes longer than 1 cell diameter with Cdc42V12 and CRMP-2, suggesting some 
involvement of Cdc42 in neurite elongation.
Cells expressing GFP RhoAVM were small and round with no peripheral structures 
(Figure 3.4e), on laminin as well as on poly-L-lysine. Counts were very similar to the 
GFP control in cells in 10% serum (Figure 3.5a-d).
Co-expression of HA CRMP-2 with GFP RhoAVM produced different phenotypes. 
Some cells produced filopodia and lamellae, and some cells exhibited elongated cell 
bodies (Figure 3.4f,g). There was a small but significant increase (P < 0.02) in the 
number of round Rac phenotypes when CRMP-2 was co-expressed with RhoAVM, 
compared with expression of RhoAVM alone (Figure 3.5a). In addition to this 
increase, there was an increase (P < 0.01) in the number of spiky Rac phenotypes 
when CRMP-2 was co-expressed with RhoAVM (Figure 3.5b). There was a small but 
significant increase (P < 0.01) in the number of cell processes longer than 1 cell 
diameter (Figure 3.5c) but this difference was not as great as the effect observed on 
poly-L-lysine (Figure 3.2c). The number of cells with shorter processes remained the 
same (Figure 3.5c).
The substrate on which NlE-115 cells were cultured was an important factor in 
determining cell morphologies, with laminin and poly-L-lysine having different
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Figure 3.6. Comparason of Rac morphologies observed in N1E-115 on different 
laminin sources.
Cells were plated on laminin from ION or Gibco-lnvitrogen, and the number of Rac 
morphologies observed was quantified. Error bars represent SEM.
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effects on the morphologies produced with the Rho GTPases and CRMP-2. It was 
also found that laminin from different sources showed quantitatively different effects 
when CRMP-2 was co-expressed with RhoAV14. On previous experiments, laminin 
was obtained from ICN, and an alternative laminin source was obtained from Gibco- 
lnvitrogen. NlE-115 cells were transfected with RhoAV14 alone, or co-expressed 
with CRMP-2, and generated significantly more Rac phenotypes when plated on 
laminin from Gibco-lnvitrogen (P < 0.006) (Figure 3.6). RhoAV14 and CRMP-2 co­
expression produced approximately 1% Rac phenotypes on ICN laminin, and 8% Rac 
phenotypes on Gibco-lnvitrogen laminin. Subsequent experiments were performed 
using laminin from Gibco-lnvitrogen.
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3.1.4 CRMP-2 alters R ad and RhoA morphologies
On Gibco-lnvitrogen laminin substrate, RaclV12 alone had a greater effect on NIE- 
115 cell morphology. The number of Rac phenotypes was > 20% of cells expressing 
RaclV12 (Figure 3.7a), compared with 6% on poly-L-lysine (Figure 3.2a), and 10% 
on ICN laminin (Figure 3.5A). When CRMP-2 was co-expressed with Rac 1VI2 in 
cells on Gibco-invitrogen laminin, there was a highly significant decrease (P < 3.6 x 
10^) in the number of round Rac phenotypes, fi*om > 20% to around 3% (Figure 
3.7a). In these experiments, cells bearing processes equal to, and longer than 1 cell 
diameter, were quantified. The number of cells with processes remained the same for 
both cells expressing RaclV12, and those co-expressing Rac 1VI2 and CRMP-2, 
suggesting that the decrease in round Rac phenotypes was not a consequence of the 
production of processes (Figure 3.7a).
The effects of RhoAV14 and CRMP-2 co-expression in the generation of Rac 
phenotypes were enhanced on Gibo-invitrogen laminin, (Figure 3.7b). Alone, 
RhoAV14 had very little effect on the morphology of cells in 10% serum, when 
compared with the GFP control. There were no Rac phenotypes and very few cells 
with processes (Figure 3.7b). However, when CRMP-2 was co-expressed with 
RhoAV14, there was a highly significant increase (P < 3.9 x 10^) in the number of 
Rac phenotypes fi*om 0% with RhoAV14 alone to 8% when RhoAV14 was co­
expressed with CRMP-2. The number of Rac phenotypes in cells co-expressing 
CRMP-2 and RhoAV14 was 8%, although this represents a major effect since 
dominant positive RhoA would normally be expected to have an opposite effect on 
outgrowth.
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Figure 3.7. Graphical representation of the effect of HA CRMP-2 on morphologies 
observed with GFP Rac1V12 (a) or GFP RhoAV14 (b).
N1E-115 were transfected with dominant positive Rad or RhoA alone, or with HA CRMP- 
2. Cells were plated on Gibco-lnvitrogen laminin, and cultured in 10% serum. Counts were 
obtained from three separate experiments, and error bars represent SEM.
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Coupled to this increase in the number of Rac phenotypes, was a significant increase 
(P < 0.001) in the number of cells bearing processes, from 6% in cells expressing 
RhoAV14 alone, to 15% with cells expressing RhoAV14 and CRMP-2. This effect is 
unusual as RhoA is usually associated with contraction and the inhibition of 
outgrowth, and dominant active RhoA is a strong inhibitor of outgrowth (Kozma et al 
1997).
These results further suggested that the expression of CRMP-2 alone could increase 
the number of process bearing cells. When CRMP-2 alone was expressed in cells in 
10% serum, there was a significant increase (P < 0.03) in the number of cells with 
processes (Figure 3.7b), although this increase has not been consistent, and suggests 
that under certain conditions, CRMP-2 alone can induce the formation of processes. 
CRMP-2 has been shown to play a role in axonal development of cultured 
hippocampal neurones (Inagaki et al, 2001), and in other studies has been shown to 
induce neurite outgrowth in NlE-115 cells (Fukata et al, 2002). In this study all 
experiments were performed in 10% serum-containing media. However, Fukata et al, 
(2002) expressed CRMP-2 in cells cultured in 5% serum-containing media. NlE-115 
cells undergo differentiation when deprived of serum (Reagan et al, 1990) and so the 
serum content of the media could have a large effect on the morphologies of these 
cells expressing Rho GTPases and CRMP-2, as well as the substrate. It is also 
possible in these experiments there was some variability in the serum, with some 
serum batches activating RhoA more strongly, and so result in some variability in cell 
morphologies, especially in the absence of a strong signalling pathway, such as the 
expression of dominant positive GTPases.
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3.2 Time-lapse analysis of CRMP-2 and the Rho GTPases 
in NlE-115 cells
The transfection experiments, analysed at a fixed time point, demonstrated that 
expression of CRMP-2 with RhoAVM and R aclV ll could affect cell morphology 
after 16 hours. However these experiments do not provide an indication of how these 
changes occur over time. This was investigated using time-lapse microscopy to 
observe NlE-115 cells on laminin, and either transfected or microinjected with 
GTPase cDNA and CRMP-2 cDNA mammalian expression vectors.
3.2.1 Time-lapse analysis of CRMP-2 and RaclV12 co-injection in 
NlE-115 neuroblastomas.
Cells plated on laminin-coated coverslips were injected with both GFP RaclV12 
DNA and GFP CRMP-2 DNA. The cells were monitored fi*om the time of injection, 
and images were taken at set time points in order to observe any changes over time 
(Figure 3.8a,b). When injected alone, GFP RaclV12 caused the cells to flatten and 
spread after 1 hour, and then induced the formation of lamellipodia and membrane 
ruffles (Figure 3.8a). However, injection of GFP CRMP-2 had no effect on cell 
morphology (Figure 3.8a). Following co-injection of GFP CRMP-2 and GFP 
RaclV12, only minimal morphological changes occurred during the 6 V% hour time 
period investigated. The initial round cell, with no peripheral structures, became 
slightly flattened with few filopodia at points around the edge, approximately 4 hours 
post-injection. Despite the filopodia becoming more pronounced after the 6 hour 
period, the cell did not resemble the flat round Rac phenotype shown in earlier 
experiments (See Figure 3.1), in response to RacIV12.
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Figure 3.8a. Phase contrast time-lapse analysis of NlE-115 injected 
with GFP CRMP-2 or GFP Rac1V12.
Cells were plated on laminin over night. DNA was injected at 1 pg/ml at time 
point 0. Cells were analysed over the time points indicated. Scale bar 
equals 25pm.
130
Chapter 3 Results 1
Tim e 0 3h15m insSOmins
4h15m ins 5h15m ins
1
6 h35m ins
Figure 3.8b. Phase contrast time-lapse analysis of N1E-115 
injected with GFP CRMP-2 and GFP Rac1V12.
Cells were plated on laminin over night. DNA was injected at 
1 pg/ml at time point 0. Cells were analysed over the time points 
indicated. Scale bar equals 25pm.
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3.2.2 Time-lapse analysis of RaclV12 DNA injection, followed by 
CRMP-2 DNA injection.
When GFP RaclV12 cDNA was injected alone, cells spread extensively and 
produced lamellipodia and a recognisable Rac phenotype (Figure 3.9). GFP CRMP-2 
cDNA was subsequently injected into the same cell, at time point 2hours 40mins. 
Over the following 4 hours, a dramatic change in morphology was observed (Figure
3.9). Within 35 minutes the cell began to collapse around the edge and the main cell 
body became thin and retracted back, leaving thin processes. Over the next 3 hours 
the cell periphery became thinner, and retracted back into the cell. By the final time 
point, 6 hours 40 minutes, the cell had changed considerably.
These time-lapse studies suggest that CRMP-2 is able to inhibit Racl signalling when 
both cDNA’s are injected into cells together. Furthermore, if CRMP-2 cDNA is 
injected following Racl activation and stabilisation of a Rac morphology, it is able to 
cause cell collapse reversing the effects of Racl. It is unclear how CRMP-2 was 
preventing the formation of Rac phenotypes, although this effect could be due to 
direct inhibition of Racl, activation of RhoA or some other mechanism.
3.2.3 Time-lapse analysis of the role of RhoA and Cdc42 in CRMP-2- 
induced collapse of Rac morphologies in RaclV12 expressing NlE- 
115.
To investigate the mechanism involved, and whether other members of the Rho 
family of GTPases participated in generating the morphological response to CRMP-2 
and Racl VI2, dominant negative GTPases were used to determine whether they
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Figure 3.9. Phase contrast time-lapse analysis of NlE-115 injected with GFP Rac1V12, 
and subsequently Injected with GFP CRMP-2.
Cells were plated over night on laminin, and injected with GFP Rac1V12 DNA at l^g/ml. After 
2h 40mins, GFP CRMP-2 DNA was injected into the same cell at 1^g/ml. A typical cell is 
shown, and recorded at the time points indicated. Scale bar equals 26pm.
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blocked the response. Cells were first transfected with RaclV12 and allowed to form 
the Rac phenotype over night. The following day, cells exhibiting Rac phenotypes 
were injected with either CRMP-2 cDNA alone or CRMP-2 cDNA in combination 
with dominant negative GTPases cDNA (Figure 3.10). Each injection was repeated 
three times, and a typical result of each injection is shown (Figure 3.10).
The injection with CRMP-2 alone in a RaclVI2 expressing cell, (Figure 3.10a) 
resulted a very similar effect as with previous microinjection experiments (see Figure
3.9), with cell periphery collapsing. The collapse was not complete however, with 
some retraction fibres remaining at the original cell edge, and perhaps even extending 
further (Figure 3.10a, see arrow). This collapse occurred over a much shorter time 
course than the previous time-lapse at 2 V2 hours, possibly because the cells had been 
expressing RaclV12 overnight, expressing higher levels of RaclVI2, and so 
exhibited stronger Racl signalling, and had formed a full Rac phenotype initially.
In order to determine whether the collapse involved activation of RhoA signalling, 
dominant negative RhoAN19 was used to block RhoA signalling. RaclVI2 
expressing cells, with established Rac phenotype, were co-injected with RhoAN19 
with CRMP-2 cDNAs (Figure 3.10b). In this case there was no elaborate collapse of 
the periphery, however the lamellipodia around the edge did collapse slightly and 
appeared to form dense retraction fibres. The cells were monitored for over 4 hours, 
but the phenotype formed by 3 hours appeared to be stable (Figure 3.10b).
When CRMP-2 cDNA was injected into Racl VI2 expressing cells, some areas of the 
periphery did not collapse, but appeared to form filopodia (Figure 3.10a), structures
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Figure 3.10. Phase contrast analysis of NlE-115 expressing GFP RaclVI2, 
injected with GFP CRMP-2, alone or with dominant negative RhoA or Cdc42.
Cells plated on laminin and cultured in 10% serum, were transfected with GFP 
Racl V I2, and left overnight to express. Following morning, CRMP-2 was injected alone 
(a), with GFP RhoANIO (b) or with Cdc42N17 (c), at time point 0. Injection of GFP 
RhoANIQ or GFP Cdc42N17 alone is shown (d). All DNA’s were injected at Ipg/ml. 
Scale bar equals 25pm.
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usually associated with Cdc42. Therefore, in order to test for any Cdc42 involvement 
in the maintenance of the filopodia, CRMP-2 and Cdc42N17 cDNA’s were co­
injected into a Racl VI2 expressing cell. This resulted in a very different morphology, 
with cells collapsing completely, typically within 2 hours (Figure 3.10c). There were 
no filopodia remaining, and by the end, there were no peripheral structures visible. 
Control RaclVI2 cells injected with either Cdc42N17 or RhoAN19 cDNAs in the 
absence of CRMP-2 showed that these constructs alone had no effect on pre- 
established Rac morphology (Figure 3.10d).
These time-lapse studies indicate that both Cdc42 and RhoA are both involved in the 
cellular collapse response to CRMP-2 with active Rac. A single experiment is shown 
for each condition. The experiment was performed on three separate occasions, 
producing the same response.
3.2.4 CRMP-2 and Rho AVI 4 in time-lapse
In order to observe the changes occurring when CRMP-2 and RhoAVM are co­
expressed, GFP CRMP-2 and GFP RhoAVM cDNA’s were co-injected into NlE-115 
neuroblastomas cells. The cells started round, with no peripheral structures, typical of 
the NlE-115 cell line cultured in 10% serum, (Figure 3.11). However, after 2 hours 
there were changes in cell morphology. Typically filopodia started to form, and then 
the cells began to spread. By 5 hours, cells had a very flat, and spread phenotype, with 
small filopodia around the edge. This morphology appears to be a Rac-like phenotype, 
although the presence of filopodia would suggest some Cdc42 involvement. This 
experiment was repeated on three occasions, and a typical response is shown in Figure 
3.11.
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Figure 3.11. Phase contrast time-lapse analysis of NlE-115 co-injected with GFP 
RhoAVM and GFP CRMP-2.
Cells were plated overnight on laminin, in 10%serum. GFP RhoANIQ and GFP CRMP-2 
were co-injected at time point 0. DNA’s were injected at1 ^ g/ml, and images taken at the 
time points indicated. Scale bar equals 25|jm.
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3.2.5 The role of Racl and Cdc42 on the effect of CRMP-2 with 
RhoAVM
The time-lapse study of CRMP-2 and RhoAVM suggested that both Racl and Cdc42 
might be involved, since cells produced both filopodia and cell spreading (Figure 
3.11), effects associated with Cdc42 and Racl, respectively. To investigate the role 
Racl and Cdc42 play in the effect of CRMP-2 with RhoAVM, dominant negative 
GTPases were used. Transfections were carried out with RhoAVM alone, RhoAVM 
co-expressed with CRMP-2, or RhoAVM and CRMP-2 together with either Rac INI 7 
or Cdc42N17, to block the effects of Racl and Cdc42 respectively.
RhoAVM RhoAVM + CRMP-2 RhoAVM + CRMP-2 RhoAVM + CRMP-2
+ Rac1N17 +Cdc42N17
DNA transfected
Figure 3.12. CRMP-2 and RhoAVM induced Rac phenotypes involve both Racl 
and Cdc42.
N1E-115 were transfected with the DNA constructs shown. Three different fields of 
view, of at least 50 cells, were counted per experiment, over three separate 
experiments. Error bars represent SEM.
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Results showed that RaclNlT strongly inhibited the effect of CRMP-2 with 
RhoAVM (Figure 3.12). The percentage of Rac phenotypes, produced with RhoAVM 
and CRMP-2, was reduced from 8% to 1% in the presence of RaclNl? (P < 0.0004). 
Cdc42N17 exerted a lesser effect, reducing the number of Rac phenotypes from 8% 
down to 4% (P < 0.04). This suggests that, although both Racl and Cdc42 are both 
involved in the phenotype seen with CRMP-2 and RhoAVM, Racl is the major 
contributor to the morphologies counted, and suggests that Racl is activated 
independently of Cdc42. However, Cdc42N17 did reduce the number of cells 
demonstrating the Rac phenotype, and so is involved. Racl may be activated 
downstream of Cdc42, as well as by a separate, Cdc42-independent mechanism.
3.3 The effect of CRMP-2 phosphorylation on Rho GTPase 
induced morphologies
CRMP-2 has been shown to be a substrate for the RhoA effector ROK, which 
phosphorylates CRMP-2 at threonine 555 (Arimura et al, 2000). To examine whether 
this phosphorylation site contributed to the ability of CRMP-2 to alter Racl and RhoA 
signalling, it was mutated to alanine (See Methods). The effect of this mutant, CRMP- 
2T555A, was investigated in combination with either Racl V12 or RhoAVM.
3.3.1 CRMP-2T555A with Racl V12 and RhoAV14
The T555A mutation completely blocked the ability of CRMP-2 to inhibit the Rac 
phenotype with RaclV12 (Figure 3.13a). The number of Rac phenotypes when 
RaclV12 was co-expressed with the CRMP-2T555A mutant, was the same as for the 
Racl VI2 control, with 25% Rac phenotypes. Both were significantly different (P <
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Figure 3.13. The effect of the T555A mutation of CRMP-2 function.
N1E-115 were transfected with GFP Rac1V12 alone, or in combination with FLAG 
CRMP-2 or FLAG CRMP-2T555A (a). Cells were also transfected with GFP RhoAV14 
alone or in combination with FLAG CRMP-2 or FLAG CRMP-2T555A (b). Cells 
demonstrating Rac phenotypes were counted. Three experiments were performed 
with three different fields of view counted. Error bars represent SEM.
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P<2.5 X 10'  ^ and P<0.004) from the RaclV12 and CRMP-2 wild type transfection. 
However elimination of the phosphorylation site had no effect in combination with 
RhoAVM (Figure 3.13b). RhoAVM co-expressed with either CRMP-2T555A or 
CRMP-2 wild type produced around 9% Rac phenotypes. The difference from the 
RhoAVM control was equally significant for both CRMP-2 (P < 0.002) and CRMP- 
2T555A (P < 0.003) co-expressed with RhoAVM. This result was unexpected as 
CRMP-2 is phosphorylated at T555 by ROK, and therefore might have been expected 
that phosphorylation at this site would have been downstream of RhoAVM and 
required for this activity. CRMP-2 has been shown to be phosphorylated at T555 
downstream of LPA (Arimura et al, 2001), and so is phosphorylated downstream of 
RhoA in some pathways. While CRMP-2 may indeed be phosphorylated downstream 
of RhoAVM when both are co-expressed in NlE-115 cells, it appears that is not 
required for the ability of CRMP-2 to activate Racl when co-expressed with 
RhoAVM. However, CRMP-2 is phosphorylated by ROK during the collapse 
produced by RaclVI2 and CRMP-2. The collapse process does appear to involve 
RhoA signalling as RhoAN19 blocked CRMP-2-induced collapse of Racl phenotypes 
(Figure 3.10b).
3.3.2 CRMP-2 induced inhibition of RaclV12 morphologies, 
involves ROK
To determine whether it was indeed ROK that phosphorylated CRMP-2 at T555 
during the collapse of Rac phenotypes, Racl VI2 was co-expressed with CRMP-2, in 
the presence of either kinase dead ROK, or RhoAN19 (Figure 3.14). In the presence 
of kinase dead ROK, the effect of CRMP-2 with RaclV12 was eliminated. Co­
expression of RaclV12 with CRMP-2 significantly reduced the number of round Rac
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phenotypes from the RaclVI2 control value (P < 0.0003) and from that of 
RaclV12/CRMP-2/kinase dead ROK transfection (P < 9 x 10' )^. The transfection of 
Rac 1V12/CRMP-2/kinase dead ROK was also significantly different from the 
Rac 1V12/CRMP-2/RhoAN 19 (P < 0.0002).
RhoAN19 had a lesser, and intermediate effect, than kdROK on Rac phenotypes, (P < 
0.001), but in combination with RaclVI2 and CRMP-2 the production of rac 
phenotypes was still significantly reduced and there was no significant difference 
from Rac 1V12/CRMP-2 in the absence of RhoAN 19.
&
I I  20
R a d  V I2 R a d  V I2+ 
CRMP-2
R adV 12+
CRMP-2
KDROK
R a d  V I2+ 
CRMP-2 
RhoAN 19
DNA Transfected
Figure 3.14. The effect of ROK and RhoA on morphologies produced by 
CRMP-2 and Rac1V12.
N1E-115 cells were transfected with GFP Rac1V12 alone, or in combination with 
FLAG CRMP-2, FLAG CRMP-2 and kinase dead ROK, or FLAG CRMP-2 and GFP 
RhoAN19. Cells with Rac phenotypes were counted. Three separate experiments 
were performed, with three different fields of view counted for each. Error bars 
represent SEM.
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The transfections involving kinase dead ROK correlate well with the inability of the 
CRMP-2T555A to inhibit the production of round Rac phenotypes (Figure 3.13b). It 
also suggests that ROK is responsible for phosphorylation of CRMP-2 at T555, to 
inhibit Racl signalling.
The expression of RhoAN 19 had a slight effect on the number of Rac phenotypes, but 
this was not statistically different from those produced by co-expression of RaclV12 
with CRMP-2. In time-lapse experiments, RhoAN 19 was able to block CRMP-2- 
induced collapse with RaclV12, and so this result appears to be in contradiction to 
that result. This may be due to the time scale of the experiment. The time-lapse 
experiments were performed over a few hours, whereas these transfection studies 
were performed over 16 hours. Possibly by this time point, RhoAN 19 has much less 
of an effect. This result might indicate that kinase inactive ROK is a far more 
effective inhibitor of function, than RhoAN 19. Alternatively, the ability of ROK to 
phosphorylate CRMP-2, when co-expressed with RaclVI2 could be independent of 
RhoA. Other GTPases have been shown to bind to ROK, such as RhoE (Riento et al, 
2003), Gem and Rad (Ward et al, 2002), but these all inhibit ROK function. It is 
possible another GTPase, other than RhoA binds to, and activates ROK. Kinase 
inactive ROK would interact with ROK substrates and prevent the kinase active 
endogenous form from phosphorylating them. However RhoAN 19 sequesters GEF’s, 
and so should prevent endogenous GEF’s from activating endogenous RhoA, but may 
affect others GEFs such as Trio.
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3.3.3 Morphological studies in Swiss 3T3 fibroblasts
The NlE-115 neuroblastoma cells provided some insights into the effect of CRMP-2 
with the Rho GTPases. However, the Swiss 3T3 fibroblast cell line is a model 
commonly used for studying RhoA and Racl signalling and their effects on the actin 
cytoskeleton. They show clear and well defined RhoGTPases morphology, with RhoA 
forming stress fibres and focal adhesions, and Racl forming lamellipodia, ruffles, and 
dissolution of stress fibres and focal adhesions (Ridley and Hall, 1992; Ridley et al, 
1992). RhoAVM expression in NlE-115 cells produces rounded phenotypes similar 
to those cultured in 10% PCS media alone, and NlE-115 cells do not form stress 
fibres. Swiss 3T3 fibroblasts were therefore used to further investigate effects of 
CRMP-2 on Rho signalling.
When cultured in 10% serum, Swiss 3T3 fibroblasts form actin stress fibres, and focal 
adhesions, (Figure 3.15b,v,x) in a RhoA dependent manner (Ridley et al, 1992). 
Swiss3T3 cells cultured in 1% serum produce filopodia, and have few stress fibres, 
while expression of RhoAVM results in the formation of dense stress fibres and 
causes the cells to round up (Figure 3.15a,i).
Swiss 3T3 fibroblasts were injected with the relevant cDNAs, and allowed to express 
for four hours, before fixing and staining. RhoAVM expression produced very clear 
and characteristic phenotypes (Figure 3.15a,i), small rounded cells with very dense 
and thick stress fibres. RhoA activation is known to cause the formation of focal 
adhesions (Ridley and Hall, 1992), which anchor the stress fibres to the membrane 
allowing them to span the width of the cell. When CRMP-2 was co-injected with 
RhoAVM, the cells did not form these dense stress fibres, and instead formed
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Figure 3.15a.
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Figure 3.15. The effect of CRMP-2 and CRMP-2T555A on RhoA and Racl-induced 
morphologies in Swiss 3T3 fibroblasts.
Cells were injected with GFP RhoAVM (a) or GFP Rac1V12 (b), along with FLAG CRMP-2 
or FLAG CRMP-2T555A. Cells were stained with TRITC conjugated phalliodin to label actin, 
and anti-vinculin antibody (Sigma) was used in the R a dV I2 experiments to label focal 
adhesions, while GFP fluorescence indicated GTPase expression. All DNA’s were injected 
at 50^g/ml. Where necessary arrows indicate injected cells. Scale bar equals 25pm.
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filopodia, with actin structures around the cell periphery (Figure 3.15a(ii)). This 
demonstrated a difference between the two different cell lines; in the NlE-115 cells, 
co-expression of RhoAVM with CRMP-2 produced Rac phenotypes, but in Swiss 
3T3 cells, they produced a Cdc42 phenotype. This suggests the two cell types have a 
predisposition to either Racl or Cdc42 signalling when RhoA signalling is inhibited. 
As with the NlE-115 transfections, the T555A mutation had no effect on the ability of 
CRMP-2 to alter RhoAVM morphologies (Figure 3.15a, iii).
When expressed in Swiss 3T3 cells, cultured in 10% serum, RaclV12 also produced a 
very characteristic phenotype (Figure 3.15b, vi). There were few stress fibres crossing 
the cell, but the actin formed dense structures around the cell periphery forming 
lamellipodia. The cells did not have the typical angular shape of fibroblasts, but 
instead form rounded ruffles around the edge. Staining for vinculin, a protein present 
in focal adhesions, showed that although there were no large focal adhesions, as seen 
in control cells, there were many smaller focal adhesions around the cell periphery, 
which have been previously reported in response to Racl activation (Nobes et al, 
1995) demonstrating that adhesion is an important component of lamellipodia 
formation. Expression of CRMP-2 alone had little effect compared to the uninjected 
cells (Figure 3.15b,iv-v).
When CRMP-2 and RaclVI2 were co-expressed, the cell formed a more angular 
shape (Figure 3.15b,ii,vii). The vinculin staining showed that some dense focal 
adhesions have been formed. Also some stress fibres had formed, crossing between 
the focal adhesions. This suggests that there is RhoA signalling in these cells, 
resulting in these structural changes. Expression of the CRMP-2T555A mutant
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abolished this effect, and very few stress fibres or focal adhesions were observed 
further suggesting that phosphorylation at threonine 555 is required for CRMP-2 to be 
able to inhibit RaclV12-induce phenotypes. However, cells expressing CRMP- 
2T555A and RaclV12 did not appear to form as many ruffles as RaclV12 alone, 
suggesting the T555A phosphorylation mutation did not completely block the effect 
of CRMP-2 on RaclV12 morphologies.
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Chapter 3 summary
The Rho family of GTPases have a well established role in the regulation of the actin 
cytoskeleton (Ridley and Hall, 1992; Ridley et al, 1992), and their effects in the 
neuroblastoma cell line NlE-115 have been well characterised (Kozma et al, 1995). 
The data here suggest that CRMP-2, a neurospecific protein involved in the semaSA 
pathway, can alter the effects of the GTPases.
The transfection experiments showed that when co-expressed with Rac IV12, CRMP- 
2 reduced the production of Rac phenotypes, and when co-expressed with RhoAVM, 
CRMP-2 induced the production of neurites and Rac phenotypes. CRMP-2 had a ,uch 
lesser effect when co-expressed with Cdc42V12.
When CRMP-2 and RaclVI2 were co-injected, and subject to time-lapse analysis 
there was no production of lamellipodia or processes. When cells already expressing 
RaclVI2 were microinjected with CRMP-2, the cell collapsed in localised regions, 
leaving microspikes/retraction fibres and promoting filopodia in others. The 
microspikes and collapse appear to be due to different members of the Rho GTPases 
as RhoAN 19 blocked the collapse, while the filopodia were blocked with Cdc42N17. 
The time-lapse analysis of NlE-115 cells expressing both RhoAVM and CRMP-2 
showed that the cells flatten and spread out, before producing filopodia around the 
edge.
CRMP-2T555A, a non-phosphorylatable ROK mutant had the same effect as CRMP- 
2 with RhoAVM, and resulted in generation of Rac phenotypes. When expressed with 
RaclV12, CRMP-2T555A was not able to inhibit the formation of Rac phenotypes.
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Expression of kinase inactive Rho kinase confirmed that Rho kinase was responsible 
for phosphorylating CRMP-2 in this pathway.
The use of Swiss 3T3 fibroblast cells enabled the investigation of positive RhoA 
signalling. Expression of Rho AVI 4 in Swiss 3T3 cells cultured in low serum, results 
in formation of very dense stress fibres and focal adhesions. In these cells, CRMP-2 
expressed with RhoAVM, produces a Cdc42 like phenotype with filopodia. When 
CRMP-2 was co-expressed with Racl V12, there was a loss of lamellipodia and some 
focal adhesions were formed and also some stress. This appeared to be dependent on 
the T555 site.
These results indicate that CRMP-2 is able to switch Racl and RhoA morphologies, 
in two different cell lines, and this switch is, at least in part, regulated by 
phosphorylation at threonine 555 by ROK.
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4.1 Interactions between CRMP-2 and Rho GTPases
4.1.1 Binding of CRMP-2 and the Rho GTPases.
The ability of CRMP-2 to alter GTPase function suggested CRMP-2 might interact 
directly with the Rho GTPases, and so inhibit activation of their effectors. In order to 
test this, dotblots were performed using recombinant CRMP-2, probed with labelled 
recombinant Rho GTPases (Figure 4.1a). Recombinant GST control, GST CRMP-2, 
and cleaved CRMP-2 were pipetted into a nitrocellulose membrane. PAK CRIB, 
which binds RaclV12 and Cdc42V12, and ROK Rho A Binding Domain (RBD), 
which binds RhoAV14, were used as positive controls. GST was also included to 
ensure any interaction was not due to the GST tag. The dotblots were incubated with 
recombinant Racl V12, RhoAV14 or Cdc42V12 loaded with a^^P GTP (Figure 4.1a).
e Ü
■ #
» %
•
RhoAV14
Rac1V12
Cdc42V12
I—
CO
O
® a :
Ü o
CL
CO CL 
COO
Figure 4.1a. Dot blot showing the binding of CRMP-2 with the Rho GTPases.
GSTCRMP-2, cleaved CRMP-2, GST, ROK RB or PAK CRIB (5pg) on nitrocellulose were 
incubated with 5pg of ^^P-GTP loaded GSTRhoAV14, GSTRac1V12 or GSTCdc42V12 for 
10 minutes, and washed before being exposed to hyperfilm for 24 hours (see Materials and 
Methods, Chapter 2).
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Figure 4.1b. Coomasie stain of proteins used for dotblot.
Indicated proteins were subject to PAGE to check purity. 5pg of proteins were loaded, and 
the gel incubated with coomase stain for 2 hours, before incubating in destain overnight. 
Most proteins appeared to be intact with little breakdown. However cleaved CRMP-2 
showed some degradation, although appeared to be fairly pure.
Both RaclV12 and Cdc42V12 bound very strongly to the PAK CRIB control, 
although RhoAV14 did not bind as strongly to RBD. This could be due to the 
preparation of the RBD protein sample. The dotblots demonstrated that both Racl VI2 
and RhoAV14 bound strongly to CRMP-2. Cdc42V12, however, demonstrated a 
much weaker interaction. The cleaved CRMP-2 showed a much stronger interaction 
with Rho A and Racl than the GST CRMP-2 construct suggesting the GST tag may
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interfere with the interaction. This experiment was repeated three times indicating that 
CRMP-2 can interact directly with both Rho A and Racl, because there were no other 
proteins present. All proteins were subject to PAGE, and stained with coomasie to 
ensure they were pure, and had not degraded (Figure 4.1b).
However, subsequent CRMP-2 protein samples showed inconsistency in results on 
the dotblot assay, and it would appear that the ability of RhoGTPases to bind 
recombinant CRMP-2 protein is variable, and may depend on some unidentified 
factor in preparation of this protein. CRMP-2 did not bind on western blots, indicating 
that the native confirmation of the protein might be important.
4.1.2 CRMP-2 Immunoprecipitates with the Rho GTPases in Cos-7 
cells
Immunoprécipitation experiments were performed in Cos-7 cells, to test whether 
CRMP-2 can interact with the GTPases in vivo. Cos-7 cells were co-transfected with 
FLAG tagged dominant positive GTPases, and HA tagged CRMP-2. The Cos-7 cells 
were left to express for 16 hours, and then lysed. The GTPases were 
immunoprecipitated by incubating the lysate with anti-FLAG antibody conjugated to 
sepharose beads for 3 hours at 4°C. After incubation, the beads were washed three 
times in lysis buffer before adding SDS loading buffer and running them on a SDS 
gel. Probing a western blot with HA antibody demonstrated CRMP-2 co-precipitation.
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Figure 4.2. Immunoprécipitation of CRMP-2 with the Rho GTPases
FLAG tagged RhoAV14, Rac1V12 or Cdc42V12 were immunoprecipitated from Cos7 cells 
coexpressing HA CRMP-2. Probing a western blot with anti-HA antibodies was performed to 
test for the presence of CRMP-2.
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Immunoprécipitations with all three GTPases showed the presence of CRMP-2 
(Figure 4.2), demonstrating that in Cos-7 cells, CRMP-2 associates with all three key 
members of the Rho family of GTPases. The immunoprécipitations were equally 
strong with all three GTPases, which is in contrast with the dot blot, where Cdc42V12 
demonstrated a weaker interaction than RhoA and Racl. However the difference 
observed between the dotblot and the immunoprécipitation could be due other 
proteins involved in the interaction. Although CRMP-2 co-precipitates with RaclV12, 
RhoAV14 and Cdc42V12, these interactions may not be direct. Alternatively, CRMP- 
2 may be able to interact with Cdc42 in vivo because of structural differences between 
the proteins synthesised in the Cos? cells, and those synthesised in bacterial cells.
4.13 CRMP-2 may be a RhoA effector, but not a Racl effector
Since CRMP-2 was found to associate with RhoA, Racl and Cdc42, further 
immunoprecipitatons were performed to test whether CRMP-2 only interacted with 
the GTP-bound form of the GTPases, and so was a putative effector. Only Racl and 
RhoA were used in these experiments because of their stronger interactions on the 
dotblot, and their effects on cell morphologies. RhoAV14 or RhoAN19 were 
immunoprecipitated from Cos? cells co-expressing CRMP-2. Following 
immunoprécipitation of FLAG tagged GTPases, the presence of HA CRMP-2 was 
tested using anti-HA mouse monoclonal antibody on western blots (Figure 4.3). 
CRMP-2 could be co-precipitated with FLAG RhoAV14, but not FLAG RhoAN19, 
immunoprecipitates (Figure 4.3a). However, when HA CRMP-2 was expressed with 
either RaclV12 or RaclNl?, CRMP-2 could be co-precipitated with either 
constitutively active, or dominant negative Racl, (Figure 4.3b).
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Figure 4.3. Immunoprécipitation of dominant positive RhoA and Racl with 
CRMP-2.
FLAG RhoA (a) and Rad (b) dominant positive and dominant negative constructs 
were immunoprecipitated from Cos7 cells co-expressing HA CRMP-2. Probing a 
western blot with anti-HA antibody was performed to test for the presence of CRMP-2.
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The dominant positive GTPase mutants have defective GTPase activity, and remain 
bound to GTP. Therefore these mutants can represent GTP bound RhoA or Racl. 
However, the method of action of the dominant negative mutants is not as well 
understood. They are believed to sequester GEF’s, (Reviewed in Feig, 1999) and so 
they may not be GDP bound. However, they do not activate effectors, and so can 
represent the inactive state of RhoA or Racl. Therefore the use of dominant negative 
GTPases can provide an indication as to whether or not a protein is an effector for 
RhoA or Racl, and were used to show that Cdk5 was a novel Racl effector (Nikolic 
etal, 1998).
An alternative approach to determining whether a protein is an effector, involves the 
use of GTPases that are capable of hydrolysing GTP, which are then used in the 
dotblot, to ascertain whether the target protein binds to GTP bound or/and GDP bound 
GTPase.
4.2 Co-localisation of CRMP-2 with the GTPases
4.2.1 Co-localisation of CRMP-2 and the RhoGTPases in cerebellum 
granule neurones
To examine whether CRMP-2 and the GTPases were likely to interact in vivo, co­
localisation studies of endogenous proteins were performed. Cerebellum granule 
neurones (CGC) isolated from day 3 postnatal rats (obtained from J.Pocock) were 
stained for CRMP-2 (mouse monoclonal from Ihara, Japan; Gu et al, 2000) and
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RhoA
Rad
Figure 4.4. Colocalisation studies using cerebellum granule neurones from postnatal 
day 3 rats.
Cells were fixed and stained with anti-CRMP-2 rabbit polyclonal (in house) and either anti- 
Rac1 mouse monoclonal (Transduction labs) or anti-RhoA mouse monoclonal (Santa Cruz) 
antibodies. Colocalisation was performed using a confocal microscope and Zeiss LSM 
software. Scale bar equals 50pm.
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either RhoA (rabbit Santa Cruz) or Racl (rabbit Santa Cruz). Co-localisation between 
the FITC labelled RhoA or Racl, and the Cy5 labelled CRMP-2 was analysed using 
confocal microscopy.
Both Racl and RhoA co-localised with CRMP-2 (Figure 4.4), although in different 
cellular compartments. CRMP-2 and RhoA appeared to co-localise in the neurite 
shafts and down to the growth cones, and neurite branch points. However, Racl and 
CRMP-2 both localised to the cell body, neurite branch points and the base of 
neurites. This slight difference in colocalisation may indicate that CRMP-2 plays a 
different role with RhoA than with Racl, in neurite morphology. However this result 
has not been quantified, and so must be further examined before drawing conclusions.
4.2.2 Co-localisation of CRMP-2 and the Rho GTPai^srin drg’s
CRMP-2 has been shown to play an important role in the sema3A collapse pathway 
(Goshima et al, 1995). Dorsal root ganglia (drg) neurones, which respond to semaSA 
by collapse of growth cones (Eickholt et al, 1997) and are repulsed by semaSA in vivo 
(Wright et al, 1995), are widely studied. Drg neurones were removed from day 1 
postnatal Wistar rats and cultured for 24 hours before fixing and staining with CRMP- 
2 polyclonal antibody (in house) and mouse monoclonal Racl (Transduction Labs) or 
RhoA (Santa Cruz) antibodies. Slides were then analysed on fluorescent microscope 
using digital camera and Provision software (Figure 4.5a). Strong CRMP-2 staining 
was observed in drg neurones, and appeared to co-localise with staining of both Racl 
and RhoA. From merged images, and co-localisation software (indicated white), co­
localisation appeared to be down neurites and in the cell body (Figure 4.5a).
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Figure 4.5a. Staining of drg neurones for endogenous CRMP-2, and either Racl or 
RhoA.
Cells were prepared from day 1 postnatal rats and stained with anti-CRMP-2 rabbit 
polyclonal (in house) and either anti-Rac1 mouse monoclonal (Transduction labs) or anti- 
RhoA mouse monoclonal (Santa Cruz) antibodies. Images were obtained using a digital 
camera and Provision software. Merged images are a composite of Cy5 and FITC 
images, and areas of colocalisation are indicated in white. Scale bar equals 50pm.
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These images were obtained from a fluorescent microscope, and so do not represent a 
single focal plane. Therefore it is possible the co-localisation is a result of the 
antibodies staining different depths through the cells. However, this does provide 
some evidence for endogenous CRMP-2 existing in similar cellular locations to Racl 
and RhoA.
To provide further evidence for colocalisation, slides were analysed on a confocal 
microscope, which allows images to be obtained through a single focal plane. CRMP- 
2 co-localised weakly with Racl in the cell body and down some neurite shafts 
(Figure 4.5b). The co-localisation in the cell body appeared to be around the 
periphery, suggesting they may interact at the membrane. RhoA co-localised with 
CRMP-2 in the cell body, with very little detected in the neurite shafts (Figure 4.5b). 
The RhoA staining was strong in the cell body but very little was detected in the 
shafts or growth cones, although CRMP-2 staining was throughout the cell. There 
appeared to be very little RhoA in the neurites to co-localise with CRMP-2.
4.3 Identifying the GTPase binding region in CRMP-2
4.3.1 Formation of GST CRMP-2 fragments
In order to identify the GTPase binding regions of CRMP-2, a number of CRMP-2 
fragments were made, and cloned into the mammalian GST vector. Use of the GST 
vector would allow the constructs to be expressed in Cos-7 cells, and isolated from 
the cell lysate using glutathione- conjugated sepharose beads. The N-terminal and C- 
terminal fragments were made using PCR, producing two halves of approximately 
30Ô residues each. Cutting the full-length sequence with restriction enzymes, and
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Figure 4.5b. Colocalisation of endogenous CRMP-2 and either RhoA or Rad in in drg 
neurones.
Cells were prepared from day 1 postnatal rats and stained with anti-CRMP-2 rabbit 
polyclonal (in house) and either anti-Rac1 mouse monoclonal (Transduction labs) or anti- 
RhoA mouse monoclonal (Santa Cruz) antibodies. Colocalisation was performed using a 
confocal microscope and LSM software. Scale bar equals 50pm.
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cloning the fragments into the vector made three additional fragments. All three were 
N-terminal fragments, consisting of 1-112, 1-180 and 1-253 amino acid residues 
(Figure 4.6a). All fragments were expressed in Cos? cells to ensure proteins were 
produced at the correct size (Figure 4.6b).
4.3.2 Immunoprécipitation studies using CRMP-2 fragments with 
Racl and RhoA
CRMP-2 does not contain any sequence similarity to GTPase binding regions of any 
of the main GTPases binding proteins, GAP’s, GEF’s, GDI’s or effectors, so the 
sequence does not provide any indication of the area of interaction.
CRMP-2 protein fragments were then co-expressed with GTPases to test for their 
interaction. CRMP-2 fragments were purified using glutathione beads while HA 
tagged RhoA or Racl were used to indicate co-precipitation of the GTPases. Neither 
RhoA nor Racl interacted with the CRMP-2 1-112 firagment. However, both 
interacted with all the other Augments (Figure 4.7). While RaclV12 appeared to 
interact equally well with all fragments, RhoAV14 demonstrated a stronger 
interaction with the 291-573 and 1-180 Augments, than with the 1-297 and 1-253 
fragments. There was no pull down with GST alone, indicating the GST tag did not 
associate with the GTPases. RhoA and Racl associated with all but one of the 
Augments. This could be due to a single large domain required for interaction, running 
from residues 113 to over 300. Alternatively, more than one region of CRMP-2 
contributed to RhoAV14 and RaclV12 binding. To answer this question, and isolate 
the region, or regions of CRMP-2 that bind to the GTPases, a more comprehensive set 
of CRMP-2 fragments would be needed.
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Figure 4.6(a). Representation of CRMP-2 fragments
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Figure 4.6(b). Western blot showing expression of GST tagged CRMP-2 
fragments In Cos7 cells.
Lysates from Cos7 cells were subjected to western blot analysis using anti-GST 
mouse monoclonal antibody (Sigma).
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The three dimensional structure of CRMP-1 has been recently resolved (Deo et al, 
2004), and with the CRMP family of proteins sharing 70% identical protein sequence, 
it is likely they adopt the same three dimensional structure. This structure can used to 
draw some conclusions about CRMP-2 structure. It appears that regions of the N and 
C terminals are positioned close to each other in the tertiary structure. It is therefore 
possible that Racl and RhoA interact with the same region of the structure, which is 
composed of sequences from the N and C terminals. Two a-helices and a P-sheet, 
formed from the region of protein between 112 and 180. It is therefore possible this 
region plays a role in the interaction of CRMP-2 and Racl or RhoA. Other regions in 
the C terminal also lie close to this structure, and may form an accessory region for 
the interaction, and may explain why both the N and C terminal sequences can bind to 
Racl and RhoA.
4.3.3 CRMP-2 1-112 fragment shows different cellular localisation
The CRMP-2 1-112 was the only fragment that did not associate with RhoA or Racl 
(Figure 4.7). To check for any difference in localisation, all the GST fragments were 
expressed in Cos-7 cells. These were then fixed and stained using an anti-GST 
antibody (mouse monoclonal, Santa Cruz) (Figure 4.8a). All the fragments except, 
CRMP-2 1-112, demonstrated the same localisation seen with frill length CRMP-2 in 
NlE-115 (see Chapter 1). They were very punctate and localised to particulate 
structures. However, CRMP-2 1-112 had a very diffuse cytoplasmic localisation, 
which was the same as seen with GST alone.
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Figure 4.7. Western blot showing co-precipitation with GST CRMP-2 fragments 
and either Racl V I2 (a) or RhoAV14 (b).
GST constructs and HA GTPases were expressed in Cos7 cells before isolation using 
glutathione beads. Cell lysates and glutathione beads were subjected to western blot 
analysis and the presence of GTPases determined using anti-HA antibodies (Babco).
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This N-terminal region of CRMP-2 does not associate with cellular membranes. 
CRMP-2 has been shown to be membrane-associated (Mintum et al, 1995), and this 
was observed with all the other CRMP-2 fragments. It is possible that this 1-112 
fragment is not involved with membrane anchoring, and may lack some membrane 
localisation sequence required to send proteins to the membrane, such as myristilation 
(Hancock et al, 1990). The 1-112 fragment was the only cytosolic fragment, and the 
only one that did not associate with RhoA or Racl.
Over expression of RaclV12 and RhoAV14 results in a diffuse localisation (Figure 
4.8b), even though endogenous GTPases are thought to be transported to the 
membrane to exert their effects on the actin cytoskeleton (Hancock et al, 1989). The 
dominant positive GTPases, and the CRMP-2 1-112 fragments we therefore in the 
same cellular compartments, suggesting this CRMP-2 fragment is lacking a domain 
required for interaction.
It would appear from these results that both Racl and RhoA bind to a region in 
CRMP-2 outside the first 112 amino acid residues, because the 1-112 fragment did 
not associate in immunoprécipitation studies, while the 1-180 did. A region of CRMP- 
2 from 112-180 may be important for GTPase interaction. The differences in the 
localisation of the two CRMP-2 fragments could affect this conclusion, and it is 
possible that CRMP-2 and Racl or RhoA only interact when both are present at the 
membrane. A CRMP-2 sequence with the 112-180 region deleted would help answer 
this.
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Actin stain GST stain
CRMP-2
1-297
GST 
CRMP-2 
291-573
GST 
CRMP-2 
1-112
GST 
CRMP-2 
1-180
CRMP-2
1-253
Figure 4.8 (a). Cos7 cells transfected with GST CRMP-2 fragments.
Cells were fixed and stained using anti-GST mouse monoclonal antibody (Sigma), and 
TRITC conjugated phalloidin. Imaging was performed using axiovert microscope with 
digital camera and Metamorph software. Scale bars equal 25pm.
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GFP
TRITC phalloidin GFP
GFP
RhoAV14
GFP
Rac1V12
Figure 4.8 (b). Cos7 cells transfected with GFP. GFP Rac1V12 or GFP Rho AVI 4.
Cells were fixed and stained using TRITC conjugated phalloidin. Imaging was performed 
using axiovert microscope with digital camera and Provision software. Scale bar equals 
25pm.
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Chapter 4 summary
Morphologies from Chapter 3 suggested CRMP-2 can alter CXPase function, and so 
one possible mechanism could be direct interaction of CRMP-2 with the Rho 
GTPases, inhibiting activation of their effectors. To answer this question, dotblot 
assays and immunoprécipitation experiments were performed.
The dotblot assay demonstrated that CRMP-2 could interact directly with the Rho 
GTPases. Both RhoAV14 and RaclV12 showed a strong interaction with the cleaved 
CRMP-2, and a weaker one with the GST CRMP-2. Immunoprécipitation 
experiments demonstrated that RhoAV14, Racl V12 and Cdc42V12 could all interact 
with CRMP-2 equally well when co-expressed in Cos? cells.
To obtain some information as to whether CRMP-2 was an effector for RhoA or 
Racl, immunoprécipitations were performed using dominant positive and dominant 
negative mutants. This showed that CRMP-2 co-immunoprecipitates with active 
RhoA, but with both active and inactive Racl.
In cerebellum granular neurones CRMP-2 colocalised with RhoA in the cell body, 
and along some neuritis. CRMP-2 colocalised with Racl in the cell body and at the 
base of neurites. Immunostaining of drg neurones demonstrated much stronger 
CRMP-2 staining, and Racl colocalised to the cell body and down the neurites, 
whereas RhoA colocalisation was mainly in the cell body, with very little in the 
neurites.
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In an attempt to determine the GTPase binding region of CRMP-2, several fragments 
were made and cloned into a GST vector. Both RhoA and Racl interacted with all 
CRMP-2 fragments, except the 1-112 fragment. In addition, all CRMP-2 fragments 
were membrane associated except the 1-112 fragment.
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5.1 SemaSA collapse in neuroblastoma NlE-115 cells 
permanently expressing a2-chimaerin
Results from Chapters 3 and 4 suggested that CRMP-2 could regulate Racl and 
RhoA, possibly through a direct interaction. CRMP-2 is a crucial component of the 
sema3A collapse pathway (Goshima et al, 1995), but its ftmction in sema3A 
signalling is unknown. Therefore, the role of CRMP-2 in sema3A collapse was 
investigated. CRMP-2 was isolated from a screen for novel interactors of a2- 
chimaerin (PhD Thesis, G.Ferrari), and so the role of this GAP in sema3A collapse 
was also investigated.
5.1.1 Time-lapse analysis of semaSA retraction
Experiments were performed to investigate the role of CRMP-2 in sema3A-mediated 
neurite retraction. The NlE-115 cell line permanently expressing a2-chimaerin, 
a2.13, was used in sema3A collapse phase time-lapse analysis. These are NlE-115 
neuroblastoma cells that have been previously transfected with vectors encoding a2- 
chimaerin and also a neomycin resistance gene (Hall et al, 2001). This clonal cell line 
is cultured in G418 (Calbiochem) to maintain the vector in the population. These were 
used in preference to parental NlE-115 cells because of their ability to produce large 
neurites and growth cones when cultured in media containing 10% PCS (Figure 5.1a). 
NlE-115 cells have previously been shown to respond to sema3A, inducing neurite 
retraction (van Horck et al, 2002). Growth cone collapse and neurite retraction were 
first investigated using time-lapse analysis. NlE-115 a2.13 cells were plated in 10% 
FCS, onto laminin-coated glass coverslip bottom dishes to ensure optimum 
microscope imaging. A microscope with a CO2 box and heated stage was used to
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maintain the cells for the duration of the experiment. Neurites with growth cones were 
selected, and monitored for 30 minutes, to ensure they did not collapse in the absence 
of sema3A (Figure 5.1a). Neurites and growth cones appeared to be stable for the 
duration of the time-lapse. For sema3A collapse studies, neurites were selected and 
monitored for 10 minutes prior to treatment with sema3A, with images taken every 30 
seconds. A microinjection needle containing purified sema3A (50pg/ml, obtained 
from B. Eickholt; see Materials and Methods) was placed near the neurites, ensuring a 
free stream of fluid from the needle. The neurites were monitored for 30 minutes. All 
time-lapse experiments were repeated 10 times. The nature of collapse of the growth 
cones was variable, with some growth cones collapsing although the neurites did not 
retract. Only complete neurite retraction was quantified as a sema3A-induced 
response.
Out of 10 neurites examined, 6 showed a rapid response to sema3A, (Figure 5.1b). In 
the sample shown, the neurite began to retract at around 20 minutes, and by the end of 
the 30 minute period the neurite had retracted back from the needle. To examine the 
actin dynamics in the growth cone during collapse, o2.13 cells were transfected with 
GFP-actin to allow fluorescent imaging of the actin in the growth cone. Prior to 
sema3A treatment, the actin in the growth cone was rich in polymerised actin, with 
clear actin filaments extending to the edge of the growth cone from the centre (Figure 
5.1c). There were also dense actin structures at the base of the growth cone. Following 
addition of sema3A from the needle, the actin filaments in the middle of the growth 
cone appeared to dissolve, along with the dense actin structures at the base of the 
growth cone. This dissolution of the actin appeared to happen almost immediately, 
and the actin at the base of the growth cone had dissolved by 4 minutes.
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Figure 5.1a. Time-lapse of untreated neurite in N1E-115 ceil line
expressing a2-chimaerin.
Phase contrast images time-lapse microscopy of neurites from a2.13 ceils. Neurites were monitored for 
30 minutes to ensure they were stable, and did not collapse, images were taken at the time points 
indicated.
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Figure 5.1 b.c. Growth cone collapse and neurite retraction In N1E-115 cell line
expressing a2-chlmaerln.
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Phase contrast images (b) and flourescent GFP actin (c) time-lapse microscopy of neurites from a2.13 
cells. A microinjection needle containing semaSA was placed near the growth cone at time point 0. 
Time in minutes, -10 to +24 as indicated.
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Once the filaments had broken down, the growth cone began to collapse at around 10 
minutes, leaving retraction fibres protruding from the edge. The growth cone then 
collapsed completely and retracted back from the needle. This time-lapse experiment 
suggests that the collapse of the growth cone is a consequence of act reorganisation, 
and dissolution of actin structures, as actin dissolution preceded retraction. Growth 
cone collapse does not appear to be an actin contraction driven process, which would 
involve RhoA and ROK, signalling to form dense contractile actin filaments that 
could contract the growth cone.
5.1.2 Roscovitine blocks sema3A retraction in neuroblastoma NIE
-115 cells permanently expressing a2-chimaerin
The time-lapse experiments were repeated with a2.13 cells treated with roscovitine, a 
Cdk5 inhibitor (De Azevedo et al, 1997). a2.13 cells were treated with the Cdk5 
inhibitor, roscovitine over night prior to sema3A treatment. In the presence of lOpM 
roscovitine, the neurites did not collapse (Figure 5.2a), but instead appeared to 
produce filopodia at approximately 8 minutes. These filopodia remained for the whole 
30 minutes, but were not static and appeared to be constantly growing and retracting. 
There was no neurite retraction in 7 of the 10 neurites examined. This time-lapse 
experiment suggests Cdk5 is a crucial component of the sema3A collapse/retraction 
pathway. Recently Saski et al (2002) have shown that roscovitine can inhibit 
sema3A-induced collapse, and that drg neurones isolated from Cdk5 knockout mice 
do not respond to sema3A (Sasaki et al, 2002).
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Figure 5.2. Time-lapse analysis of the role of ROK and Cdk5 in 
semaSA-mediated collapse of neurites from a2.13 cells.
00
Cells were treated with roscovitine (a) (10|xM) or Y-27632 (b) (10|iM) overnight to 
inhibit CdkS and ROK respectively. A microinjection needle containing semaSA 
was placed near the growth cones at time point 0. Time points are in minutes, 
as indicated.
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5.1.3 Seina3A-niediated retraction is independent of ROK
ROK is an important component of many collapse pathways, following RhoA 
activation (Katoh et al, 1998; Hirose et al, 1998; Bito et al, 2000). To test the role of 
the RhoA/ROK pathway in the collapse, a2.13 cells were cultured in the specific 
ROK inhibitor Y-27632 (lOpM) over night prior to sema3A treatment (Uehata et al, 
1997). However, Y-27632 did not block the collapse (Figure 5.2b), and even appeared 
to enhance the collapse affect. In the example shown, the neurites started to retract 
after about 20 minutes, and had retracted away from the needle by 30 minutes. In this 
experiment 9 out of 10 neurites collapsed, producing the highest count for collapse 
out of all conditions examined. These time-lapse experiments indicate the sema3A 
collapse pathway is independent of ROK, while CdkS is a crucial component of this 
signalling pathway.
5.1.4 CRMP-2S522A blocks sema3A collapse
CRMP-2 has been shown to be a substrate for p35/Cdk5, and the site of 
phosphorylation was mapped to serine 522 (PhD Thesis, T. Jacobs). The ability of the 
roscovitine to inhibit sema3A-mediated retraction, suggested the possibility that CdkS 
phosphorylates CRMP-2 in response to sema3A. Therefore, to examine the role of 
CRMP-2 in the sema3A-collapse pathway, the a2.13 cells were transfected with 
constructs encoding either CRMP-2, or a phosphorylation mutant, CRMP-2S522A, in 
combination with GFP as a fluorescent marker.
Transfected CRMP-2 appeared to have no affect on the Sema3A collapse (Figure 
5.3a). In the example shown, the lamellipodia at the growth cones appeared to migrate 
down the neurite after 8 minutes, and by 16 minutes the neurite followed, retracting
179
Figure 5.3. Time-lapse analysis of CRMP-2(a) and CRMP-2S522A (b) on
semaSA-induced neurite retraction.
Ceils were transfected with CRMP-2 (a) or CRMP-2S522A with GFP, and allowed to express overnight. 
Fiourescence analysis was used to indentify GFP expression which was used as a maker of CRMP-2 
or CRMP-2S522A expression. A microinjection needle was placed near the neurites at time point 0. 
Time indicated is is minutes.
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from the needle. At the 30 minute time point, the neurite had retracted back to the 
lamellipodia, which were still intact. In other experiments, the growth cones collapsed 
with neurites retraction. 8 out of 10 neurites retracted. When expressed in the «2.13 
cell line, CRMP-2S522A inhibited the sema3A collapse (Figure 5.3b). As with 
roscovitine, the neurites appeared to produce filopodia, which were not stable, but 
continuously grew and retracted back. By the 30 minute time point, there was no sign 
of neurite retraction. Counts for these cells showed that only 3 out of 10 neurites 
collapsed.
Each sema3A collapse time-lapse experiment was repeated ten times, and for each 
condition the number of neurites that retracted is summarised in Figure 5.4. With 
sema3A alone, 6 out of 10 neurites retracted. The clearest effect of sema3A was with 
«2.13 cells treated with lOpM Y-27632, where 9 out of 10 neurites retracted, which 
represents an increase over the control experiment. Both CRMP-2S522A expressing 
cells and lOpM roscovitine treated cells produced similar results with 3 out of 10 
neurites retracting. This suggests that Cdk5 activity is crucial to sema3A collapse, as 
well as phosphorylation at serine 522 in CRMP-2.
Studies on the specificity of the roscovitine have shown that roscovitine has a IC50 of 
17pM for CK1Ô, 3.1pM for DYRKIA (Dual-specificity tyrosine-phosphorylated and 
regulated kinase), and 0.25pM for Cdk2, and so at the concentration used, roscovitine 
is fairly specific for CDK’s (Bain et al, 2003). Similarly, Y-27632 has a IC50 of 
SOOnM for ROK-2, 600nM for PRK-2, 8.3pM for MSK-2 and 44pM for PHK, and so 
again, Y-27632 is fairly specific at the concentrations used in this study, (Davies et al, 
2000)
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5.1.5 Quantification of sema3A collapse assay
To analyse the effects seen using time-lapse analysis in larger numbers of cells, sema- 
induced retraction was quantified after fixation of the cells. Cells were plated on poly- 
L-lysine coverslips in 1% serum media, and following transfection or inhibitor
Cell Treatment Number Retracted
None 0/10
SemaSA 6/10
SemaSA 
+ Rosocovitine
S/10
SemaSA 
+ Y-276S2
9/10
SemaSA 
+ CRMP-2 
expression
8/10
SemaSA 
+ CRMP-2S522A 
expression
4/10
Figure 5.4. Table showing total counts from time-lapse analysis of sema3A- 
Induced neurite retraction.
Each experiments was repeated 10 times, with a needle placed near the neurite, 
delivering semaSA. Each neurite was categorised to whether or not it retracted in the 
30 minutes time period. Cells were treated with lOpM of each kinase inhibitor
treatment, semaSA-containing cell media was added to half the coverslips. The 
sema3A media (obtained from B.Eickholt) was added at a 1/50 dilution, (working 
concentration of 1 pg/ml) and cells were then left for 30 minutes. Cells were fixed and 
stained (with TRITC-labelled phalloidin) following 30 minutes sema3A treatment. All 
transfections were performed using GFP in addition to the relevant cDNA to identify 
transfected cells. The absence of any peripheral structures, with the exception of
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No Serna 
Serna
GFP CRMP-2 CRMP-2S552A Y-27632
C ell T re a tm e n t
Roscovitine
Figure 5.5. The role of CRMP-2, Cdk5 and ROK In sema3A-lnduced neurite retraction 
In a2.13 cell lines.
Cells were transfected with the constructs, or treated with the kinase inhibitors (lOpM for 
roscovitine and Y-27632), and treated with control or semaSA media (1pg/ml). Cells were 
then categorised as to whether they were contracted or not. The absence of any peripheral 
structures was considered contracted. The number of cells counted for each treatment 
with/without semaSA treatment were, 469/448 for GFP, 441/368 for CRMP-2, 254/348 for 
CRMP-2S522A, 457/401 for Y-27632 and 437/475 for Roscovitine. Each experiment was 
performed in triplicate over three separate occasions. Error bars represent SEM.
microspikes, was scored as contracted. Counts for three coverslips were averaged, 
over three different experiments performed. Graphs show averages and SEMs.
SemaSA caused significant retraction in the GFP control experiment (Figure 5.5). 
There were a high percentage of contracted cells in the absence of semaSA, 
approximately 40%, which this rose to approximately 60% with semaSA treatment. 
The increase in collapsed cells following semaSA treatment was larger in cells
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expressing wild type CRMP-2, where there were more contracted cells in the absence 
of semaSA treatment. Following the addition of semaSA there with over 70% 
contracted cells, suggesting that over expression of CRMP-2 may increase the 
collapse effect of semaSA. CRMP-2S522A blocked semaSA retraction, supporting the 
effects observed with the time-lapse experiments. Although there was a slight trend 
towards an increase in the number of contracted cells with the semaSA, this was not 
statistically significant.
Results in the case of semaSA treatment in the presence of roscovitine and Y-276S2 
confirm those of the time-lapse experiments, where Y-276S2 did not inhibit neurite 
retraction. When cells were fixed and stained without semaSA, there were fewer 
contracted cells due to the inhibition of endogenous ROK, allowing activation of 
Racl and Cdc42 signalling pathways and resulting in a stimulation of more 
outgrowth. Against this lower background, the semaSA resulted in approximately 
65% contracted cells. This difference proved to be highly significant, and shows that 
ROK is not required for the semaSA retraction pathway in these cells.
When a2.1S cells were treated with roscovitine, semaSA collapse was completely 
blocked. The number of contracted cells with the semaSA was almost identical to that 
of the control cells. CdkS is, thus, a crucial component of the semaSA collapse 
pathway, without which, retraction is completely inhibited.
Taken together, these results, and those indicated by the time-lapse analysis, show 
both roscovitine and the CdkS phosphorylation mutant, CRMP-2SS22A, block
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sema3A collapse. Y-27632 enhanced the effect of sema3A collapse, and so ROK does 
not appear to be required in this collapse pathway.
5.2 The role of CRMP-2 and CdkS in drg neurone growth 
cone collapse
In the nervous system, drg neurones are responsive to sema3A (Wright et al, 1995) 
and are frequently used for studying growth cone collapse in the sema3A pathway. 
These peripheral neurones respond well to sema3A in vitro (Fan et al, 1995; 
Messersmith et al, 1995) and therefore were used to determine whether effects of 
CRMP-2 and the kinase inhibitors observed in the a2.13 cells were relevant to 
sema3A signalling in primary neurones.
5.2.1 drg neurones express CRMP-2 and a2-chimaerin
CRMP-2 was isolated as a novel a2-chimaerin interactor (PhD Thesis, G.Ferrari), and 
so drg neurones were prepared (see Materials and Methods) and stained for 
endogenous CRMP-2 and a2-chimaerin. CRMP-2 distribution was punctate and 
membrane-associated, as observed when CRMP-2 was over expressed in NlE-115 
cells, (see Chapter 3, Figure 3.3) suggesting the punctate localisation of transfected 
CRMP-2 is not an artefact of over-expression. The particulate CRMP-2 appeared to 
localise in the cell body and along the neurites, (Figure 5.6a).
Rat drg neurones appeared to express high levels of a2-chimaerin, (Figure 5.6b) 
throughout the cell body, and down neurites. Expression appeared to be diffuse 
throughout the cell.
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Actin (green) and 
Cy5 (red) Dual signal Cy5(signal alone)
CRMP-2 tu b u lin C o lo c a lis a tio n
Figure 5.6. Endogenous staining of dorsal root ganglia neurones.
Neurones were fixed and stained for endogenous CRMP-2 (a) using anti CRMP-2 
rabbit polyclonal (in house), and for a2-chimaerin (b), using anti-a2chimaerin rabbit 
polyclonal (in house). Neurones were also stained for CRMP-2 and tubulin, using anti- 
ptubulin mouse monoclonal (Sigma). Co-localisation of CRMP-2 and tubulin was 
performed using confocal microscopy and LSM software. Scale bars equal 50pm.
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5.2.2 CRMP-2 co-localises with |3-tubulin in rat drg neurones
CRMP-2 has been shown to bind to tubulin and regulate microtubule dynamics 
(Fukata et al, 2002). To investigate this association, drg neurones were stained for 
both CRMP-2 (rabbit polyclonals, in house) and P-tubulin (Sigma, mouse 
monoclonal). P-tubulin staining was intense in the neurites with some staining in the 
cell body, while CRMP-2 appear to stain the cell body, and some of the neurites. 
CRMP-2 co-localised with P-tubulin in the cell body and along parts of the neurites, 
suggesting they associate in some cellular compartments (Figure 5.6c).
5.2.3 Growth cone collapse in drg neurones
SemaSA-induced collapse was investigated in drg neurones to examine the signalling 
pathways downstream of semaSA, and CRMP-2 involvement in a well-established 
neuronal pathway. Time-lapse analysis of semaSA collapse in rat drg neurones growth 
cones was first undertaken to test the conditions and time of collapse (Figure 5.7). The 
drg neurones growth cones were morphologically quite different from those in a2.1S 
cells, which consisted of large lamellipodia with fan-like actin structures. In the drg 
neurones, growth cones had many more filopodia with small lamellipodia between 
them. The growth cones began to collapse after around 10 minutes following 
exposure to semaSA, and had completely retracted by 24 minutes.
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Pre-sem a3A  
9 M \
Post-sem a3A
12 m ins4 m ins 8 m ins
28 m ins
Figure 5.7. Time-lapse analysis showing collapse and retraction of rat dorsal root 
ganglia neurones in response to semaSA.
Growth cones were recorded for 10 minutes prior to semaSA treatment to ensure it was 
stable. A microinjection needle containing semaSA was placed near the growth cone, 
ensuring a constant flow of semaSA. Images were taken every SO seconds for SO minutes. 
Scale bar equals 20pm.
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5.2.4 The role of kinases and CRMP-2 in drg growth cone collapse
To establish the role of CRMP-2 in semaSA growth cone collapse, cells were first 
electroporated with mammalian expression vectors encoding selected cDNAs and 
GFP, as a fluorescent label (see Materials and Methods), or treated with inhibitors and 
cultured for 16 hours. Cultures were fixed and growth cones quantified as collapsed, 
or not collapsed (Figure 5.8).
To test the role of Cdk5 and ROK in semaSA collapse, drg neurones were prepared as 
previously described (Materials and Methods, Chapter 2). Frequently, semaSA 
collapse assays utilise embryonic drg neurones, however it has been shown that 
postnatal, and even adult drg neurones are still highly responsive to semaSA (Tanelian 
et al, 1997). During the course of this study, in the absence of semaSA drg neurones 
typically had 20-30% collapsed growth cones. However when treated with semaSA 
this value rose significantly to 60% (Figure 5.9). Other investigators, using embryonic 
chick drg neurones have reported 80-90% collapse with semaSA (Eickholt et al, 1997) 
suggesting that whilst embryonic drg neurones may have a heightened level of 
sensitivity to semaSA, the use of postnatally derived cells is valid.
Roscovitine (lOpM) completely inhibited the semaSA-induced collapse and in these 
neurones actually demonstrated a significant decrease in the number of collapsed 
growth cones compared with the untreated control. Treatment of drg neurones with 
lOpM Y-276S2 had no effect on semaSA collapse, when compared with semaSA 
alone; 65% growth cones collapsed with semaSA treatment in the presence of ROK 
inhibitor.
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Figure 5.8. Images showing dorsal root ganglia neurones in culture.
Images show drg neurones in culture (a), drg growth cones (b) and semaSA collapsed 
growth cones (c). Cells were fixed following semaSA or control treatment, and then 
stained with TRITC-labelled phalloidin. Images were taken using axiovert microscope 
and digital camera, using Metamorph software. Scale bars equal 10pm.
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+ sem a3A  
- sem a3A
« 40
Control Roscovitine 
Cell Treatment
Y-27632
Figure 5.9. The effect of Roscovitine and Y-27632 on semaSA-induced growth 
cone collapse in rat drg neurones.
The percentage of collapsed growth cones is shown prior to and after semaSA 
treatment (1pg/ml) for cultures in control conditions or treated with the kinase inhibitors 
(10pM roscovitine and Y-27632). Error bars represent SD from three separate 
experiments. Total number of growth cones counted with/without semaSA treatment are, 
control 147/194, roscovitine 16S/14S, Y-276S2 206/176.
Primary neurones show very low transfection rates by conventional methods, however 
with the use of Amaxa electroporator equipment, drg neurones could be successfully 
electroporated with cDNAs cloned in mammalian expression vectors. This equipment
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was used to introduce cDNA constructs of CRMP-2 and GFP in the drg neurones to 
examine their effect in semaSA mediated growth cone collapse (Figure 5.10).
In control cultures were cells were electroporated with GFP alone, semaSA treatment 
resulted in around 70% growth cone collapse (Figure 5.10). Expression of CRMP-2 
had no effect on semaSA-induced collapse with 70% collapsed growth cones 
following semaSA treatment. However expression of CRMP-2S522A significantly 
inhibited semaSA-induced collapse, with both treated and untreated cultures having 
40% collapsed growth cones. It is of interest that in the absence of semaSA treatment, 
cultures expressing CRMP-2S522A had a significantly increased growth cone 
collapse than in the GFP (p < 0.01) or CRMP-2 (p < 0.02) expressing cultures. This 
would seem to suggest that in the absence of semaSA teratment, CRMP-2S522A can 
cause some growth cone collapse, or affect the morphology of the growth cones.
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Figure 5.10. The role of CRMP-2 and S522A on semaSA-medlated growth cone 
collapse in rat drg neurones.
The percentage of collapsed growth cones is shown for control and semaSA treatment 
(1pg/ml), for cultures expressing CRMP-2 constructs. Error bars represent SD from three 
separate experiments. Total number of growth cones counted with/without semaSA 
treatment are GFP 174/148, CRMP-2 161/142, CRMP-2S522A 95/106.
192
Chapter 5 Results 3
Serine 522 has been shown to be a phosphorylation site for Cdk5 (PhD thesis, T. 
Jacobs), and the CRMP-2S522A mutation prevents phosphorylation by Cdk5 at this 
site. Cdk5 is crucial for semaBA-mediated collapse in drg neurones (Sasaki et al, 
2002), and so the ability of CRMP-2S522A to inhibit collapse suggests CRMP-2 
maybe a downstream substrate of CdkS in the semaSA pathway.
5.3 The role of a2-chimaerin in semaSA and PMA-indueed growth 
cone collapse
The neuronal RacGAP, a2-chimaerin, has been shown to interact with CRMP-2 (PhD 
Thesis, G. Ferrari; PhD Thesis, T. Jacobs), as well as with p35, the neuronal regulator 
of CdkS (Qi et al, 2004). Therefore, it was possible that it is involved with semaSA- 
mediated collapse, as well as CRMP-2. This GAP contains three domains, an SH2 
domain, a GAP domain and a Cl domain, which acts as a phorbol ester receptor. 
Binding of the artificial phorbol ester compound, PMA, to the Cl domain, changes 
the conformation of the protein, thereby activating the GAP activity (Ahmed et al, 
1990; Ahmed et al, 1993; PhD thesis, T. Jacobs). PMA, a strong activator of PKC 
(Kikkawa et al, 1983), has been shown to cause collapse in drg neurones (Fournier et 
al, 2000).
5.3.1 a2-chimaerin in PMA-induced growth cone collapse
To examine whether a2-chimaerin plays a role in growth cones response to PMA, or 
whether collapse was attributable to PKC, collapse assays were performed using drg
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neurones, treated with PKC inhibitor Bisindolylmaleimide (lOpM) or expressing the 
a2-chimaerin GAP-inactive mutant, R304G.
120
***
" 80
+ PMA 
- PMA
Control PKC Inhibitor a2-chimaerin R304G 
GAP inactive
Figure 5.11. The effect of PKC Inhibitor and a2-chimaerin in PMA-induced growth 
cone collapse in drg neurones.
The percentage of collapsed growth cones is shown with semaSA and control treatment. 
Error bars represent SD from three separate experiments. Total number of growth cones 
counted with/without semaSA treatment were control 67/49, PKC inhibitor -  
bisindolymaleimide (10pM) 76/5S, a2chimaerin RS04G 97/84.
PMA in DMSO, or DMSO control, was added to the cultures, which were left for 30 
minutes before fixing and staining. PMA was used at lOOnM, a final concentration 
that has been shown to cause growth cone collapse (Fournier et al, 2000).
PMA caused nearly 100% growth cone collapse, compared with the basal value of 
approximately 20% collapsed growth cones (Figure 5.11). This was a larger response
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than previously observed with semaSA, where about 70% collapsed growth cones was 
observed. The PKC inhibitor (lOpM) was added four hours prior to semaSA 
treatment, but had little effect on the PMA-induced collapse (Figure 5.11). Expression 
of the GAP inactive a2-chimaerin RS04G mutant reduced the response to PMA, 
showing approximately 50% collapsed growth cones, which is much lower than that 
of PMA-treated growth cones in the presence or absence of the PKC inhibitor. These 
results suggest that the PMA collapse response of drg neurones is not due to 
activation of PKC, but to activation of a2-chimaerin. In addition, this suggests that 
activation of a2-chimaerin GAP activity by PMA may be sufficient to cause growth 
cone collapse.
5.3.2 The role of a2-ehimaerin in semaSA-mediated collapse
To test if a2-chimaerin played a role in semaSA collapse, three different GFP tagged 
a2-chimaerin constructs were expressed in drg neurones, which were then subject to 
the semaSA collapse assay. The effects of a2-chimaerin, GAP inactive mutant, 
RS04G, and an SH2 mutant, R7SL, which inhibits phosphotyrosine interactions with 
the SH2 domain (Hall et al, 2001), were quantified (Figure 5.12).
In drg neurones expressing GFP, semaSA produced around 45% collapsed growth 
cones (P < 0.0001) (Figure 5.12), which was a lower proportion than in previous 
results (Figure 5.10), where semaSA typically induced 70% growth cone collapse. It 
is unclear why there was a difference in the proportion of collapsed growth cones.
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Transfected a2-chimaerin produced a slightly larger effect with nearly 60% of growth 
cones collapsed following semaSA treatment (P < 0.00001) (Figure 5.12). However, 
both the a2-chimaerin GAP mutant and SH2 domain mutants totally blocked the
* * *
o 40
+ semaSA 
- semaSA
GFP
o2-chim aerin, 
a2-chim aerin R304G
GAP inactive
a2-chim aerin  
SH2 mutant, R73L
Figure 5.12. The role of a2-chlmaerln in semaSA-induced growth cone 
collapsed in drg neurones.
The percentage of collapsed growth cones is shown with control and semaSA 
treatment (1pg/ml). Error bars represent SEM from three separate experiments 
performed in triplicate. Total number of growth cones counted with/without 
semaSA treatment are GFP 242/299, a2-chimaerin 214/SS1, a2-chimaerin RS04G 
2S9/412, a2-chimaerin R7SL 22S/298.
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semaSA-induced collapse. SemaSA produced very little difference in the number of 
collapsed growth cones in cells expressing the RS04G GAP inactive a2-chimaerin. 
Expression of the R7SL SH2 mutant, caused a slight decrease in the number of 
collapsed growth cones following semaSA treatment, although this was not 
significant.
These results suggest that the GAP domain of a2-Chimaerin is crucial to the semaSA 
collapse pathway. In addition, a functional SH2 domain is required, implying a2- 
Chimaerin must interact with some other component of the pathway for collapse to 
occur. CRMP-2 interacts with the SH2 domain of a2-Chimaerin in vitro, (PhDThesis, 
T. Jacobs) and so CRMP-2 could be the in vivo target of the SH2 during semaSA 
collapse, but this has yet to be determined.
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Comparison of: With: P Value
GFP Control Roscovitine Treatment 0.0001 ***
GFP Control Y-27632 Treatment 0.08 NS
Roscovitine
Treatment
Y-27632 Treatment 0.0003 ***
GFP Control CRMP-2 Expression 0.5 NS
GFP Control CRMP-2S522A
Expression
0.005 **
CRMP-2
Expression
CRMP-2S522A
Expression
0.0008 ***
Comparison of: With: P Value
Control PKC Inhibitor 
Treatment
0.3 NS
Control a2-chimaerin R304G 
Expression
0.003 **
PKC Inhibitor 
Treatment
a2-chimaerin R304G 
Expression
0.008 **
GFP Control a2-chimaerin
Expression
0.01 *
GFP Control a2-chimaerin R304G 
Expression
0.009 **
GFP Control a2-chimaerin R73L 
Expression
0.0003 ***
a2-chimaerin
Expression
a2-chimaerin R304G 
Expression
0.0007 ***
a2-chimaerin
Expression
a2-chimaerin R73L 
Expression
1.4 X 10^ ***
a2-chimaerin
R304G
Expression
a2-chimaerin R73L 
Expression
0.2 NS
Figure 5.13. Table showing significance values for data from figures 5.9, 5.10, 5.11 
and 5.12.
Values were obtained using students t-test, from original data.
198
Chapter 5 Results 3
Chapter 5 summary
To examine the role of CRMP-2 in semaSA-mediated collapse, collapse assays were 
performed in NIE-115 cells permanently expressing a2-chimaerin. Under control 
conditions, a proportion of theSe growth cones collapsed in response to semaSA 
within about 30 minutes. The ROK inhibitor Y-27632 had no effect on the semaSA- 
induced collapse of growth cones, while the Cdk5 inhibitor, roscovitine, blocked the 
semaSA collapse. Wildtype CRMP-2 did not affect the collapse, but mutation of the 
CRMP-2S522A, mutated at the CdkS phosphorylation site, blocked collapse.
Drg neurones were prepared from postnatal day 1 rats and cultured before performing 
growth cone collapse assays. The results from the collapse assays of drg neurones 
were comparable with those obtained from the cell lines. Both roscovitine and 
CRMP-2S522A inhibited semaSA collapse. The ROK inhibitor, Y-27632 did not 
inhibit the collapse, and appeared to enhance the effect, while CRMP-2 wildtype did 
not have an effect on collapse. Drg neurones have been shown to collapse in response 
to the phorbol ester, PMA, a powerful activator of PKC. In the drg neurones, 
treatment with a PKC inhibitor did not inhibit PMA-induced growth cone collapse, 
while a GAP inactive a2-chimaerin mutant reduced the percentage of collapsed 
growth cones by half. When studied in the semaSA collapse assay in drg neurones, 
wild type a2-chimaerin slightly and significantly increased the collapse effect of 
semaSA, while both the GAP inactive and SH2 phosphotyrosine binding inactive 
mutants strongly inhibited collapse.
199
Chapter 6 Discussion
Chapter 6
Discussion
200
Chapter 6 Discussion
6.1 Discussion
The Rho family of GTPases have a well established role in the regulation of the actin 
cytoskeleton (Ridley and Hall, 1992; Ridley et al, 1992), and their effects in the 
neuroblastoma cell line NlE-115 have been previously characterised (Kozma et al, 
1995). In addition, the Rho GTPases are involved in growth cone remodelling, axonal 
guidance and neuritogenesis. CRMP-2 is homologous to the C.elegans protein, 
Unc33, which plays an important role in the development of the nervous system 
(Goshima et al, 1995; Mintum et al, 1995; Byk et al, 1996). CRMP-2 is also crucial 
for sema3A-induced growth cone collapse (Goshima et al, 1995), although no specific 
fimction has been assigned to it. The purpose of this study was to examine effects of 
CRMP-2 on the morphologies induced by the Rho family of GTPases. A link between 
CRMP-2 and the Rho GTPases had been suggested by work showing that CRMP-2 is 
a ROK substrate (Arimura et al, 2000), and that CRMP-2 interacts with the RacGAP 
a2-chimaerin (PhD thesis G. Ferrari, 2000; PhD thesis T. Jacobs.)
6.1.1 CRMP-2 switches RhoA and Reel morphologies
Results obtained fi*om this study demonstrate that CRMP-2 can regulate Rho GTPase 
function. CRMP-2 was able to switch between RhoA and Racl signalling in NlE-115 
neuroblastomas and Swiss 3T3 fibroblasts (Chapter 3). Co-expression of CRMP-2 
with RhoAV14 produced Rac phenotypes and neurites (Figure 3.2; 3.3; 3.5), which 
were dependent on both Racl and Cdc42 (Figure 3.12). Co-expression of CRMP-2 
with RaclV12 caused localised collapse, which was dependent on RhoA (Figure 
3.10)
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In growth cone guidance, the local regulation of the Rho GTPases, and the ability to 
switch between Racl and RhoA signalling pathways could be very important, for 
example, during path finding of neuronal growth cones, which have to respond to 
both attractive and repulsive guidance cues as they develop (Dickson, 2002). Under 
these circumstances, CRMP-2 may play an important role in the regulation of the Rho 
GTPases in neuronal growth cones during their development.
The mechanism by which CRMP-2 was able to effect these changes remains unclear. 
Racl and RhoA have been shown to have opposing effects on neuronal cell 
morphology (Kozma et al, 1997; Luo, 2001), with Racl causing outgrowth and 
peripheral structures, and RhoA causing retraction. However activation of Racl can 
also lead to the activation of RhoA when expressed in fibroblasts (Ridley and Hall, 
1992), although this occurs after a time delay. Therefore in these experiments, it is 
possible that, when co-expressed with CRMP-2, Racl VI2 was capable of signalling 
through to activate endogenous RhoA, causing retraction and cell rounding. This 
signalling does not usually occur in NIE-115 neuroblastoma cells, where Racl and 
RhoA usually act antagonistically (Kozma et al, 1997). CRMP-2 may activate an 
endogenous signalling mechanism from RaclV12 to endogenous RhoA.
There is no previous evidence to indicate that RhoA can signal through to activate 
Racl. In other cell types, Racl activation is upstream of RhoA in a hierachal 
relationship (Ridley et al, 1992). The morphological effects observed in this study 
indicate there is Racl activity downstream of RhoAV14 co-expressed with CRMP-2. 
These effects were relatively small, compared with dominant active Racl, suggesting 
that there is not a strong activation of Racl when CRMP-2 and RhoAVM are co­
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expressed. This could be explained by activation of endogenous Racl, which would 
not produce such a dramatic phenotype as the expression of RaclVI2, a strong 
activator of Racl signalling.
A possible explanation for these results would be the activation of an endogenous 
GAP or GEF. The experiments were carried out with dominant positive GTPases. 
While it is unlikely that GAPs can still exert some effect on these mutants, the 
endogenous GTPases could be affected by down regulation of a GAP or by up 
regulation of a GEF. CRMP-2 has been shown to interact with the RacGAP a2- 
chimaerin in vitro (PhD Thesis, G. Ferrari) and in vivo (PhD Thesis, T. Jacobs), so 
CRMP-2 may be able to active endogenous GAPs, to down regulate endogenous 
Racl. There is so far no evidence that CRMP-2 is able to regulate a2-chimaerin GAP 
activities, but it may form a component of a regulatory complex, which can influence 
the GAP activity of a2-chimaerin, such as sequestering the Rac GAP, and allowing 
activation of endogenous Racl.
Alternatively, CRMP-2 may activate endogenous GEFs, which could then activate 
alternative RhoGTPase members. CRMP-2 has not been shown to interact with any 
GEFs, although GEFs have been shown to play a role in some sema-mediated 
signalling. The Rho GEF, PDZ-RhoGEF binds to plexin B and is involved in 
semaphorin4D/plexin-B signalling pathways (Perrot et al, 2002; Swiercz et al, 2002) 
to activate RhoA. At present GEFs have not been identified in semaSA-mediated 
growth cone collapse, but it could well be that GEFs are also involved, and so may 
interact with CRMP-2 to influence the activity of the Rho GTPases.
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The effects observed when CRMP-2 and RhoAVM were co-expressed were small, 
and so rather than activating a Rac GEF, a more probable explanation may be that 
CRMP-2 is able to block RhoAVM signalling, by either inhibiting RhoAVM itself, or 
the downstream effector Rho-kinase (ROK), a serine/threonine kinase. CRMP-2 was 
found to bind directly to RhoAVM (Chapter 4, Results 2), and so may compete with 
ROK for RhoA binding.
6.1.2 The enzymatic function of CRMP-2
Some clues to the function of CRMP-2 are suggested by its high degree of sequence 
similarity to liver dihydropyrimidinase (Wang and Strittmatter, 1997). These enzymes 
are involved in the breakdown of guanosine-based molecules, although at present 
there is no evidence to suggest CRMP-2 exhibits any enzymatic function, and some 
key residues are not conserved in CRMP-2 (Wang and Strittmatter, 1996). However, 
an interesting notion is that CRMP-2 is involved in the regulation of cGMP in the 
neurones. All guidance cues discovered to date can be modulated by either cGMP or 
cAMP, and the sema3A repulsive pathway can be reversed to an attractive pathway 
by increasing cGMP concentration leading to an increase in PKG activity (Song et al, 
1998). CRMP-2 appears to play a role in both outgrowth (Inagaki et al, 2001; Fukata 
et al, 2002) and in repulsion (Goshima et al, 1995), and so regulation of intracellular 
cGMP levels could enable cells to regulate CRMP-2 and so control both processes. 
Since CRMP-2 is able to switch Racl and RhoA induced morphologies, it is possible 
that CRMP-2 acts downstream of cGMP to regulate RhoA and Racl, and so enable 
growth cones to respond to sema3A in different ways.
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Guanine is a purine, which consists of pyrimidine ring fused to a imidazole ring, and 
while dihydropyrimidinases catalyse the breakdown of pyrimidine rings. However it 
is still possible that the homology CRMP-2 shows with these enzymes, would still 
enable it to breakdown purines, possibly by catalysing the pyrimidine ring.
6.1.3 CRMP-2 interacts with RhoA and Racl
One possible mechanism, by which CRMP-2 could alter Rho GTPases-induced 
morphologies, would be to bind to the GTPases altering their effector binding or 
upstream signalling. Binding assays were performed between CRMP-2 and the Rho 
GTPases, and preliminary results using dotblot assays showed that recombinant 
CRMP-2 bound directly to RhoA and Racl (Figure 4.1). Due to problems obtaining 
purified recombinant full length and fragments of CRMP-2 protein, it was not 
possible to repeat the dotblot assay with subsequent protein preparations. This 
suggests this interaction is variable, and is not of as high affinity as the interaction 
between the GTPases and their effectors, such as the Racl/PAK interaction. Dotblots 
have been used to show whether interacting proteins are effectors, i.e. bind selectively 
to active, GTP-bound GTPases, (Manser et al, 1992, Govind et al, 2001), however 
due to the variability of CRMP-2 protein preparations, these could not be performed. 
The reason behind this difference in protein samples is not clear. It is possible that the 
E.coli strain used to grow the recombinant protein exhibited some differences in 
processing the protein, such as phosphorylation or protein folding. CRMP-2 may 
undergo conformational changes during bacterial expression, which could influence 
binding, or may need some other modification to bind to the GTPases. Although 
CRMP-2 interactions were detected on dotblots, they could not detected on western 
blots, suggesting the conformation of CRMP-2 is important for interactions. All
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proteins expressed were subject to PAGE to ensure they were of the correct size and 
there was little breakdown, and so it is unlikely that degradation of protein affected 
the binding assay.
CRMP-2 is synthesised more effectively in mammalian cells, such as Cos-7 cells, and 
so immunoprécipitation studies with dominant negative and dominant positive 
GTPase constructs were performed to investigate their interaction in vivo. RaclV12, 
RhoAVM and Cdc42V12 could all be co-precipitated with CRMP-2 when co­
expressed in Cos? cells. The possibility that the interaction is indirect cannot be ruled 
out, but this result shows the proteins are capable of associating in vivo.
Dominant negative GTPase constructs were used in immunoprécipitation experiments 
to test if CRMP-2 was an effector of RhoA or RaclV12. This procedure has been 
used previously to show that Cdk5 is a Racl effector (Nikolic et al, 1998). While 
CRMP-2 could be co-precipitated with RacNl?, it could not with RhoAN19, 
suggesting that CRMP-2 is a RhoA effector. However, CRMP-2 bound to both 
RaclNl? and RaclV12, suggesting that Racl in a GTP-bound state was not required. 
However, dominant negative GTPases exert their effects by titrating out GEF activity, 
and so further studies would need to be performed to confirm these observations.
In an attempt to isolate the region in CRMP-2 responsible for GTPase binding, a 
number of protein fragments were made (Chapter 4), and used for 
immunoprécipitation studies in Cos? cells. As the 1-112 CRMP-2 fragment was the 
only one which did not associate with either Racl VI2 or RhoAVM in Cos cells, there 
may be a large interacting domain stretching from just after 112 to around 300, just
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after the start of the C-terminal fi*agment. This would need to be confirmed with C- 
terminal deletions. The 3D structure of CRMP-1 has shown that the N and C-terminal 
halves of the protein are very closely associated, and so regions from both fragments 
could be involved in the interaction with the GTPases.
It is possible that CRMP-2 1-112 did not interact with Racl or RhoA because of its 
localisation. CRMP-2 and Racl/RhoA may only interact when both are present at the 
membrane. Full-length CRMP-2 is membrane-associated (Mintum et al, 1995, 
Chapter 3), while active RhoA and Racl would both be transported to the membrane 
to exert their effects on the actin cytoskeleton (Hancock et al, 1989). However 
overexpression of dominant positive Racl or RhoA results in a diffuse localisation, so 
CRMP-2 1-112 would be in the same cellular compartments as Racl and RhoA, and 
so the GTPases would be available to interact with this CRMP-2 fragment.
6.1.4 CRMP-2 and ROK
RhoA is activated in response to lysophosphatidic acid (LPA), which signals through 
G-protein G13 (Gohla et al, 1998), to activate pllSRhoGEF (Hart et al, 1998; 
Kranenburg et al, 1999). Once active, RhoA is able to activate its downstream 
effector, ROK. One of the key substrates of ROK is the myosin binding subunit 
(MBS) of myosin phosphatase. Myosin phosphatase binds to myosin light chain 
(MLC) to dephosphorylate and inactivate it. Phosphorylation of MBS by ROK 
inactivates it, so it can no longer downregulate MLC and hence enables formation of 
actin stress fibres, and myosin contraction. ROK can also directly phosphorylate 
MLC, enabling it to regulate MLC activity through direct and indirect mechanisms 
(reviewed in Amano, 2000).
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One possible mechanism, by which CRMP-2 could inhibit RhoA-induced 
morphologies, would be to bind to and inhibit ROK, and there is evidence to link 
CRMP-2 to ROK. Firstly, CRMP-2 is a substrate of ROK, and mutation of the 
phosphorylation site, T555, can inhibit LPA-induced collapse in neurones (Arimura et 
al, 2000). This not only demonstrates that CRMP-2 could play a role in ROK 
signalling pathways, but also indicates a role of CRMP-2 in response to LPA. 
Secondly, CRMP-2 interacts with an N-terminal extended CRMP-1 isoform, which 
binds to the ROK kinase domain and blocks the kinase function (Leung et al, 2002). 
Therefore CRMP-2 could affect ROK function by direct association, or through 
association of other CRMP members.
The Rho kinase site in CRMP-2, threonine 555, was mutated to alanine to see if it 
played any role in the ability of CRMP-2 to affect Rho GTPase function. While 
wildtype CRMP-2 was able to inhibit the formation of Rac phenotypes when co­
expressed with RaclV12, CRMP-2T555A had no effect on the RaclV12 
morphologies (Chapter 3). Further experiments using kinase-inactive ROK confirmed 
that ROK was responsible for phosphorylating CRMP-2 at this site, and not another 
kinase phosphorylating the same site. Therefore CRMP-2, when expressed with 
RaclV12, needs to be phosphorylated by ROK, to be able to block the formation of 
Rac phenotypes. This result was unexpected, as it was thought that phosphorylation of 
CRMP-2 by ROK would occur downstream of RhoA, when RhoAVM and CRMP-2 
were co-expressed. However, CRMP-2T555A was still able to induce the formation 
of Rac phenotypes when co-expressed with RhoAVM, indicating that 
phosphorylation of CRMP-2 by ROK is not required for this function of CRMP-2. 
RhoA and its effector ROK are both involved in the formation of focal adhesions
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(Ridley and Hall, 1992; Leung et al, 1995), and it is possible that they will play an 
active role in the formation of the Rac phenotypes, allowing the peripheral membrane 
to adhere to the substrate and maintain the cell morphology. Therefore, cells 
expressing Racl VI2 may still contain active ROK available to phosphorylate CRMP- 
2, which appears to be required to down regulate Racl signalling (Chapter 3). Due to 
the antagonistic relationship of Racl and RhoA, this could lead in more RhoA/ROK 
signalling, potentially causing a positive feed back loop resulting in more CRMP-2 
phosphorylation by ROK, and hence a greater downregulation of Racl. The 
consequence of CRMP-2 phosphorylation at T555 is unknown, but this could alter its 
conformation or interactions with other CRMP family members. CRMP proteins form 
heterotetramers, similar to dihydropyrimidinases (Wang and Strittmatter, 1997), 
which may be functionally important. Therefore regulation of tetramer formation 
could alter CRMP-2 function.
6.1.5 C-terminal of CRMP-2
The C-terminal of CRMP-2 appears to be important to CRMP-2 function in the 
formation of axons. Overexpression of CRMP-2 in hippocampal neurones promotes 
the formation of multiple axons, which become long and thin (Inagaki et al, 2001). 
However truncation of the C-terminal 24 amino acid residues resulted in the 
formation of a single axon, while the truncation of the C-terminal 191 amino acid 
residues resulted in either a single axon or no axons at all (Inagaki et al, 2001). 
Furthermore, CRMP-2 is localised to neurofibrillary tangles in Alzheimer’s disease 
(Yoshida et al, 1998), and three C-terminal phosphorylation sites, threonine 509, 
serine 518 and serine 522, were all hyper-phosphorylated in neurofibrillary tangles 
(Gu et al, 2000). These findings suggest that the C-terminal is important in the
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regulation of CRMP-2 activity in neuronal morphology.
6.1.6 CRMP-2 and microtubule dynamics
CRMP-2 has been shown to bind to tubulin heterodimers (Fukata et al, 2002) and 
promote tubulin assembly, while deletion of the CRMP-2 tubulin-binding region can 
block axonal growth and branching (Fukata et al, 2002). CRMP-1,2 and 4 all exist as 
two splice forms, a 64kDa isoform and an 80kDa variant isoform (Leung et al, 2002; 
Quinn et al, 2003). The 62kDa CRMP-2 promotes organised microtubules, while the 
N-terminal extended variant CRMP-2b causes disorganisation of microtubules 
(Yuasa-Kawada et al, 2003). Taken together these studies show that CRMP-2 plays an 
important role in the regulation of microtubules in the cell. Staining of drg neurones 
showed that CRMP-2 and tubulin colocalise in drg neurones (Chapter 5). Whether 
this plays any role in the ability of CRMP-2 to regulate Rho GTPases function is not 
clear, although microtubule dynamics affect Rho GTPase activity (see section 6.1.6).
CRMP-2 overexpression can induce neurite formation when expressed in NlE-115 
cells cultured in 5% serum (Fukata et al, 2002). Although the ability to induce 
neurites was dependent on the presence of the tubulin-binding region, this region 
alone was not sufficient to promote neurite formation, indicating that other regions of 
CRMP-2 are needed along with the tubulin binding region to form neurites (Fukata et 
al, 2002). This latter observation contradicts observations in this study, where alone 
CRMP-2 had little effect on morphology, and those of Gu et al, 2000, where CRMP-2 
over expression in Neuro2a cells caused membrane blebbing. This difference could be 
due to the conditions in which the NlE-115 cells were cultured. In this study cells 
were cultured in 10% serum, while the experiments showing CRMP-2 induces
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neurites (Fukata et al, 2002) were carried out in 5% serum. NlE-115 cells undergo 
differentiation when deprived of serum (Reagan et al, 1990), and so the serum content 
of the media has a major effect on the morphology of the cells. In addition, results in 
this study have shown cell morphology is influenced by the substrate, which also 
contributes to neurite outgrowth (Samer et al, 2000). The apparent differences in the 
ability of CRMP-2 to promote neurite outgrowth may be substrate dependent.
6.1.7 Microtubules and the actin cytoskeleton
There is considerable interplay between the actin cytoskeleton and the microtubule 
cytoskeleton, and CRMP-2 could regulate microtubule dynamics, leading to 
regulation of the Rho GTPases. Racl binds directly to tubulin (Best et al, 1996), while 
the downstream effector of both Racl and Cdc42, PAK, phosphorylates the 
microtubule destabilising protein, stathmin at serine 16, down regulating its effects on 
microtubules (Daub et al, 2001). Microtubules appear to be required for cell migration 
(Ballestren et al, 2000), and a number of GEF’s have been found to associate with 
them, such as the Racl/RhoA GEF, GEF-Hl (Ren et al, 1998) and its mouse 
homologue, Lfc (Glaven et al, 1999). There is a direct interaction between 
microtubules and actin, as well as cross-linking proteins such as MIP-90 and calponin. 
The growth of microtubules induces the activation of Racl, while microtubules also 
enable RhoG to activate Racl and Cdc42 (reviewed in Waterman-Storer, 1999). The 
shortening of microtubules induces myosin activation and an increase in contractility, 
raising the possibility that RhoAGEF, GEF HI, is released and activated as 
microtubules depolymerise (Kolodney and Elson, 1995). Therefore, if CRMP-2 is 
able to regulate the assembly and disassembly of microtubules, it could have a 
profound affect on the RhoGTPases, and hence the actin cytoskeleton.
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6.1.8 The role of actin and ROK in sema3A-mediated growth cone
collapse
To examine the role on CRMP-2 in the semaSA pathway, neurite retraction assays 
were performed in NlE-115 cells permanently expressing a2-chimaerin. The parental 
NlE-115 cells have been shown to respond to sema3A (Van Horck et al, 2002), and 
permanent expression of a2-chimaerin induces longer neurites (Hall et al, 2001). 
Observations from fluorescent imaging of GTP-actin in growth cones suggest that 
sema3A induced growth cone collapse involves actin dissolution (Chapter 5, Figure 
5.1), rather than contraction of actin filaments, which is in agreement with previous 
findings (Fan et al, 1993). It has been suggested that semaSA and semaSF collapse in 
drg neurones is independent of ROK (Arimura et al, 2000; Sahay et al, 2003). 
Arimura et al, (2000), indicated that sema3A collapse is independent of ROK-induced 
contraction, and this is in agreement with data from this study showing that sema3A 
induced growth cone collapse is not affected by the ROK inhibitor Y-27632 (Chapter 
5, Results 3), although elsewhere the involvement of ROK in sema3A-mediated 
growth cone collapse has also been inferred (Dontchev et al, 2002). The lack of 
involvement of ROK in sema3A-mediated growth cone collapse is interesting, as 
several neuronal guidance cues involved in neurite retraction and inhibition of neurite 
growth involve RhoA and ROK. Several substrates such as Nogo, Myelin Associated 
Protein (MAG) and Chondroitin Sulphate Proteoglycans (CSPG), which are inhibitory 
to neuronal regeneration, have all been shown to activate RhoA, leading to inhibition 
of neuronal growth (Niederost et al, 2002; Fournier et al, 2003; Monnier et al, 2003). 
In addition, ephrins have been shown to activate RhoA (Wahl et al, 2000) and RhoA 
is also activated downstream of plexinB, (Driessens et al, 2001).
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While the time-lapse analysis of sema3A-induced collapse demonstrated that ROK 
does not play a role in the collapse pathway (Chapter 5, Results 3, Figure 5.1), some 
involvement of RhoA cannot be ruled out, since RhoA activates effectors other than 
ROK, e.g. mDia, citron, and CRMP-2 may itself prove to function as a RhoA effector, 
as suggested by results in Chapter 4, Results 2. The RhoA effector. Citron contains no 
kinase domain (Maduale et al, 1995), although it appears to play a role in the 
regulation of RhoA and ROK in controlling actin assembly around cell organelles 
such as the Golgi (Camera et al, 2003). An alternative splice variant, Citron-kinase, 
which does contain a kinase domain, inhibits neurite outgrowth in NlE-115 cells (Di 
Cunto et al, 2003), and phosphorylates the regulatory light chain of myosin II 
(Yamashiro et al, 2003). Unlike ROK, it does not phosphorylate the myosin binding 
subunit of myosin phosphotase, and is thought to play a role in cytokinesis 
(Yamashiro et al, 2003). Therefore, RhoA could still be active in the collapse 
pathway, but signalling through an effector other than ROK. To demonstrate any 
involvement of RhoA, collapse assays would need to be repeated using the dominant 
negative RhoA, RhoAN19, or C3 toxin, which is a potent inhibitor of RhoA (Aktories 
etal, 1989).
6.1.9 The role of p35/Cdk5 in sema3A-mediated growth cone 
collapse
CRMP-2 is a substrate of p35/Cdk5, (PhD Thesis, T.Jacobs), and so considering the 
role CRMP-2 in sema3A collapse, any potential involvement of Cdk5 in sema3A 
collapse was examined using kinase inhibitors. P35/Cdk5 had been suggested to play 
a role in growth cone collapse (Nakayama et al, 1999) and recent results showed an
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involvement in EphA2 guidance signalling (Cheng et al, 2003) and semaSA signalling 
(Sasaki et al, 2002). Treatment of the cells with the Cdk5 inhibitor, roscovitine (De 
Azevedo et al, 1997), completely blocked semaSA retraction in both the a2.13 cells 
and in rat drg neurones, showing that Cdk5 is an important component of the semaSA 
collapse pathway. During the course of this project, it was shown that drg neurones 
obtained from Cdk5 knockout mice did not respond appropriately to semaSA, and 
treatment with roscovitine blocked semaSA collapse (Sasaki et al, 2002).
The pS5/Cdk5 phosphorylation site in CRMP-2 was mapped to serine522 (PhD 
Thesis, T.Jacobs), and this site was mutated to allow the effect of this site to be 
studied. While wildtype CRMP-2 did not affect neurite retraction in the a2.1S cells, 
or growth cone collapse in drg neurones, expression of CRMP-2S522A was able to 
block both semaSA-induced collapse in both cell types. The inhibition of collapse by 
roscovitine implicates Cdk5 phosphorylation of CRMP-2 in the semaSA-mediated 
collapse pathway, although phosphorylation of CRMP-2 by Cdk5 following semaSA 
treatment has not been shown directly. In the absence of direct evidence for the 
phosphorylation of CRMP-2 by Cdk5, it is possible that this site in CRMP-2 is 
phosphorylated by another kinase. However the phosphorylation of CRMP-2 by 
Cdk5, downstream of semaSA would fit with CRMP-2 playing a role in microtubule 
dynamics (Fukata et al, 2002). Staining of drg neurones for CRMP-2 showed that it is 
present throughout the length of neurites of drg neurones (Chapter 5), and not only in 
the growth cone. CRMP-2 has been shown to bind to and regulate tubulin assembly 
(Fukata et al, 2002), and co-localises with tubulin in cell staining (Chapter 5, Results 
2, Figure 5.6). Consequently, Cdk5 phosphorylation of CRMP-2 may regulate CRMP- 
2 function in microtubule assembly. An effect on microtubules could cause neurite
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retraction. P35/Cdk5, and its phosphorylation of tau, play an important role in 
microtubule dynamics (Baumann et al, 1993), although the consequence of CRMP-2 
phosphorylation, and its downstream signalling cascade is unknown.
The involvement of Cdk5 in the sema3A pathway may be associated with 
phosphorylation and inactivation of PAK (Nikolic et al, 1998). This would reduce 
Racl and Cdc42 signalling to the actin cytoskeleton, which could affect the 
maintenance of the actin structures in the growth cone. However, there is so far no 
evidence that inhibition of PAK can cause growth cone collapse, although PAK has 
been shown to play an important role in guidance (Ang et al, 2003).
LIM kinase is transiently phosphorylated in the sema3A collapse pathway, and then 
phosphorylates the actin severing protein cofilin (Aizawa et al, 2001). Inhibiting 
either of these phosphorylation sites suppresses sema3A collapse (Aizawa et al,
2001). LIM kinase can be phosphorylated by either ROK or PAK, at the same site 
(Edwards et al, 1999; Maekawa et al, 1999; Ohashi et al, 2000). LIM kinase could be 
phosphorylated by PAK, downstream of sema3 A, because ROK does not appear to be 
involved in sema3A-induced neurite retraction (Chapter 5, Arimura et al, 2000). 
However kinases related to ROK, such as MRCK, may show similar substrate 
specificity (Leung et al, 1998).
Although PAK, along with Dock, are required for photoreceptor guidance in 
Drosophila (Hing et al, 1999), there is presently no evidence to suggest the 
involvement of PAK in the sema3A collapse pathway and this would be interesting to 
focus on during future research.
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If growth cone collapse and neurite retraction were regulated by microtubule 
dynamics, this may explain the lack of involvement of ROK, which has a major role 
in actin dynamics. However actin changes are important in semaSA growth cone 
collapse (Fan et al, 1993), possibly through the involvement of LIM kinase and cofilin 
(Aizawa et al, 2001). The breakdown of microtubules may lead to the release of the 
tubulin-associated RhoA GEF, GEF HI (Kolodney and Elson, 1995), and so may 
activate RhoA. This raises the possibility that semaSA results in breakdown of 
microtubules, resulting in RhoA activation. Although this collapse pathway appears to 
be independent of ROK, it is possible that RhoA could cause neurite retraction though 
another effector. The involvement of CRMP-2 and p5S/Cdk5, which have been shown 
to influence microtubule dynamics, in the semaSA signalling pathway strongly 
suggests some role in microtubule regulation during this collapse pathway.
6.1.10 Signalling pathways upstream of CRMP-2 in semaSA- 
mediated growth cone collapse
Information on the upstream components of semaSA signalling has come from work 
showing Cdk5 associates with plexinA2 via the tyrosine kinase Fyn (Sasaki et al,
2002), which phosphorylates tyrl5 in Cdk5 activating it. Cdk5 and Fyn are crucial to 
semaSA growth cone collapse. Fyn itself phosphorylates plexinA2, although its 
activity does not affect the interaction with plexinA2. Therefore, it would appear 
activation of Fyn results in phosphorylation of both plexinA2 and Cdk5, possibly 
resulting in a Cdk5/plexinA2/Fyn complex. How this signals through to CRMP-2 is 
unclear. There may be recruitment of CRMP-2 to the complex, leading to its 
phosphorylation, as CRMP-2 is membrane associated (Mintum et al, 1995; Chapter 
S,4). Recently, CRMP-2 has been shown to be capable of associating with plexinA,
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when overexpressed in Cos-7 cells (Deo et al, 2004).
Another protein thought to play a role in CRMP function, is CRMP-3 Associated 
Molecule (CRAM)(or CRMP-5), which contains 563 amino acid residues and shows 
50% homology with the other CRMP family proteins (Inatome et al, 2000). Although 
the function of CRAM is unknown, its expression is upregulated during PC 12 
differentiation. Associated with both CRAM and CRMP-3 is the tyrosine kinase Fes 
(Mitsui et al, 2002). This tyrosine kinase associates with and phosphorylates 
plexinA 1. Kinase-inactive Fes suppresses sema3A-mediated collapse, suggesting that 
Fes, CRAM and CRMP-3 all play a role in the sema3A pathway (Mitsui et al, 2002). 
Although it is unknown whether CRMP-2 is involved in this complex, the CRMP 
proteins form tetrahetramers (Wang and Strittmatter, 1997), so CRMP-2 could 
associate with CRMP-3. Sema3A can interact with NP-1 and either plexinAl or 
plexinA2. Both plexinAl and plexinA2 can transduce sema3 signalling equally well, 
(Takahashi et al, 2001), so it is possible two distinct signalling pathway exists, with 
plexinAl signalling through Fes, CRAM and CRMP-3, while plexinA2 signals 
through Fyn, Cdk5 and CRMP-2. There may be some redundancy in signalling, or 
these two pathways may converge downstream, perhaps at the level of the CRMP 
family of proteins.
6.1.11 PMA-induced growth cone collapse
Drg neurones have been shown to collapse in response to the phorbol ester, PMA 
(Fournier et al, 2000), which is a powerful activator of PKC (Orr et al, 1992). In this 
study, PKC kinase inhibitor did not block PMA-induced growth collapse. PMA is also 
a strong activator of a2-chimaerin (Ahmed et al, 1993), and GAP inactive a2-
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chimaerin mutants reduce the percentage of collapsed growth cones by 50% (Chapter 
5). These data suggest that growth cone collapse in response to PMA is due to 
activation of a2-chimaerin GAP activity. This implies that activation of a2-chimaerin 
is sufficient to cause growth cone collapse. In the semaSA pathway, a2-chimaerin 
appears to be required for growth cone collapse (Chpater 5, Results 3), although the 
signalling mechanisms that activate a2-chimaerin in response to semaSA are 
unknown. There is no evidence to date to show there is involvement of any 
phospholipids in semaSA pathway, which could activate a2-chimaerin in vivo. The 
production of diaclyglycerol (DAG) could potentially activate a2-chimaerin in this 
pathway, but whether DAG plays a role in collapse pathways has not been 
determined. DAG can be produced by PLC, activated by heterotrimeric G proteins or 
by PLCy activated by tyrosine kinase (Reviewed in Liu et al, 2004), although PLC 
inhibition causes growth cone collapse, and it would be difficult to determine the role 
of PLC in growth cone guidance (Ming et al, 1999).
Under some conditions, PMA has been shown to cause phosphorylation of a-adducin 
by ROK (Fukata et al, 1999). a-adducin is involved in the association of spectrin and 
F-actin under ruffling membranes, and accumulates around the membranes of PMA 
stimulated Madin-Darby canine kidney (MDCK) cells. Knockout of this 
phosphorylation site or inhibition of either RhoA or ROK, prevents PMA induced 
ruffling or cell migration in these cells (Fukata et al, 1999). These observations may 
be cell specific, however this could suggest a role for ROK in the formation of 
membrane ruffles and in cell migration, processes that are involved in the guidance of 
neuronal growth cones. ROK does not appear to play a role in semaSA-mediated 
collapse, and results seemed to suggest that inhibition of ROK enhanced the effect of
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semaSA (Chapter 5). This could be due to a requirement for ROK to maintain 
membrane ruffles, and inhibition of ROK could make the growth cones less stable, 
and so more susceptible to collapse.
Results show PMA treatment caused a high degree of growth cone collapse (Chapter 
5, Results 3), which appears to be independent of PKC, while requiring, at least in 
part, the GAP activity of a2-chimaerin. However, ROK may play a role in the 
collapse of these growth cones if, in response to a strong activator such as phorbol 
ester, it is able to phosphorylate substrates other than a-adducin, like MBS, resulting 
in contraction rather than maintenance of the growth cone. In order to test this idea, 
the PMA collapse experiments would need to be repeated with the ROK inhibitor.
The effects of PMA on growth cones collapse in the presence of PKC inhibitor, and 
its inhibition by GAP inactive a2-chimaerin, suggest that activation of a2-chimaerin 
GAP activity can cause growth cone collapse. It is therefore possible that 
downregulation of Racl signalling is sufficient to collapse neuronal growth cones. 
Inhibition of Racl signalling may prevent the maintenance of the actin structures 
required to form the growth cone. However, activation of a2-chimaerin also enables 
its interaction with target proteins (PhD thesis, T. Jacobs), and these could be 
responsible for generating collapse
In response to sema4D, plexinB 1 has been shown to bind to RaclGTP, and prevent it 
from recruiting PAK (Vikis et al, 2002), and the binding of RaclGTP to plexinB 1 
results in RhoA activation (Driessens et al, 2001). Thus, the prevention of signalling 
from RaclGTP to PAK can, under some circumstances, ultimately result in growth
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cone collapse. There are, however, some important differences between the 
sema4D/plexinB signalling pathway and the semaSA/plexinAl-signalling pathway. 
Firstly, unlike plexinB/sema4D, no RhoA GEF has been identified in semaSA- 
mediated guidance, and so there is no clear way of activating RhoA in response to 
plexinA. Although the semaSA collapse was found to be ROK-independent (Chapter 
5, Results S), the involvement of RhoA itself has not been studied. CRMP-2 and Racl 
leads to RhoA activity (Chapter S, Results 1), and so may provide a mechanism of 
RhoA activation downstream of the plexins.
Secondly, Racl does not bind to plexin-A1 (Driessens et al, 2001; Vikis et al, 2002), 
and so alone this receptor has no direct way of regulating Racl activity. This raises 
the interesting possibility of CRMP-2 binding to and regulating, or being regulated 
by, Racl or RhoA, providing a link between plexinAl and the GTPases. CRMP-2 
appears to bind to Racl in either the active or inactive state, while only binding to 
active RhoA (Chapter 4), suggesting CRMP-2 could have more influence on positive 
RhoA signalling than positive Racl signalling. By analogy with the sema4D pathway, 
where plexinB binds to a RhoGEF and signals through RhoA, plexinA could be 
predicted to bind to a RacGEF and signal through active Racl.
Although Racl does not bind to plexinAl, other GTPases do bind. Both Rndl and 
RhoD bind plexinAl, and compete for the same binding site. The binding of Rndl 
results in activation of plexinAl signalling, while binding of RhoD prevents binding 
Rndl and so prevents plexinAl signalling (Zanata et al, 2002). RhoD appears to act 
antagonistically to RhoA, and promotes the disassembly of stress fibres and focal 
adhesions (Tsubakimoto et al, 1999), as well as possibly playing a role in the
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regulation of endosomes (Gasman et al, 2003). The Rnd proteins are unusual 
GTPases, as they have a very low intrinsic GTPase activity, and so are GTP bound. 
Rndl binds to and activates pl90RhoGAP (Wennerberg et al, 2003), as well as 
playing a role in the development and regulation of dendritic spines (Ishikawa et al,
2003).
Sema3A collapse requires active Racl, and expression of the dominant negative Racl, 
RaclNl? can block collapse (Jin and Strittmatter, 1997). Racl is usually involved in 
outgrowth and the production of peripheral actin structures (Ridley et al, 1992; 
Kozma et al, 1997). In response to the repulsive guidance receptor, EphA2, there is a 
transient downregulation of Racl activity followed by up regulation (Jumey et al,
2002). In response to both EphA2 and sema3A, Racl activity is required for actin 
reorganisation and endocytosis of the membrane (Jumey et al, 2002), which are 
important components of drg neurone growth cone collapse. This may explain the 
requirement for active Racl in the growth cone, and the down regulation of Racl may 
involve the GAP activity of a2-chimaerin.
6.1.12 a2-Chimaerin in sema3A-medited growth cone collapse
The RacGAP, a2-chimaerin, contains an SH2 domain and a regulating phorbol ester 
receptor. Cl domain, and is expressed in brain tissue and the testis (Hall et al, 1993). 
It is involved in neuritogenesis in N1E-II5 cells (Hall et al, 2001), and interacts with 
CRMP-2 in vitro (PhD Thesis, G. Ferrari) and in vivo (PhD Thesis, T.Jacobs). When 
activated, this powerful GAP causes collapse in Cos? cells and neurite retraction in 
NlE-115 neuroblastoma cells (PhD thesis, T. Jacobs). While a2-chimaerin slightly 
and significantly increased the collapse effect of sema3A (Chapter 5), two specific
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domain mutants, the GAP inactive and SH2 phosphotyrosine binding inactive 
mutants, both blocked the collapse. This strongly suggests a2-chimaerin is a crucial 
component of the semaSA collapse pathway.
It is unclear whether a2-chimaerin can be activated by phosphorylation, or through 
phosphotyrosine interaction with the SH2 domain. However, its involvement in the 
semaSA collapse pathway requires a functional phosphotyrosine/SH2 binding. 
Whatever the activation mechanism is in vivo, it is clear from the semaSA collapse 
assays, that a2-chimaerin is an important component of the semaSA-mediated 
collapse. SemaSA-mediated collapse requires both the GAP activity and also the 
ability of the SH2 domain to bind phosphotyrosine. CRMP-2 is an in vitro target of 
the a2-chimearin SH2 domain, although this is not phosphotyrosine dependant (PhD 
thesis, T. Jacobs), suggesting the SH2 domain interacts with another target in vivo.
From the time-lapse analysis of GFP-actin, it was observed that the collapse involved 
actin reorganisation and dissolution, but not the formation of dense contracting actin 
structures, which is in agreement with previous observations (Fan et al, 1993). An 
active GAP in the growth cone could downregulate Racl, preventing maintenance of 
the growth cone. That the SH2 mutant also blocked the collapse, even more efficiently 
than the GAP mutant, suggests that the SH2 domain of a2-chimaerin must interact 
with a phosphotyrosine target for a2-chimaerin to be able to exert its effects. Whether 
the interaction of the SH2 with its target is necessary for GAP activation or for correct 
localisation, is not clear, but the tyrosine kinases Fyn and Fes have both been shown 
to play a role in semaSA collapse, and both phosphorylate the cytoplasmic domains of 
plexin-As (Mitsui et al, 2002; Sasaki et al, 2003).
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There is some evidence to suggest that the a2-chimaerin SH2 domain may bind to its 
own GAP domain to maintain an auto-inhibited state (PhD Thesis, T. Jacobs). The 
cytoplasmic domains of plexins have some GAP homology but no GAP function, 
(Rohm et al, 2000) as well as being tyrosine phosphorylated, so a2-chimaerin SH2 
could bind to this region of plexins, and so localise a2-chimaerin to the area of 
collapse. CRMP-2 also binds to the a2-chimaerin SH2 domain when co-expressed in 
Cos? and NlE-115 cells (PhD Thesis, T.Jacobs), although it is not known whether 
this interaction occurs in neurones, or in response to semaSA. To test these ideas, 
further interaction must be performed to try and identify whether CRMP-2 and a2- 
chimaerin interact in response to semaSA stimulation, and if not, what the in vivo a2- 
chimaerin SH2 targets are in this pathway.
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6.2 Conclusion
These results have demonstrated that CRMP-2 is able to affect Rho GTPase function, 
and switch Racl and RhoA signalling. When co-expressed with RhoAVM, CRMP-2 
resulted in the formation of Rac-like phenotypes and outgrowth, morphologies more 
usually associated with Racl and Cdc42 activation. Both Racl and Cdc42 appeared to 
play a role in the phenotypes, although Racl was the main contributor. When co­
expressed with RaclVI2, CRMP-2 resulted in the activation of both Cdc42 and 
RhoA, resulting in collapsed phenotypes. This effect was dependant on CRMP-2 
phosphorylation at T55 5 by ROK. These functions may involve the direct association 
of CRMP-2 with either Racl or RhoA, although further experiments must be 
performed to confirm whether CRMP-2 is a RhoA effector.
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Figure 6.1. Model of CRMP-2 regulation of RhoA and Racl in response to guidance cues.
If the guidance cue is switched from attractive to negative, CRMP-2 is phophorylated down stream 
of negative guidance cues, such as LPA, to inhibit Rad and promote growth cone collapse or 
growth cone turning (a). When the guidance is switched from negative to positive, CRMP-2 does 
not inhibit R a d , but remains associated to the RhoA/ROK complex, to prevent further 
downstream signalling (b).
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Over expression of RaclV12 in the neuroblastomas could be bonjologous to the 
situation in a neuronal growth cone, where Racl and Cdc42 are active to enable the 
growth cone to advance. NIE-115 cells overexpressing Racl VI2 look similar to some 
neuronal growth cones. Therefore, the fact that CRMP-2 is phosphorylated at T555A 
when collapsing RaclV2 dependant morphologies, suggests that CRMP-2 could be 
phosphorylated at this site during growth cone collapse, downstream of RhoA and 
ROK. In the situation of stimulation with a negative signalling cue, the Racl and 
Cdc42 activity must be reduce to allow collapse. In NlE-115 cells, the collapse of 
Racl active cells by CRMP-2 is dependant on ROK activity, and it’s ability to 
phosphorylate CRMP-2. Therefore, CRMP-2 may be phosphorylated by ROK 
downstream of inhibitory signalling, such as LPA, to downregulate Racl, and so 
induce collapse.
NlE-115 cells over-expressing RhoAV14 would be more analogous to a neurone 
which has not began to differentiate, and so under these conditions, it appears CRMP- 
2 may play a role to promote differentiation, although phosphorylation at T555A does 
not appear to be required. Alternatively, a growth cone, which is switching from a 
negative growth environment to a positive environment, would need to downregulate 
RhoA, while increasing Racl activity. CRMP-2 could potentially mediate this effect, 
by blocking RhoA signalling, although it is in this situation that CRMP-2 does not 
appear to be phosphorylated at T555 by ROK.
Furthermore, phosphorylation of CRMP-2 at serine 522 is crucial to semaSA-induced 
collapse. Cdk5 phosphorylates this site, and Cdk5 is essential to semaSA-induced 
collapse. It is possible that Cdk5 phosphorylates this site in CRMP-2 in response to
225
Chapter 6 Discussion
sema3A, but this remains to be established. a2-chimaerin was found to be another 
crucial component of sema3A collapse, requiring both the SH2 and the GAP domains 
indicating that a phosphotyrosine interaction links it to the pathway and its regulation 
of Racl is essential. Although a2-chimaerin interacts with CRMP-2, it is not known 
whether this interaction occurs, or is required, during semaSA-induced growth cone 
collapse.
sema3A
I
J PlexinV NP-i
Racl
GTP
ii SH2 GAP
CRMP-: Racl
Cdk5
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Microtubule
regulation
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collapse
Figure 6.2. Model of CRMP-2 and a2-chimaerin downstream of sema3A.
CRMP-2 is phosphorylated by Cdk5 resulting in CRMP-2 interaction with a2-chimaerin SH2 
domain. a2-chimaerin becomes activated and transported to the membrane where it interacts 
with plexinA. The active GAP domain down regulates Rad causing growth cone collapse. 
Alternatively, activation of a2-chimaerin by tyrosine phosphorylation or DAG, in response to 
sema3A, enables it to bind plexinA and downregulate R a d , while promoting association with 
CdkS phosphorylated CRMP-2, potentially leading to regulation of microtubules
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